{"generated_at":"2026-09-05T23:47:51.335Z","count":805,"rows":[{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FID","verdict":"partial","confidence":0.85,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"The agreement contains an express fiduciary undertaking, which is unusual for a pharmacy benefit manager, and section 5.4(b) on page 7 adds duties of utmost good faith, loyalty, candor and skill. The duty is framed around good faith performance of the contract rather than loyalty owed solely to the plan and its members. There is no requirement to disclose every form of direct and indirect compensation as part of that duty and no disgorgement remedy for value retained in breach. The model contract published by Mark Cuban and collaborators ties the fiduciary standard to sole loyalty and to giving back retained amounts, so this falls short of that standard.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 22","evidence_quote":"PBM warrants and represents that, if at any time after the Effective Date of the Contract, PBM discovers or is made aware of an actual or perceived conflict of interest, appearance of impropriety or Prohibited Communication","rationale":"Article 16 requires immediate written disclosure of actual or perceived conflicts of interest and prohibited communications, and section 4.1(a) on page 4 bars the vendor from taking any fee not accepted in writing by ERS. Section 4.1(e) on page 4 also directs manufacturer program fees to ERS rather than letting the vendor keep them. What is absent is any schedule of affiliate ownership touching plan claims, any disclosure of payments to consultants or brokers, and any quarterly or annual certification by a named officer that all direct and indirect compensation has been disclosed. Disclosure is therefore event driven rather than a standing certified accounting of revenue.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.7,"page_ref":"Page 10","evidence_quote":"Without contravening applicable law, PBM agrees to notify ERS¶ Executive Director immediately upon being able to lawfully make a public announcement of reaching any form of binding agreement in connection with and prior to any merger, acquisition, business reorganization, or other material change of PBM","rationale":"The contract requires immediate notice of any merger, acquisition or other change of ownership, management or control, and section 4.1(i) on page 4 names Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. as the affiliated specialty pharmacies. The insurance certificates at pages 55 to 58 list dozens of related entities, including MATRIX GPO, LLC and ECONDISC CONTRACTING SOLUTIONS, LLC, but that is an insurance schedule rather than a signed ownership exhibit and it is not tied to any refresh duty. There is no exhibit that identifies owners, parents, rebate aggregators and purchasing entities as such, and no obligation to update an ownership list when affiliates change. The disclosure that exists is partial and incidental rather than a complete affiliate map.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DEF","verdict":"partial","confidence":0.85,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The rebate definition is deliberately broad and reaches price protection dollars, price concessions, discounts and any other remuneration, and section 4.1(e) on page 4 folds manufacturer program and management fees into the same treatment. The definition is still limited to amounts received under a contract with a pharmaceutical manufacturer and related to formulary drug utilization, so revenue routed through a group purchasing entity or a supplier arrangement is not captured by function. Specialty is defined by which affiliate dispenses rather than by the economics of the drug, and there are no closing definitions for affiliate, generic or manufacturer revenue. Value can therefore still be relabeled outside the manufacturer contract channel.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.7,"page_ref":"Page 5","evidence_quote":"pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed to HealthSelect Medicare Rx PDP or HealthSelect PDP Participants. Such Rebates shall be paid to ERS by PBM promptly, but in no event later than on a quarterly basis until all such compensation has been received by ERS.","rationale":"The base text commits the vendor to pay all rebates and all federal subsidies to ERS on at least a quarterly basis, with best efforts to negotiate commercially reasonable rebate agreements. The share actually passed through is qualified by the phrase as set forth herein and in Exhibit D, and section 4.1(h) elsewhere refers to the applicable rate described in the fee schedule, so the text does not itself establish one hundred percent pass through. The quarterly timing is stated without the thirty day settlement deadline and without a closed list of excludable claims. Because the operative rate lives in the fee schedule while the base text does state a pass through duty, this is a genuine but incomplete protection.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NAC","verdict":"unclear","confidence":0.6,"page_ref":"Page 4","evidence_quote":null,"rationale":"The contract never uses the concept of net acquisition cost and never limits what an affiliated mail, retail or specialty pharmacy may retain on a plan claim. All reimbursement and channel pricing is committed to Exhibit D, the PBM Fee Schedule, by section 4.1(a) and the related pricing provisions on this page, and Exhibit D appears in the assembled document only as a cover sheet at page 39. The affiliated dispensing entities are named on page 4, so the parties clearly contemplated affiliate claims, but the pricing method for them is not in the text supplied. No conclusion is possible without the fee schedule.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"There is no benchmark ceiling anywhere in the base agreement, the amendments, the supplement or the service addendum. The only pricing reference point in the text is the average wholesale price source, which section 4.1(d) on page 4 fixes as Medi-span, and that is a benchmark for discount math rather than a cap. Nothing requires plan claim cost to stay at or below a published transparent cash price in any channel, and nothing provides a claim by claim check. The contract does not point to an appendix for such a ceiling, so this protection is simply absent.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CASH","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No provision protects a member from paying more than the pharmacy cash price, and the words cash price, usual and customary, accumulator and out of pocket maximum do not appear in the contractual text. Article 9 on page 12 compensates a participant for vendor error and the service addendum handles Medicare monthly payment plan invoicing, but neither addresses cheaper cash purchases or deductible credit. Plan design and cost share levels are handled by reference to the plan documents and the fee schedule without any member price ceiling. Nothing in the base agreement or the secondary documents reaches this subject.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MAC","verdict":"partial","confidence":0.85,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"Section 4.1(d) does constrain maximum allowable cost list changes to the ordinary course of business and adds a test protecting retail pharmacy participation, which is more than many agreements provide. It does not require a single list applying to both what the plan pays and what pharmacies are paid, does not require disclosure of the list to ERS or to pharmacies, and sets no update schedule. There is no pharmacy appeals path with defined timelines anywhere in the documents. Governance of the list therefore remains substantially with the vendor.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"unclear","confidence":0.65,"page_ref":"Page 4","evidence_quote":null,"rationale":"Nothing in the base agreement states whether ERS pays exactly what the network pharmacy is paid plus a disclosed administrative fee, and the word spread never appears. Section 4.1(a) and section 4.1(d) on this page commit the reimbursement schedule, discount terms and administrative fees to Exhibit D, the PBM Fee Schedule, which is present only as the cover sheet at page 39. Whether the arrangement is pass through or a guaranteed discount arrangement that lets the vendor retain a difference is determined entirely inside that fee schedule and the associated contract attachments. Section 15.6 audit rights refer to verifying costs and discounts on claims, which implies the plan can test pricing, but the pricing method itself cannot be read from the text supplied.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GPO","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"No document addresses purchase discounts, volume credits or supplier payments received by a group purchasing organization or other related purchasing entity. The rebate definition on pages 5 and 6 is limited to amounts received under contracts with pharmaceutical manufacturers, which leaves purchasing entity revenue outside the pass through duty by construction. The insurance schedule at pages 55 to 58 shows related entities that operate in this space, including MATRIX GPO, LLC, yet no clause requires their revenue to flow to the plan or to be allocated on disclosed drivers. The text does not defer this subject to an appendix, so it is absent rather than unreadable.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"Formulary control is meaningfully with the plan sponsor because changes require prior approval by authorized ERS representatives, and section 4.1(c) on page 4 separately requires written ERS approval of any material modification of plan design including the formulary. The clause openly acknowledges that manufacturer rebate arrangements are one driver of formulary changes without requiring that the plan be shown the economics behind a proposed change. There is no obligation to deliver a lowest net cost analysis with each change and no requirement to report utilization management outcomes by drug each quarter. Approval rights are strong, the supporting analytics the model contract expects are not present.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No provision imposes a lowest net cost standard on formulary decisions for this plan. There is no annual comparison of this plan against the vendor book of business and no requirement to disclose and justify a drug placed above a cheaper therapeutic equivalent. Section 4.1(h) on page 5 allows a formulary management program with cost containment initiatives subject to ERS review, which is a process right rather than a substantive net cost standard. Nothing in the amendments, the supplement or the service addendum supplies this standard.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NET","verdict":"partial","confidence":0.65,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"Two provisions give the plan some network leverage, this cooperation duty on alternate retail networks and the test in section 4.1(d) on page 4 that maximum allowable cost changes must not discourage retail pharmacy participation. The protections the model contract centres on are absent. There is no statement that claims are final when adjudicated and no bar on retroactive clawbacks or recoupment, no bar on conditioning reimbursement on volume, no anti steering restriction even though affiliated mail and specialty pharmacies are built into the design, and no any willing pharmacy right since network participation depends on vendor credentialing and a vendor contract. Members can be directed toward affiliated pharmacies without a contractual check.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"PBM warrants and represents that if, during the term of this Contract, PBM enters into any agreement with any other governmental customer or any commercial customer not affiliated with PBM, of a similar size or smaller (the Comparative Agreement), by which PBM agrees to perform, deliver or provide equivalent Services, coverages, benefits, supplies or products that PBM is providing in accordance with this Contract for more generous pricing terms","rationale":"Section 31.6 is a real most favoured pricing clause covering administrative fees, discounts, rebates and financial incentives, and it lets ERS elect to have the contract amended to give equivalent advantage. Its limits matter. The comparison is measured in the aggregate rather than line by line, it only reaches customers of similar size or smaller, and the vendor is the party that determines whether a comparative agreement exists and then notifies ERS. There is also no annual market check by an independent party with a meet, credit or release remedy, so the plan depends on vendor self reporting.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AUD","verdict":"good","confidence":0.8,"page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"Article 15 gives ERS an absolute audit right that expressly extends to the vendor arrangements and contracts with pharmaceutical manufacturers, uses auditors chosen by ERS, preserves State Auditor access under Texas Insurance Code section 1551.067, and states in section 15.13 that nothing in the vendor proposal limits these rights. Section 5.7 on page 9 gives ERS direct access to individual claim and group specific data on its own premises, and ad hoc reports must be produced at no additional charge. Section 15.9 on page 18 shifts audit costs to the vendor when errors exceed fifty thousand dollars, which makes the right practical rather than theoretical. Two limits keep this short of perfect, third party auditors must sign a non disclosure agreement with the vendor and rebate agreement audits are restricted to approved firms and to the portions the auditor deems necessary, and there is no pre adjudication claims access. Taken as a whole the audit and data access package is as strong as the model contract asks for.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 26","evidence_quote":"Upon termination or expiration of the Contract, or upon request by ERS or its designee, PBM shall promptly, in good faith, and with the standard of care required under the Contract, assign, transfer and/or deliver the ERS-related records and data in its possession to ERS","rationale":"Section 21.2 requires prompt return or transfer of plan records and data at no cost, section 21.3 requires a readable format that needs no specialized software, and section 13.6 on page 14 states that the designated confidential information is the exclusive property of ERS and the group benefits program. Article 17 on page 23 also bars use of participant data for solicitation or marketing. Against that, Article 14 on pages 15 and 16 reserves the vendor systems, methodologies and standard report formats to the vendor, the business associate agreement at page 45 lets the vendor de-identify protected health information and keep it indefinitely, and the service addendum permits use of participant data for outcomes and opportunity analyses and for other programs. Ownership of the underlying records is clear but the vendor retains meaningful reuse rights over derived data.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PERF","verdict":"unclear","confidence":0.6,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Performance guarantees are established by reference. Section 5.5 of the base agreement on page 7 points to Exhibit E, which appears in the assembled base document only as a cover sheet at page 40, and Amendment 2 replaces that exhibit effective January 1 2024 with First Amended and Restated Performance Guarantees. The page carrying those restated guarantees is fully redacted, so the measurement basis, frequency, cash reconciliation and whether shortfalls are paid dollar for dollar or capped cannot be read. Amendment 2 page 3 is the cover sheet for the same exhibit.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract, whichever ERS determines is appropriate.","rationale":"Article 9 gives ERS liquidated damages without having to prove actual damages, allows the amount to be deducted from money otherwise owed, and section 33.10 on page 32 lets ERS assess them immediately without notice for implementation failures. Termination for cause is immediate in the sole opinion of ERS, which is stronger than a two strikes exit. The weaknesses are that the remedy is discretionary and generally requires a notice of default and a cure period of at least five days, the amount is a ceiling rather than a set schedule, and the automatic credit mechanics for missed guarantees sit in the redacted performance guarantee exhibit. Enforcement is therefore real but not self executing.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 2","evidence_quote":"Amendments. The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"Section 2.6 permits change only by a written agreement executed by authorized representatives of both parties, and section 2.7 makes the article survive termination, renewal or amendment. Fee changes are subject to the same requirement, so economic terms cannot be moved by notice, portal update or a replacement exhibit issued unilaterally. The two amendments and the supplement in this record were in fact signed by both parties, which shows the mechanism operating as written. The service addendum accepts an email approval as an ERS signature, which is a form question rather than a loss of consent.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"TERM","verdict":"good","confidence":0.9,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"Section 2.4 gives ERS termination without cause on ninety days notice, immediate termination for cause, mutual termination, and a funding out if the board does not approve funds, with no termination fee anywhere in the document. Section 4.3 on page 6 requires a pro rata refund of prepaid fees within two business days of termination, and rebate and subsidy amounts continue to be paid until ERS has received all such compensation. Article 21 requires transition cooperation and delivery of records at no cost. Regulatory integrity events are covered because failures of the eligibility and conduct warranties in Article 31 allow immediate termination.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"unclear","confidence":0.6,"page_ref":"Page 4","evidence_quote":null,"rationale":"Specialty is treated as a channel rather than defined by function. Section 4.1(i) on this page defines the affiliated specialty pharmacies by naming Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. and any affiliate pharmacy that primarily dispenses specialty products, without defining specialty products themselves. Every drug level rate, channel ceiling and any acquisition cost treatment for affiliate specialty claims sits in Exhibit D, the PBM Fee Schedule, which is present only as the cover sheet at page 39. The specialty pricing controls cannot be assessed from the text supplied.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GAG","verdict":"good","confidence":0.8,"page_ref":"Page 15","evidence_quote":"PBM should assume that all reports created by it for ERS may be publicly available records, in accordance with Texas law, and may be subject to the PIA","rationale":"Article 13 runs in the plan direction rather than the vendor direction. Section 13.1 on page 13 confirms that ERS is subject to the Texas Public Information Act and must make contract information available to the public, section 13.11 states that ERS has no duty to designate vendor information as confidential and proprietary, and ERS auditors, advisors and consultants may use and retain the materials the vendor produces. Supplement 1 goes further by requiring the vendor to compile the gag clause prohibition compliance attestation information ERS must submit to federal regulators each compliance period. The one friction is that third party advisors and auditors must sign a non disclosure agreement with the vendor before receiving some material, and the service addendum is stamped as confidential information, but nothing bars ERS from sharing pricing, rebate or performance data with its advisors, members, the public or lawmakers.","model_own_total":48.1,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"partial","confidence":0.97,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"The agreement expressly makes the PBM a fiduciary and separately requires loyalty, candor, skill, and good faith. It does not state that duties run solely to the plan and members, require disclosure of all direct and indirect compensation, or expressly provide disgorgement and participant enforcement.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.96,"page_ref":"Page 22","evidence_quote":"PBM warrants and represents that, if at any time after the Effective Date of the Contract, PBM discovers or is made aware of an actual or perceived conflict of interest, appearance of impropriety or Prohibited Communication that pre-existed the Contract¶s Effective Date or arose thereafter, PBM shall immediately disclose such interest, appearance or communication in writing to ERS.","rationale":"The PBM must immediately disclose actual or perceived conflicts and address mitigation with ERS. The clause does not require quarterly and annual officer certification of all compensation, affiliate ownership, broker payments, or prospective conflicts.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.94,"page_ref":"Page 10","evidence_quote":"PBM agrees to notify ERS¶ Executive Director immediately upon being able to lawfully make a public announcement of reaching any form of binding agreement in connection with and prior to any merger, acquisition, business reorganization, or other material change of PBM¶s management, ownership or business structure","rationale":"The agreement requires notice of material ownership and control changes, and its insurance schedule identifies many affiliates. It does not provide a signed current ownership exhibit covering pharmacies, GPOs, rebate aggregators, offshore entities, and administrators with a fixed thirty-day refresh duty.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"partial","confidence":0.96,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The rebate definition functionally captures several forms of manufacturer remuneration, including price protection and concessions. Its continuation limits the definition to manufacturer contracts tied to formulary drug utilization, and the agreement lacks equally complete functional definitions for manufacturer revenue, affiliates, generics, specialty, and pharmacy payments.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"partial","confidence":0.95,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed to HealthSelect Medicare Rx PDP or HealthSelect PDP Participants. Such Rebates shall be paid to ERS by PBM promptly, but in no event later than on a quarterly basis until all such compensation has been received by ERS.","rationale":"The PBM must remit all contract-defined rebates to ERS at least quarterly. The definition is narrower than all manufacturer revenue, does not clearly reach every affiliate or channel, and does not require remittance within thirty days after quarter end with invoice-level support and interest.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"unclear","confidence":0.97,"page_ref":"Page 4","evidence_quote":null,"rationale":"Page 4 places the compensation and reimbursement schedule in Exhibit D, while the incorporated Appendix A pricing attachments are not included in the available text. Those withheld pricing materials prevent a determination whether affiliate mail and specialty claims use acquisition cost plus a stated fee with no hidden margin.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the reimbursement, MAC, claim payment, fee, formulary, audit, and pricing provisions in the base agreement and all four secondary documents. None sets a lower-of benchmark and actual acquisition cost ceiling, provides cash-price protection, bans affiliate steering to evade a ceiling, or supplies an enforceable remedy for ceiling violations.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the claims, participant cost, reimbursement, pharmacy, and Medicare Prescription Payment Plan provisions in the base agreement and all secondary documents. None requires the participant to receive the lower of the negotiated amount or cash price, credit the full paid amount to deductible and out-of-pocket totals, or bar accumulator and maximizer programs.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.98,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"The clause affirmatively allows the PBM to modify MAC pricing under an ordinary-course standard. It does not require one disclosed list, fixed update timing, claim-level source support, rapid appeals, retroactive corrections, or access for ERS and pharmacies.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"unclear","confidence":0.96,"page_ref":"Page 4","evidence_quote":null,"rationale":"Page 4 states that compensation and reimbursement are governed by the Fee Schedule in Exhibit D, and the incorporated Appendix A pricing attachments are not in the available record. Without those financial terms, it is not possible to determine whether spread pricing and pharmacy payment retention are prohibited and reconciled.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the rebate provisions, PBM and agent definitions, affiliate insurance schedule, audit clauses, and all secondary documents, including references to procurement and group purchasing entities. No clause requires pass-through of GPO, purchasing, data, volume, credit, or other non-rebate payments, allocates shared payments, or provides ERS a make-whole right.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 5","evidence_quote":"As provided in the RFP, the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"ERS must approve formulary modifications before implementation, which provides meaningful sponsor control. The provision allows rebate arrangements to influence changes and does not require lowest-net-cost selection, approval of every tier and utilization-management change, conflict safeguards, or quarterly drug-level outcome reporting.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"I reviewed the formulary, rebate, fee, performance, audit, and reporting provisions in the base agreement and all secondary documents. None requires lowest-net-cost formulary selection, drug-level comparison of rebates and fees against lower-list-price alternatives, or an annual independent evaluation with a repayment remedy.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.91,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"ERS retains sole discretion to implement an alternate retail network and the PBM must cooperate in good faith. The agreement does not expressly ban affiliate steering and self-preference, require any willing pharmacy admission, prohibit clawbacks, or forbid volume guarantees to PBM-owned pharmacies.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"partial","confidence":0.97,"page_ref":"Page 29","evidence_quote":"for more generous pricing terms (lower administrative fees, lower compensation, more generous discounts, more generous rebates, and/or more generous financial incentives or terms), measured in the aggregate, then this Contract, at ERS¶ sole option, shall be amended to accord equivalent advantage to ERS.","rationale":"The agreement grants ERS an aggregate most-favored pricing adjustment when the PBM gives better terms to a comparable unaffiliated customer. The protection is limited by comparability and aggregate measurement, relies on PBM assessment, and lacks an annual independent market check and retroactive true-up mechanism.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.98,"page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"ERS receives broad audit rights over contract performance, ERS-related records, manufacturer arrangements, and affiliate pharmacy claims, with cost shifting after significant findings. Rebate audits are constrained by independence, insurance, nondisclosure, timing, and access limited to portions deemed necessary, and the agreement does not clearly provide live pre-adjudication claim access.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 45","evidence_quote":"de-identify PHI and maintain such de-identified health information indefinitely; provided that all identifiers are destroyed or returned in accordance with this Agreement.","rationale":"The agreement affirmatively permits the PBM to retain de-identified plan information indefinitely. Although ERS has ownership and access protections for plan records, indefinite reuse conflicts with the rubric requirement to prohibit retention and reuse except for narrow plan-serving purposes.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"unclear","confidence":0.99,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Amendment 2 replaces the performance guarantees with the First Amended and Restated Performance Guarantees, but page 4 containing those terms is fully redacted. That redaction prevents review of guarantee categories, denominators, exclusions, reporting, and amounts.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.97,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract, whichever ERS determines is appropriate.","rationale":"ERS may impose liquidated damages per default or per day and retains other remedies, creating a meaningful enforcement mechanism. The damages are discretionary rather than automatic routine credits, and the visible text lacks a two-strikes termination trigger tied to repeated performance-guarantee misses.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.99,"page_ref":"Service addendum, page 2","evidence_quote":"ESI shall provide ERS with a minimum of thirty (30) calendar days written notice prior to effecting any material modifications or changes to the pricing structure of the M3P program.","rationale":"The service addendum affirmatively permits material pricing-structure changes through thirty days written notice rather than prior signed sponsor consent. This direct pricing exception defeats an otherwise strong written-amendment and no-oral-modification framework.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"good","confidence":0.99,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice;","rationale":"ERS has an express convenience-termination right on ninety days written notice, independent of breach. The agreement also requires return of prepaid amounts and transition cooperation without imposing an exit penalty.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"unclear","confidence":0.97,"page_ref":"Page 4","evidence_quote":null,"rationale":"Page 4 defines the PBM specialty pharmacy and places compensation and reimbursement in Exhibit D, while the incorporated Appendix A pricing attachments are unavailable. The visible documents therefore do not establish whether specialty pricing uses transparent acquisition cost plus a fee or instead uses a benchmark subject to a cost ceiling and periodic invoice reconciliation.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"partial","confidence":0.96,"page_ref":"Page 13","evidence_quote":"PBM agrees that it is required by Texas law to make any information pursuant to this Contract, and not otherwise excepted from disclosure under the PIA, available in a format that is accessible by the public at no additional charge to ERS.","rationale":"The agreement recognizes Texas public-records duties and allows legally required disclosure, which preserves a meaningful transparency route. It also permits confidentiality designations and requires nondisclosure agreements for auditors, while pricing in the service addendum is redacted, so sponsor, advisor, auditor, and public disclosure rights are not fully unconditional.","model_own_total":36.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:29:16.140547+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit\nG, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"The scope of services exhibit has the plan sponsor agree in advance that Express Scripts is not a fiduciary of the plan and has no discretionary authority, and the parties recite that they dealt at arm's length. The only fiduciary duty Express Scripts accepts is for its handling of an appeal. Express Scripts also reserves the right to stop serving any plan located in a state that would require a pharmacy benefit manager to be a fiduciary. The model contract published by Mark Cuban and collaborators does the opposite and puts a duty of loyalty to the plan and its members at the center, so this is the clearest contradiction in the document.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 115","evidence_quote":"ESI and\nESI’s wholly-owned subsidiaries or affiliates derive revenue in one or more of the ways as further described in the\nFinancial Disclosure to ESI PBM Clients set forth in the Proposal (“Financial Disclosure”), as updated by ESI from time\nto time.","rationale":"Compensation beyond the administrative fees is disclosed only by pointing to a generic Financial Disclosure to ESI PBM Clients that sits inside the proposal, a document that is on file with the A&M System rather than in the produced contract, and that Express Scripts may update on its own. There are no dollar amounts, no plan specific accounting of retained revenue, and no officer certification that everything has been disclosed and remitted. The subject is addressed, but far more weakly than the model contract published by Mark Cuban and collaborators requires.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.6,"page_ref":"Page 6","evidence_quote":"ESI agrees to provide the A&M System reasonable\nadvance notice prior to the effective date of any merger, acquisition, business reorganization, or other change\nof ESI management or ownership.","rationale":"There is no ownership or affiliate disclosure exhibit anywhere in the document. What exists is a promise of advance notice before a merger, acquisition, reorganization or change of ownership, and the A&M System agrees to keep that notice confidential. A few affiliates are named in passing, including Accredo Health Group and Express Scripts Specialty Distribution Services as specialty pharmacies on page 110 and Medco Containment Life Insurance Company as the Medicare plan sponsor on page 116, but there is no list of owners, group purchasing organizations or rebate aggregators and no duty to refresh a list when ownership changes.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DEF","verdict":"partial","confidence":0.7,"page_ref":"Page 110","evidence_quote":"“Brand/Generic Algorithm” or “BGA” means ESI’s standard and proprietary brand/generic algorithm, a copy of which\nmay be made available for review by Sponsor or its Auditor upon request.","rationale":"The definitions that survive redaction generally hand the labelling power to Express Scripts rather than tying terms to economic function. Whether a drug counts as brand or generic is decided by Express Scripts' own proprietary algorithm, the maximum allowable cost list is whatever Express Scripts develops or selects, and the specialty drug list is maintained and updated by Express Scripts. The central definitions of rebates, manufacturer administrative fees and specialty product are blacked out in the definition list on page 111, so the pass through language cannot be tested against them.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PASS","verdict":"bad","confidence":0.85,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial\ninterest in such fees and revenues described in the Financial Disclosure and, accordingly, A&M System acknowledges\nthat neither it, any Member, nor the Plan, has a right to receive, or possesses any beneficial interest in, any such fees\nor revenues;","rationale":"Instead of promising the plan one hundred percent of manufacturer revenue, the contract states that Express Scripts and its affiliates keep the beneficial interest in those revenues and that the A&M System has no right to receive them beyond the specific amounts written into the pricing exhibit. The rebate obligation on page 114 reads only that Express Scripts will pay the amounts set forth on Exhibit C, which is a guaranteed amount arrangement rather than a full pass through. The dollar figures in Exhibit C-3 are redacted, but the structure that leaves the surplus with the vendor is visible in the unredacted text.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NAC","verdict":"unclear","confidence":0.7,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Pricing for the Express Scripts owned mail and specialty pharmacies lives in Exhibit C-2 and in Exhibit D, Specialty Drugs Under the Mail Order Pharmacy Program. Exhibit D is blacked out in full across pages 54 to 106 and the mail pharmacy rate pages in Exhibit C-2 are blacked out as well. The only readable trace is the heading for ESI Mail Pharmacy ingredient cost and dispensing fee guarantees on page 25, which shows the affiliate channel is priced against guarantees rather than at documented acquisition cost, but the terms themselves cannot be read.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"unclear","confidence":0.65,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"A ceiling that caps plan cost at a published benchmark would appear in the general pricing terms and claims reimbursement rates of Exhibit C. Those pages are blacked out except for headings. The surviving headings on page 24 describe average aggregate annual ingredient cost and dispensing fee guarantees, which suggests testing on an annual average rather than claim by claim, but the actual text cannot be read so no verdict is possible.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"CASH","verdict":"unclear","confidence":0.6,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"The usual and customary cash price is defined on page 112, which shows the concept is used in the pricing rules, but the pricing rules that would make the member pay the lesser of the cash price and the plan price sit in the blacked out general pricing terms of Exhibit C-1 and C-2. Nothing readable in the document addresses crediting a cash purchase toward the deductible or out of pocket maximum, or accumulator adjustments against manufacturer assistance. The redaction is the reason this cannot be decided.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.75,"page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules\ndeveloped or selected by ESI.","rationale":"The maximum allowable cost list is defined as whatever schedule Express Scripts develops or selects. Nothing in the readable text requires a single list to govern both what the plan pays and what pharmacies are paid, requires the list to be disclosed to the A&M System, sets an update schedule, or gives pharmacies an appeals route with deadlines. Vendor controlled pricing lists on both sides of the transaction are the classic route to spread pricing, which is what the model contract published by Mark Cuban and collaborators is written to block.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"a “bona fide dispute” means that, based on the results of an initial claims audit, there is a reasonably\nvalid basis for believing that ESI has billed the A&M System an amount other than the amount\nreimbursed to the pharmacy or has otherwise not passed through the pharmacy contracted rate.","rationale":"The agreement clearly contemplates that the A&M System is billed the rate paid to the retail pharmacy, and it gives the System a further audit right when a claims audit suggests Express Scripts billed something different. The audit protocol on page 127 backs this up but only for a sampling of claims and only if the System has a pass through arrangement for participating pharmacy claims. There is no across the board promise that the plan pays exactly what the pharmacy is paid in every channel, and the mail and specialty pricing that would show any retained margin is blacked out.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.7,"page_ref":"Page 115","evidence_quote":"In\nnegotiating any of the fees and revenues described in the Financial Disclosure or in this Contract, ESI and ESI’s wholly-\nowned subsidiaries and affiliates act on their own behalf, and not for the benefit of or as agents for A&M System,\nMembers or the Plan.","rationale":"There is no clause covering purchase discounts, volume credits or supplier payments collected by an affiliated purchasing entity, and no offshore group purchasing organization is named anywhere in the document. Worse than silence, the financial disclosure clause says Express Scripts and its affiliates negotiate that revenue on their own behalf and not for the plan, and keep it. That is the exact outcome the group purchasing pass through clause of the model contract published by Mark Cuban and collaborators exists to prevent.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 110","evidence_quote":"The drugs\nand supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but\nnot limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The formulary is built by the Express Scripts pharmacy and therapeutics committee, adopted by the sponsor, and then changed by Express Scripts over time for reasons that expressly include manufacturer rebate arrangements. Additions and deletions are treated as adopted by the sponsor automatically unless the A&M System affirmatively elects not to implement them through a set up form. The sponsor therefore has a veto but not the advance approval, lowest net cost analysis and quarterly utilization management reporting the model contract calls for.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the produced text sets a lowest net cost standard for formulary decisions or promises a comparison against the vendor's whole book of business. The formulary definition on page 110 and the formulary support clause on page 114 describe how the list is built and changed but say nothing about net cost to this plan, and no clause requires disclosure when a drug is placed above a cheaper equivalent. The phrase net cost does not appear anywhere in the document, and the only mention of book of business data on page 123 concerns Medicare reinsurance projections.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.8,"page_ref":"Page 112","evidence_quote":"Subject to Applicable Law, ESI will make Members aware of the ability to fill their\nprescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings, and provide\nsupporting services (e.g. pharmacist consultation) in connection with any prescription dispensed by the\nESI Mail Pharmacy.","rationale":"Express Scripts is expressly authorized to promote its own mail pharmacy to members, and it may move the plan between its networks and subnetworks as it chooses. Participating pharmacies are defined to exclude affiliated mail and specialty pharmacies, and Express Scripts disclaims any liability for them. There is no anti steering promise, no any willing pharmacy right, and no rule that a claim is final once adjudicated. Instead the retail audit clause on page 4 lets Express Scripts recover money from network pharmacies and keep fifteen percent of what it recovers, which is the opposite of the clawback protection in the model contract.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"There is no most favored pricing promise and no market check anywhere in the produced text. Page 2 fixes the Exhibit C pricing terms for the term of the contract unless both parties agree in writing, and page 115 allows repricing only if a change in law burdens Express Scripts, so the pricing can only move by agreement or by that trigger. Nothing entitles the A&M System to pricing at least as good as comparable clients or to a remedy of meet, credit or release after a benchmarking exercise. The words market check and most favored do not appear in the document.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 127","evidence_quote":"The Sponsor may select an initial number of manufacturer contracts to enable Sponsor to audit fifty percent (50%) of the total\nRebate payments due to Sponsor for two (2) calendar quarters during the twenty-four (24) month period immediately\npreceding the audit (the “Rebate Audit Scope and Timeframe”).","rationale":"The audit rights here are real but heavily fenced. The A&M System gets one claims audit a year at no cost over a rolling twenty four months, the State Auditor's authority is acknowledged, and rebate agreements can be reviewed, yet the auditor must be approved by Express Scripts, may not be a competitor or provide litigation services against Express Scripts, and a rebate audit reaches only half of the rebate payments for two quarters. Manufacturer and pharmacy contracts may be viewed on site only, with no copies and with Express Scripts entitled to inspect the auditor's notes. Routine claims level and financial data delivery on a schedule is not promised, and support for government audits carries Express Scripts' standard charges.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"All such records, including\nany research, reports, studies, data, or other documents that are specifically generated by ESI for the\nA&M System and are specific to its program under this Contract, shall be the property of the A&M\nSystem","rationale":"The A&M System owns the reports and studies Express Scripts generates specifically for its program, owns member identifiable health information and eligibility files, and Express Scripts may not sell member level data or take anything of value for it. That is narrower than sole ownership of every plan data set. The confidentiality clause on page 8 assigns anonymized claims data and the data of the Express Scripts mail and specialty pharmacies to Express Scripts, the business associate agreement on page 130 lets Express Scripts create and disclose de identified data, and nothing requires delivery in machine readable form on request.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"PERF","verdict":"unclear","confidence":0.65,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Performance guarantees plainly exist, because the audit protocol on page 126 lists performance guarantees subsequent to true up as one of four auditable components and page 3 refers to performance standards obligations. The guarantees themselves, how often they are measured, whether they use plan specific data and whether shortfalls are paid in cash or as capped credits all sit in Exhibit C, which is blacked out apart from its headings. No verdict is possible on the strength of the remedies.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.7,"page_ref":"Page 127","evidence_quote":"To the\nextent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding\nadjustments to Sponsor through credits to a future invoice(s). If ESI is unable to reprocess claims and issue corresponding\ncredits to Sponsor through this process, ESI will make adjustments to Sponsor via a check or credit.","rationale":"Remedies here are not self executing. Money comes back only after both sides accept the audit results, and a new audit cannot begin until the previous one is closed by agreement. There are no liquidated damages, no automatic credits for missed guarantees or late reports, and no clause that lets the A&M System exit after a second material breach or a regulatory integrity failure. The System does have a general right to terminate for material breach after a forty five day cure period on page 5, which is why this is weaker than the model rather than absent.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"AMD","verdict":"partial","confidence":0.75,"page_ref":"Page 117","evidence_quote":"the\nprogram pricing terms hereunder may be equitably modified by MCLIC to reflect the reduction or\nelimination of the number of Part D Eligible Retirees","rationale":"The base agreement is strong on this point: page 5 says any amendment must be in writing and signed by both parties, and page 2 freezes the Exhibit C pricing terms for the term unless both parties agree in writing. The Medicare addendum then carves out an exception that lets the Express Scripts affiliate equitably modify the program pricing terms on its own if the number of Part D eligible retirees falls materially. Express Scripts may also update the financial disclosure and the specialty drug list on its own, so a small amount of economic drift is possible without a signature.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"TERM","verdict":"good","confidence":0.75,"page_ref":"Page 5","evidence_quote":"the\nA&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written\nnotice.","rationale":"The A&M System may walk away for any reason on ninety days written notice, and no termination fee, penalty or wind down charge appears in the readable text. Either party may also terminate for uncured material breach, and there are separate exit rights if Express Scripts is acquired, fails the accessibility or cybersecurity requirements, or fails its public information duties, along with a loss of funding exit. The caution is that the conditions attached to rebate payments in Exhibit C-3 are blacked out, so whether earned rebates survive a termination cannot be confirmed, and the Medicare addendum lets the vendor delay final payments pending reconciliation.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"unclear","confidence":0.7,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Specialty drug economics are the single biggest hole in this release. Exhibit D, Specialty Drugs Under the Mail Order Pharmacy Program, is blacked out from page 54 through page 106, the specialty product pricing section of Exhibit C-2 on page 25 is blacked out, and the specialty rebate section of Exhibit C-3 is blacked out as well. The readable text does show that the specialty drug list is maintained and updated by Express Scripts and that its specialty pharmacies are affiliates, but the drug level rates and any acquisition cost discipline cannot be seen.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it\nto be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"Exhibit F designates the entire program pricing terms, the specialty and mail order exhibit and the clarifications as confidential and proprietary and claims they are exempt from the Texas Public Information Act, and Express Scripts reserves the right to designate still more. The confidentiality article on page 8 goes further and treats drug pricing information, rebate contracts and manufacturer administrative fee information as Express Scripts property. The A&M System still must obey the Public Information Act and must notify Express Scripts of requests so it can argue for an exemption, but that is only a right to fight disclosure, and the result is visible in this document: the prices taxpayers pay are blacked out.","model_own_total":27.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary","rationale":"The contract explicitly disclaims fiduciary duty, stating that ESI acts as an independent contractor and that neither the plan nor the sponsor intends for ESI to be a plan fiduciary, leaving ESI free to act in its own interest.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not require a named officer to certify quarterly and annually that all direct and indirect compensation has been disclosed and remitted to the plan.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no signed ownership and affiliate disclosure exhibit in the contract, and no requirement for the PBM to update such an exhibit within 30 days of any change in ownership or control.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 112","evidence_quote":"1.28. “Specialty Product List” means the list of Specialty Products applicable to Sponsor and maintained and updated by ESI from time to time.","rationale":"Definitions rely on vendor discretion and algorithms rather than economic function. Specialty products are defined by a list maintained by ESI, and generic or brand status is determined by ESI's proprietary Brand/Generic Algorithm.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"unclear","confidence":0.95,"page_ref":"Pages 35 to 38","evidence_quote":null,"rationale":"The rebate exhibit (Exhibit C-3) is heavily redacted, making it impossible to determine if 100% of manufacturer revenue is passed through to the plan.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Exhibit C-2 (Claims Reimbursement Rates) is heavily redacted, obscuring the reimbursement rates and dispensing fees for affiliate pharmacies.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Because the claims reimbursement pricing guarantees in Exhibit C-2 are redacted, it is unclear if the contract applies a benchmark ceiling or cheapest lawful option.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Exhibit C-2 is redacted, concealing the pricing terms and whether members are protected by cash price guarantees and deductible credits.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Although a MAC List is defined in the Scope of Services, the pricing terms in Exhibit C-2 are redacted, making it impossible to see if a single MAC list applies to both plan and pharmacy reimbursement.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"unclear","confidence":0.95,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"Exhibit C-2 (Claims Reimbursement Rates) is heavily redacted. Without the pricing schedules, it is impossible to verify if the plan pays exactly what the pharmacy is paid.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure","rationale":"The contract explicitly states that ESI and its affiliates retain all proprietary rights and beneficial interest to revenues described in the Financial Disclosure, meaning these revenues do not flow to the plan.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 110","evidence_quote":"The drugs\nand supplies included on the Formulary will be modified by ESI from time to time","rationale":"The plan sponsor has the discretion to elect not to implement formulary changes, but the default mechanism allows the PBM to modify the formulary over time.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a lowest net cost standard for formulary decisions and lacks any requirement for an annual book of business comparison.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no network protections visible in the unredacted text preventing retroactive clawbacks, volume-conditioned reimbursement, or steering into PBM-owned pharmacies.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"unclear","confidence":0.95,"page_ref":"Pages 21 to 39","evidence_quote":null,"rationale":"Because the entirety of Exhibit C (Program Pricing Terms) is heavily redacted, any potential most favored pricing or market check clauses cannot be assessed.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"bad","confidence":0.9,"page_ref":"Page 3","evidence_quote":"Auditing representatives selected by the A&M\nSystem (the “Auditor’) and approved by ESI, whose approval shall not be unreasonably withheld","rationale":"The plan's audit rights are compromised because they must obtain ESI's approval for their selected auditor. Additionally, the audit is limited to once annually.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not state that the plan sponsor is the sole owner of all claims, rebate, and eligibility data, nor does it restrict the PBM from reusing or reselling plan data.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"unclear","confidence":0.95,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Exhibit C, which would contain administrative services and clinical program fees and corresponding performance guarantees, is redacted.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract lacks self-executing enforcement mechanisms like automatic liquidated damages for missed guarantees, and there is no two-strikes exit clause for regulatory integrity failures.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The contract requires all amendments to be in writing and signed by both parties, preventing the PBM from making unilateral changes.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"partial","confidence":0.95,"page_ref":"Page 5","evidence_quote":"Without restricting any other legal, contractual or equitable remedies otherwise available, the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"The plan may terminate the contract without cause with 90 days' notice, but it does not explicitly protect against forfeiture of earned amounts or name a regulatory integrity event as grounds for termination.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"unclear","confidence":0.95,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Exhibit D (Specialty Drugs Under the Mail Order Pharmacy Program) is completely blacked out, blocking any analysis of specialty drug pricing controls.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it to be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"The PBM designates the contract's pricing terms and specialty exhibits as confidential and proprietary to exempt them from the Texas Public Information Act, restricting the government from fully disclosing its costs.","model_own_total":13.4,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"The contract expressly rejects fiduciary status except for the narrow appeals function. It also describes the economic bargain as arm's length and lets ESI act for itself, not solely for the plan and members. This directly contradicts the loyalty and care obligation in the model.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"bad","confidence":0.97,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure","rationale":"The referenced Financial Disclosure is only in the unproduced proposal and may be updated by ESI. The contract affirmatively reserves beneficial ownership of these revenue streams instead of requiring complete disclosure and remittance. It also contains no named officer certification made quarterly and annually.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.91,"page_ref":"Page 6","evidence_quote":"ESI agrees to provide the A&M System reasonable advance notice prior to the effective date of any merger, acquisition, business reorganization, or other change of ESI management or ownership.","rationale":"The contract identifies several operating affiliates and requires advance notice of ownership or management changes. It does not contain a signed, comprehensive ownership and affiliate exhibit covering every parent, subsidiary, purchasing entity, rebate aggregator, mail pharmacy, and specialty pharmacy. It also lacks the model's 30-day refresh requirement.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"unclear","confidence":0.93,"page_ref":"Pages 35 to 37","evidence_quote":null,"rationale":"The rebate exhibit's amounts, payment terms, and conditions are substantially blacked out on pages 35 to 37. Visible scope definitions do not show a comprehensive economic definition of manufacturer revenue or rebates. The hidden rebate conditions prevent a reliable determination of whether fees, price protection, and other value can be relabeled outside pass-through obligations.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.94,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges that neither it, any Member, nor the Plan, has a right to receive, or possesses any beneficial interest in, any such fees or revenues; provided, that ESI will pay A&M System amounts equal to the amounts expressly set forth in this Contract.","rationale":"The contract limits the plan to amounts expressly promised and denies it a beneficial interest in other ESI and affiliate revenue. That reservation contradicts a complete pass-through of manufacturer revenue of every kind. The rebate percentages and timing are also blacked out, but the visible retained-revenue clause is independently adverse.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"unclear","confidence":0.98,"page_ref":"Pages 25 to 106","evidence_quote":null,"rationale":"Mail and specialty ingredient cost guarantees begin on page 25, and the specialty and mail order exhibit spans pages 53 to 106. Those provisions are heavily or fully blacked out. Because affiliate pharmacy rates and acquisition-cost mechanics would be located there, the produced text does not permit a reliable verdict.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"unclear","confidence":0.97,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"The claims reimbursement rates and general pricing terms are located on pages 24 to 34 and are substantially blacked out. The visible text does not show whether a public benchmark ceiling applies claim by claim in every channel. Redaction, rather than simple silence, prevents the determination.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"unclear","confidence":0.9,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"The visible scope defines usual and customary price and permits a member-submitted cash claim, but it does not reveal the operative reimbursement formula. The claims pricing pages that could establish a cash-price cap are substantially blacked out. The produced text also does not reveal whether all cash purchases receive deductible and out-of-pocket credit or whether accumulator adjustments apply.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.94,"page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules developed or selected by ESI.","rationale":"The definition gives ESI control to develop or select the MAC list. The produced agreement does not require one disclosed list for both plan billing and pharmacy payment, a fixed update schedule, or a pharmacy appeal process. PBM control without those safeguards permits the spread mechanism the model clause is designed to prevent.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"unclear","confidence":0.96,"page_ref":"Pages 24 to 34","evidence_quote":null,"rationale":"The audit protocol says what happens if the sponsor has a pass-through pricing arrangement, but it does not establish that this agreement actually uses one. The operative claims reimbursement and general pricing terms on pages 24 to 34 are substantially blacked out. Those redactions prevent a determination of whether the plan always pays exactly the pharmacy payment plus a disclosed fee.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.86,"page_ref":"Page 115","evidence_quote":"owned subsidiaries and affiliates act on their own behalf, and not for the benefit of or as agents for A&M System, Members or the Plan.","rationale":"The contract permits ESI and its affiliates to negotiate and retain revenue for their own benefit, subject only to amounts expressly promised elsewhere. It contains no pass-through rule for purchasing entities, volume credits, supplier payments, or affiliated aggregators. That structure permits related-entity revenue to remain outside the plan.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The sponsor selects or adopts the formulary and retains final authority over claim coverage. However, ESI may modify the formulary over time, including because of rebate arrangements, and additions or deletions are automatically adopted unless the sponsor opts out. That is weaker than affirmative sponsor approval of every change with supporting net-cost analysis.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"The formulary provisions on pages 110, 113 to 115, and 120 address selection, changes, prior authorization, and Medicare requirements. They do not require a lowest-net-cost standard for this plan, an annual comparison with ESI's book of business, or disclosure when a costlier drug is placed above a cheaper equivalent. No such standard appears elsewhere in the produced text.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"bad","confidence":0.94,"page_ref":"Page 112","evidence_quote":"Subject to Applicable Law, ESI will make Members aware of the ability to fill their prescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings","rationale":"The contract affirmatively authorizes ESI to promote its own mail pharmacy to members. It also states that ESI maintains multiple networks and may consolidate or migrate clients among them. The produced text has no any-willing-pharmacy right or general ban on retroactive clawbacks, so the affiliate-promotion permission directly conflicts with the model's anti-steering rule.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The fixed-pricing and renewal provisions on pages 2, 4, and 5 do not promise pricing as favorable as ESI gives comparable clients. The pricing exhibits on pages 21 to 52 show no visible market-check heading or remedy. No annual market check with a meet, credit, or release remedy appears in the produced text.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.99,"page_ref":"Page 127","evidence_quote":"The Sponsor may select an initial number of manufacturer contracts to enable Sponsor to audit fifty percent (50%) of the total Rebate payments due to Sponsor for two (2) calendar quarters during the twenty-four (24) month period immediately preceding the audit","rationale":"The plan has annual audit rights for claims, rebates, performance guarantees, and regulatory compliance. Those rights are constrained by a single combined annual audit, a 24-month window, restricted auditor qualifications, sampling limits, and review of only half of rebate payments for two quarters. ESI also bars copying contracts and may review the auditor's notes, making the rights materially weaker than the model.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.98,"page_ref":"Page 8","evidence_quote":"with respect to ESI: ESI’s reporting and other web-based applications, eligibility and adjudication systems, system formats and databanks, clinical or formulary management operations or programs, fraud, waste and abuse tools and programs, anonymized claims data","rationale":"The agreement treats anonymized claims data and several data systems as ESI property. The BAA additionally permits data aggregation and use, creation, and disclosure of de-identified health information. Those rights contradict sole sponsor ownership and the model's prohibition on PBM reuse, licensing, or sale of plan data.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"unclear","confidence":0.97,"page_ref":"Pages 39 to 52","evidence_quote":null,"rationale":"The audit protocol confirms that performance guarantees exist and are reviewed after true-up. The administrative services, clinical program fees, and related guarantee terms on pages 39 to 52 are almost entirely blacked out. The produced text therefore does not reveal measurement frequency, plan-specific measures, cash reconciliation, or whether remedies are capped credits.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.94,"page_ref":"Page 127","evidence_quote":"Sponsor agrees that once audit results are accepted by both parties, the audit shall be considered closed and final. To the extent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding adjustments to Sponsor through credits to a future invoice(s).","rationale":"Claims errors can produce reprocessing and invoice credits, and a material breach can support termination after a cure period. The credit process depends on mutually accepted audit results rather than operating automatically. The agreement does not provide a two-strikes exit or automatic damages for late reports and repeated integrity failures.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"good","confidence":0.99,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The agreement requires every amendment to be written and signed by both parties. Pricing also remains unchanged during the term except as required by law or by written agreement. These provisions prevent ESI from changing economic terms merely by notice, portal posting, or an unsigned updated exhibit.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"good","confidence":0.96,"page_ref":"Page 5","evidence_quote":"Without restricting any other legal, contractual or equitable remedies otherwise available, the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"The sponsor has a clear termination-for-convenience right on 90 days' notice, and the clause states no termination penalty. Other provisions permit termination for uncured material breach and several compliance or integrity failures. Final EGWP amounts may be delayed for reconciliation, but the text does not provide for forfeiture of earned amounts.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"unclear","confidence":0.99,"page_ref":"Pages 53 to 106","evidence_quote":null,"rationale":"Page 53 identifies Exhibit D as Specialty Drugs Under the Mail Order Pharmacy Program. The next 53 pages, which contain the exhibit's substance, are fully blacked out. Specialty definitions, drug-level ceilings, channel rates, and acquisition-cost treatment at ESI-affiliated pharmacies therefore cannot be evaluated.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 109","evidence_quote":"The Contract, Exhibit C (Program Pricing Terms), Exhibit D (Specialty Drugs Under the Mail Specialty Drugs Under the Mail Order Pharmacy Program), and Exhibit E (Clarifications)","rationale":"ESI designates the core pricing, specialty, mail order, and clarification materials as confidential or proprietary and claims they may be exempt from public disclosure. The Texas Public Information Act process remains available, but ESI reserves the right to oppose release. The resulting production blacked out the very economic terms taxpayers would need to assess.","model_own_total":17.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:25:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 26","evidence_quote":"United is not the Plan Administrator of the Plan. Any references in this Agreement to United “administering the Plan” are descriptive only and do not confer upon United any responsibilities or duties beyond the claim administration duties set forth herein.","rationale":"The model contract published by Mark Cuban and collaborators makes the pharmacy benefit manager a fiduciary that owes loyalty only to the plan and its members. This contract goes the other way and disclaims duties beyond claim processing. United is named a fiduciary only for initial benefit determinations and first level appeals on page 34, and elsewhere the text lets it keep spread, purchase discounts and interest, which is the opposite of a duty of loyalty. There is no disgorgement remedy anywhere in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 67","evidence_quote":"United shall on Customer’s behalf, administer a fee (“Consultant Fee”) to be paid to Lockton (“Consultant”). The Consultant Fees are included in Customer’s pharmacy financial terms. United shall provide Consultant with a monthly payment for all Consultant Fees collected in the amount(s) of $2.00 pmpm","rationale":"Some compensation is disclosed, which is better than nothing. The broker fee of $2.00 per member per month paid to Lockton is stated, and page 60 discloses that a United affiliate earns 1 percent to 3 percent of provider payment transactions. What is missing is the rest. Page 42 says only that United may receive access fees and marketing and administrative charges from network pharmacies without stating amounts, manufacturer administrative fees are described but never quantified, and no officer certifies quarterly or annually that all compensation has been disclosed and remitted.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no ownership or affiliate disclosure exhibit in this document. The exhibit list on page 2 names special terms, city standard terms, insurance and contractor terms, and the attachments to Exhibit D are medical services, pharmacy services, a business associate agreement, security, fees and guarantees. The only affiliate statements are scattered and general, such as the pharmacy definitions on pages 40 to 42 saying that home delivery and specialty pharmacies include United affiliates. The conflict of interest questionnaire on pages 85 and 86 is a Texas vendor ethics form about city officials, not a list of owners, subsidiaries, group purchasing organizations or rebate aggregators, and nothing requires United to refresh such a list when ownership changes.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 25","evidence_quote":"Medical Benefit Drug Rebate does not include any discount, price concession, administration fees, or other direct or indirect remuneration United receives from a drug manufacturer for direct purchase of a prescription drug","rationale":"The definitions are built on labels and carve outs rather than economic function, which is how manufacturer money escapes the pass through. The same exclusion appears in the pharmacy definition of rebate on pages 41 and 42, where money received by United or a group purchasing organization for direct purchase of a drug, and payments for products, services or analytical tools, are all defined out of the word rebate. Brand and generic are set by a Medi-Span label rather than by function, and the specialty drug list is maintained and updated by United. Only the specialty definition, which uses a test of at least three of eight criteria, comes close to what the model contract asks for.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.75,"page_ref":"Page 64","evidence_quote":"Minimum Rebate Guarantee (Traditional PDL) Rebate Sharing Percentage 100.0% 100.0% 100.0%","rationale":"On its face the City is credited a 100 percent rebate sharing percentage for all three years plus minimum per brand script guarantees, so the subject is addressed. The value of that promise is cut back in several ways. Manufacturer administrative fees are expressly outside the guaranteed rebate arrangement on page 66, purchase discounts and other manufacturer revenue are retained by United on page 45, and pages 64 and 65 exclude a long list of claim types from rebate eligibility. Payment timing is also far slower than the model, with the first payment due no later than 210 days after the incurred quarter and later payments within 90 days after each quarter.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service","rationale":"The model contract requires claims filled by pharmacies the benefit manager owns to be billed at net acquisition cost plus a stated dispensing fee. Here the affiliate home delivery and specialty pharmacies are network pharmacies under the definitions on pages 41 and 42, and this clause lets United keep a margin on what those pharmacies are paid. Nothing in the document gives the City acquisition cost invoices or a documentation default if records are not produced. Page 45 adds that United buys drugs from manufacturers for these affiliate pharmacies and keeps the resulting discounts.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in this contract caps what the plan pays by reference to an outside published price. The pharmacy pricing pages 63 through 69 are built entirely on average wholesale price discounts measured in the aggregate, with reconciliation across all claims rather than claim by claim. The definitions on page 42 include a usual and customary charge, but it is used only for what the member pays at the counter, not as a ceiling on the plan's cost. No transparent cash price benchmark or cheapest lawful option requirement appears anywhere in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.85,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount","rationale":"Members get part of what the model asks for. At a network pharmacy they will not pay more than the pharmacy's usual and customary charge or the discounted price. The protection stops there. The contract says nothing about crediting a purchase a member makes with cash outside the benefit toward the deductible or out of pocket maximum, and nothing about limiting accumulator adjustments against manufacturer assistance unless the City elects it in writing.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"The model contract requires one disclosed maximum allowable cost list that governs both what the plan pays and what the pharmacy is paid, updated on a schedule, with a pharmacy appeal path. This contract does the reverse by allowing multiple lists changed at United's sole discretion. Combined with the spread language on pages 43 and 67, that means one list can price what the City pays and another can price what the pharmacy receives. Neither list is disclosed to the City and no appeals timeline appears in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 67","evidence_quote":"On mail order drugs, specialty drugs, and retail pharmacy drugs and services including dispensing fees, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service","rationale":"This is spread pricing stated in plain words, in every channel, including dispensing fees. The model contract requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee. The same permission appears in the pharmacy services attachment on page 43 and again for specialty drugs on page 69, so it is not an isolated sentence. The City has no contractual way to learn how large that retained difference is.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"The model contract requires purchase discounts, volume credits and supplier payments received by the benefit manager or a related purchasing entity to flow to the plan. This contract states the opposite outcome for drug purchase discounts and purchase rebates. The pharmacy rebate definition on pages 41 and 42 also writes money received by a group purchasing organization out of the definition of rebate, and the same page says nothing prevents United from pursuing other sources of revenue from drug manufacturers. No allocation drivers or reporting of that revenue are provided.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 44","evidence_quote":"Customer will adopt one or more of United’s PDLs as the PDL","rationale":"The City chooses among United's prescription drug lists and page 44 calls the City the ultimate decision maker on design, so there is some sponsor role. Real control sits with the vendor. The same page says United makes the final classification of a drug to a tier and that rebates are among the factors it weighs, and the City may not distribute the list without approval. The City also receives no utilization management outcomes by drug, and page 43 says United's utilization management criteria will not be available for the City or its vendors to use.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard binds the vendor anywhere in this document. The formulary and rebate management provisions on pages 44 and 45 describe adoption of United's list and rebate negotiation across United's whole book of business without any promise that placement will produce the lowest net cost for Denton. The only place net cost appears is page 65, where United reserves rights over the drug list in language about achieving lower net drug cost for itself and its other customers. There is no annual comparison against United's book of business and no disclosure when a drug is placed above a cheaper equivalent.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.8,"page_ref":"Page 67","evidence_quote":"g) Customer utilizes a vendor, that facilitates steering members to different drugs or pharmacies to the extent these services impact the financial guarantees under this Agreement.","rationale":"The model contract forbids the benefit manager from steering claims into its own pharmacies and protects the plan's freedom to direct members to cheaper options. This contract lets United revise or revoke the whole pricing arrangement if the City hires a vendor that helps members move to cheaper drugs or pharmacies. Page 42 requires United or its affiliate to be the exclusive provider of pharmacy benefit services, and pages 41 and 42 place United's own home delivery and specialty pharmacies inside the network. There is no any willing pharmacy term and page 29 states the make up of the network can change at any time.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 66","evidence_quote":"market check during the Pharmacy Pricing Term to confirm its financial terms are competitive","rationale":"A market check exists, which is more than many contracts of this kind offer. It is narrow. The City gets one check for the whole pricing term, timed to the third quarter after the first anniversary, run by a third party both sides agree on, using at least four substantially similar customers and comparing aggregate value rather than claim level pricing. If the check shows more than three percent in annualized savings the only consequence is that the parties negotiate in good faith, so there is no automatic credit and no right to walk away, and there is no most favored pricing promise anywhere in the document.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 46","evidence_quote":"The place, time, type, scope, and duration of all audits must be reasonable and agreed to by United","rationale":"The City may audit, but the vendor controls the terms of the audit. Page 46 limits the City to one audit each calendar year with an auditor both sides agree on, an eighteen month look back, no audits in December or January, up to 300 suspected erroneous claims, and City payment of all expenses, and page 10 confirms the City bears audit cost. Rebate auditing reaches only United's top five rebate agreements or those covering 75 percent of the City's rebate revenue, whichever is less, and the auditor may not copy or keep those contracts. Routine data delivery is limited to United's standard online reports under page 42, and page 36 lets United change report content and format at will.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 14","evidence_quote":"If City requests that Contractor provide information about the Plan that is in Contractor’s possession after the Agreement terminates and any applicable run out period has expired, then Contractor may, in its discretion, provide such information subject to a fee","rationale":"The model contract makes the plan sponsor the sole owner of its claims, eligibility, accumulator and rebate data with delivery on request. Here the City's own plan information is held at the vendor's discretion after termination and can be charged for. Page 39 charges a mutually agreed fee for the one time accumulated data extract, page 47 limits transition help to twelve transmissions in United's standard format, and page 27 says United keeps records only as long as the law requires. No clause states that the City owns the data or restricts United from reusing it.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 61","evidence_quote":"With respect to the aspects of United’s performance addressed in this exhibit, these Fee adjustments are Customer’s exclusive financial remedies.","rationale":"Guarantees do exist in Attachment D-6, covering service metrics with $11,000 in fees at risk each and pharmacy discount and rebate guarantees measured against City specific claims. They fall short of the model in the ways that matter. Measurement and payment on the pharmacy and service guarantees are annual rather than quarterly, remedies come as fee adjustments and credits rather than cash, and this sentence makes those adjustments the City's only financial remedy for the covered performance.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 65","evidence_quote":"reserves the right to modify or eliminate any Rebate guarantees if there are any additional changes to Rebates received from pharmaceutical manufacturers","rationale":"Guarantee shortfalls are reconciled without the City proving damages, which is the one self executing element here. Everything else is weaker than the model contract. The guarantees themselves can be modified or eliminated by United, page 61 lets United specify new guarantees and replace the exhibit for later periods, and page 67 lists many conditions under which United may revise or revoke the pricing arrangement. There is no liquidated damages clause for late reporting and no two strikes or regulatory integrity exit for the City.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"Any new Fee will be effective as of the date the change is applicable, even if that date is retroactive","rationale":"Page 16 says the contract can be modified only in a writing signed by both parties, but page 5 undercuts that for the economics. United may change fees on 30 days written notice with a replacement Attachment D-5, may change fees when benefits or laws change or when enrollment moves by ten percent, and the new fee can apply retroactively. The City's only response is to terminate. That is exactly the notice driven change to economic terms the model contract forbids.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination of pharmacy benefit services and no reconciliation of minimum rebate guarantees will apply","rationale":"Leaving early costs the City money it has already earned. This clause and a matching provision on page 59 let United keep unremitted rebates if the City ends the pharmacy benefit before the pricing term runs out, and page 34 forfeits earned but unpaid rebates as well. Page 55 also requires repayment of the $66,000 administrative credit and $100,000 wellness credit on early termination. Termination without cause is available under page 11 only after the initial term, and no regulatory integrity event is listed as grounds for termination.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"bad","confidence":0.85,"page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service","rationale":"The specialty definition on page 42 is reasonably functional, using a test of at least three of eight clinical and handling criteria, and pages 68 through 84 list the drugs covered by the guarantee. The pricing controls are the problem. Specialty is guaranteed only as an aggregate discount of 21.00 percent for listed drugs and 14.00 percent for unlisted ones rather than as drug level ceilings, United's own specialty pharmacy is a network pharmacy, and this clause lets United keep the spread on those claims. Page 68 also lets United move a drug off the specialty designation based on market conditions.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 13","evidence_quote":"pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"The confidentiality article on pages 13 and 14 treats exactly the information the public would want as confidential commercial information. When a public records request arrives the receiving party must give notice and reasonably cooperate in seeking a protective order, which is a duty to help block release rather than a clean carve out for Texas public information law. Page 17 makes any dispute and its outcome confidential, and pages 53 and 54 restrict who may see the vendor's security audit report. Page 58 does promise language supporting the City's anti gag clause attestation, but that does not undo the confidentiality of pricing and compensation terms.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"partial","confidence":0.9,"page_ref":"Page 34","evidence_quote":"Customer appoints United a named fiduciary under the Plan with respect to (i) performing initial benefit determinations and payment","rationale":"The contract appoints the vendor as a named fiduciary for initial benefit determinations and appeals, but does not impose broader duties of loyalty and care solely to the plan for pharmacy benefit pricing, nor does it require disgorgement of retained compensation.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not require full disclosure of PBM compensation, affiliate ownership, or payments to brokers. It also lacks any requirement for quarterly and annual certification by a named officer.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include an exhibit listing the PBM's owners, parents, subsidiaries, affiliates, or group purchasing organizations, and lacks any requirement to refresh such an exhibit upon a change in control.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool","rationale":"The definition of Rebate explicitly excludes manufacturer administrative fees, purchase discounts, and remuneration received by a group purchasing organization. This narrow definition allows the PBM to relabel and retain significant manufacturer revenue.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"The contract explicitly allows the PBM to retain discounts and purchase rebates received by its affiliated home delivery or specialty pharmacies, contradicting the requirement to pass through 100% of manufacturer revenue.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 64","evidence_quote":"Mail Order Brand, AWP less                            25.50%            25.50%           25.50%","rationale":"The contract does not price affiliate pharmacy claims at net acquisition cost. Instead, mail order and specialty claims are priced using an Average Wholesale Price (AWP) discount formula, which allows the PBM to retain margin.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a published benchmark ceiling, such as a transparent cash price (e.g., NADAC), to ensure the plan claim cost never exceeds a public benchmark on a claim-by-claim basis.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"partial","confidence":0.8,"page_ref":"Page 67","evidence_quote":"Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"The contract includes a 'lesser of' logic ensuring members do not pay more than the usual and customary charge. However, it does not guarantee that every cash purchase counts toward the deductible and out-of-pocket maximum, nor does it prohibit accumulator adjustments against member assistance.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"The contract explicitly permits the vendor to use multiple MAC lists and modify them at its sole discretion, enabling classic spread pricing.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"The contract explicitly permits spread pricing across retail, home delivery, and specialty channels by allowing the PBM to retain the difference between what the plan pays and what the pharmacy is paid.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer","rationale":"The contract explicitly excludes remuneration received by a group purchasing organization from the definition of rebates, permitting the PBM or its GPO to retain supplier payments rather than passing them through to the plan.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"bad","confidence":0.9,"page_ref":"Page 44","evidence_quote":"United makes the final classification of a Prescription Drug to a certain tier of the PDL by considering a number of factors","rationale":"Rather than allowing the plan sponsor to control the formulary and approve every change, the contract delegates final classification and tiering decisions to the vendor.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a lowest net cost standard for formulary decisions, nor does it require the PBM to provide an annual comparison against its book of business or disclose the reasoning for placing a drug above a cheaper equivalent.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish pharmacy network protections such as prohibiting retroactive clawbacks, preventing the PBM from steering claims to its own pharmacies, or ensuring any willing pharmacy may participate at the plan's terms.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 66","evidence_quote":"If the market check report validates an annualized savings of greater than three (3) percent between the median of the financial terms for such substantially similar customers and Customer’s financial terms for time period that is the subject of the market check, the parties will negotiate in good faith to revise the financial terms.","rationale":"The contract permits one market check during the term. However, the remedy is limited to negotiating in good faith to revise financial terms, rather than an automatic meet, credit, or release remedy.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"bad","confidence":0.95,"page_ref":"Page 46","evidence_quote":"Customer’s auditor may not copy (through handwritten notes or otherwise) or retain contracts or related documents provided by United during such audit.","rationale":"The contract severely restricts audit rights, requiring the PBM to agree to the auditor and the scope of the audit. It explicitly prohibits the plan's auditor from copying or retaining contracts during on-site rebate audits.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"Neither party may sell, license, or grant any other rights to the other Party’s Confidential Information, (b) use the other Party’s Confidential Information for the creation, operation or improvement of any product, service or database for external or commercial use","rationale":"The contract prohibits the sale, licensing, or commercial reuse of confidential information by either party. However, it does not explicitly designate the plan sponsor as the sole owner of all claims, eligibility, and derived data sets, nor does it guarantee delivery in machine-readable form upon request.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"bad","confidence":0.9,"page_ref":"Page 61","evidence_quote":"Fees at Risk         Total Dollars at Risk for this metric                                                              $11,000","rationale":"Performance guarantees are measured annually rather than quarterly, and shortfalls are paid as capped flat-dollar amounts against fees rather than dollar-for-dollar cash reconciliation.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include self-executing enforcement mechanisms like liquidated damages outside the annual performance guarantees, nor does it provide a two-strikes exit without penalty for repeat material breaches.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 65","evidence_quote":"United reserves the right to modify or eliminate any Rebate guarantees if there are any additional changes to Rebates received from pharmaceutical manufacturers.","rationale":"The contract permits the vendor to unilaterally modify or eliminate rebate guarantees based on market changes, and allows it to review and modify its multiple MAC lists at its sole discretion.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"bad","confidence":0.95,"page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination","rationale":"The contract explicitly penalizes the plan for terminating early by stating that the PBM will forfeit and retain any pending or future rebates owed to the plan as of the termination date.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"bad","confidence":0.95,"page_ref":"Page 68","evidence_quote":"Actual utilization, using Average Wholesale Price (AWP) in dollars, using our data, of listed specialty drugs","rationale":"Specialty drugs are not priced at acquisition cost. Instead, specialty claims in the network are priced using an Average Wholesale Price (AWP) discount formula.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 13","evidence_quote":"Confidential Information: Information disclosed or made available by a Party in connection with this Agreement, including without limitation the following, regardless of form or the manner in which it is furnished: (a) pricing, discounts, reimbursement terms, payment methodologies","rationale":"The contract defines pricing, discounts, and compensation arrangements as confidential trade secrets. While it acknowledges public records laws, it requires the plan to notify the vendor and cooperate in seeking a protective order to block release.","model_own_total":8.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"partial","confidence":0.91,"page_ref":"Page 10","evidence_quote":"The Contractor warrants and represents that all services to be provided the City under the Contract will be performed using the care, skill, prudence and diligence under the circumstances then prevailing that a prudent claims administrator/fiduciary acting in a like capacity and familiar with such matters would use under similar circumstances","rationale":"The contract supplies a prudent claims administrator standard, and pharmacy claim determinations use the medical attachment's named fiduciary process. It does not impose loyalty solely to the City and members, require full conflict disclosure, or require disgorgement of compensation retained in breach. The duty is therefore materially narrower than the model clause published by Mark Cuban and collaborators.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.9,"page_ref":"Page 42","evidence_quote":"United maintains systems for processing pharmacy claims and may receive access fees and charges for marketing and administrative services as compensation for services United provides to Network Pharmacies.","rationale":"The pharmacy attachment acknowledges some compensation from network pharmacies, and the guarantee exhibit separately identifies a consultant fee. It does not disclose all compensation received by United and related entities, affiliate ownership affecting claims, or payments to all brokers and consultants. No named officer certifies complete disclosure and remittance quarterly or annually.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The pharmacy definitions and services on pages 40 through 47 identify affiliated home delivery and specialty pharmacies but do not list all owners, parents, subsidiaries, affiliates, purchasing entities, or rebate aggregators. The conflict questionnaire on pages 85 and 86 concerns local government officer conflicts rather than PBM ownership. No signed ownership exhibit or 30 day refresh duty appears anywhere in the agreement.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The Rebate definition expressly excludes direct purchase value and compensation received by United or a group purchasing organization for products, services, tools, and data analysis. Separate definitions and guarantee terms also let United control multiple MAC lists and specialty classifications. These exclusions allow manufacturer value to be relabeled outside the pass-through obligation, which is the precise loophole the model definition closes.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 45","evidence_quote":"United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"The fee exhibit states a 100 percent Rebate sharing percentage, but that promise applies only to the contract's narrowed definition. United expressly keeps affiliate pharmacy purchase discounts and purchase rebates and may pursue other manufacturer revenue. Payments also occur much later than 30 days after quarter end, so this is not full and prompt pass-through of all manufacturer revenue.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.99,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"United's definitions include affiliated pharmacies within home delivery and specialty channels. The contract then authorizes United to retain the difference between pharmacy reimbursement and the City's payment in those channels. It does not require affiliate claims to be invoiced at net acquisition cost plus a stated dispensing fee.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The pharmacy pricing guarantees on pages 64 through 68 use aggregate AWP discount targets by channel and drug category. The member lower-of rule on page 67 limits participant payment but does not cap the City's claim cost at a published cash benchmark. No claim-by-claim cheapest lawful option ceiling appears in the pricing, claims, or specialty provisions.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.97,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"The lower-of-three rule protects a member from paying more at the point of sale than the pharmacy's reported usual and customary cash charge. The agreement does not say an off-plan cash purchase counts toward the deductible and out-of-pocket maximum. It also lacks the model's written-election protection against accumulator adjustments for member assistance.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":1,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United’s periodic review and modification in its sole discretion.","rationale":"The contract expressly permits multiple MAC lists and places their review and modification in United's sole discretion. It does not require the same list for City billing and pharmacy reimbursement, disclose the lists, establish a fixed update schedule, or state a pharmacy appeal process. This directly permits the structure that the model clause is designed to prevent.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"This is an express authorization for spread pricing. It applies to home delivery, retail, and specialty pharmacy services rather than limiting the City to pharmacy reimbursement plus a disclosed administrative fee. The guarantee exhibit repeats the same retained-spread rule.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.99,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The definition expressly removes remuneration received by a group purchasing organization for direct purchase and other products or services from Rebate. No other clause passes those purchasing entity payments through to the City or allocates them on disclosed drivers. The contract therefore preserves the exact GPO revenue channel addressed by the model clause.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"bad","confidence":0.97,"page_ref":"Page 44","evidence_quote":"United makes the final classification of a Prescription Drug to a certain tier of the PDL by considering a number of factors including, but not limited to, clinical and economic factors.","rationale":"The City selects and adopts a United formulary design, but United makes the final tier classification. United can also make changes and provides negative-change notices only at the City's request. This falls short of sponsor approval of the formulary and every change and leaves decisive formulary control with the PBM.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"bad","confidence":0.94,"page_ref":"Page 44","evidence_quote":"Economic factors may include, but are not limited to, the Prescription Drug's acquisition cost including, but not limited to, available Rebates, and assessments on the cost effectiveness of the Prescription Drug.","rationale":"United may make final tier decisions using available Rebates and general cost-effectiveness factors. The agreement does not require the lowest net cost for this City, an annual whole-book comparison, or disclosure when a drug is placed above a cheaper equivalent. The rebate guarantee also financially penalizes City-directed formulary deviations, increasing the risk of rebate-driven placement.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.86,"page_ref":"Page 42","evidence_quote":"United may add or remove Network Pharmacies from the pharmacy network. United will make a reasonable effort to provide Customer with advance notice of any material changes to the network.","rationale":"United maintains the network and promises reasonable efforts to notify the City of material changes. The agreement does not make adjudicated claims final, prohibit retroactive clawbacks or volume conditions, bar affiliate steering, or grant any willing pharmacy participation. United also controls membership in the network and operates affiliated home delivery and specialty pharmacies.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"partial","confidence":0.96,"page_ref":"Page 66","evidence_quote":"Customer may conduct one market check during the Pharmacy Pricing Term to confirm its financial terms are competitive with those currently available in the market for substantially similar customers.","rationale":"The City gets one market check during the three year pharmacy pricing term, not an annual check or automatic most-favored pricing. The comparison must clear a 3 percent median threshold and leads only to good-faith negotiation of a signed amendment. There is no mandatory match, credit, or release remedy if negotiations fail.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"bad","confidence":0.98,"page_ref":"Page 46","evidence_quote":"in the case of a Rebate audit, access to United’s top 5 Rebate agreements or Rebate agreements that account for at least 75% of the Customer’s total Rebate revenue generated per year, whichever is less.","rationale":"The City may conduct one pharmacy claims audit per year, but the auditor must be mutually agreeable and sign United's confidentiality agreement. Rebate review is limited to the lesser of five agreements or agreements covering 75 percent of annual rebate revenue, and documents cannot be copied. United also controls audit logistics, limits timing and lookback, and requires mutual settlement before payment, so the rights are materially contrary to full sponsor-directed access.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.97,"page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate’s own behalf.","rationale":"The agreement allows United to reuse and disclose de-identified plan information on its own behalf. It never makes the City sole owner of claims, eligibility, accumulator, rebate, and derived datasets. Transition delivery is limited to selected files in United's standard format, and post-runout plan information may be supplied at United's discretion for a fee.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"partial","confidence":0.9,"page_ref":"Page 64","evidence_quote":"The amount the combined actual Rebate amount is less than the combined guaranteed Rebate amount.","rationale":"The pharmacy pricing schedule measures customer-specific discount and rebate shortfalls annually and states a shortfall payment amount. However, the general guarantee terms use fee credits as exclusive financial remedies, and the pharmacy guarantees contain broad exclusions and revision rights. Measurement and payment are annual rather than quarterly, so the remedy is weaker than the model's quarterly cash reconciliation.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.92,"page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer’s Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"The guarantee exhibit provides fee credits without requiring the City to prove common-law damages, which is a useful self-executing feature. Those adjustments are the exclusive financial remedy for covered performance and are subject to exclusions and gradients. The contract has ordinary breach and cure rights but no defined two-strikes exit for repeated guarantee failures or regulatory integrity events.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.97,"page_ref":"Page 5","evidence_quote":"Any new Fee will be effective as of the date the change is applicable, even if that date is retroactive.","rationale":"A general clause says amendments must be signed by both parties, but the higher-priority special terms permit Contractor fee changes by notice and even allow retroactive effect. The guarantee exhibit also permits United to replace guarantees for a later period and reserves several rights to revise or revoke pharmacy arrangements. These economic change rights contradict the model's bilateral-signature rule.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"bad","confidence":1,"page_ref":"Page 66","evidence_quote":"If Customer terminates pharmacy benefit services with United prior to the end of the Pharmacy Pricing Term, United will retain any and all pending or future Rebates payable under the Agreement as of the effective date of the termination of pharmacy benefit services and no reconciliation of minimum rebate guarantees will apply.","rationale":"The City has a general convenience termination right only after the initial term and on lengthy notice. More importantly, early pharmacy termination causes forfeiture of all pending and future rebates and eliminates minimum rebate reconciliation. That direct economic penalty contradicts termination without penalty and preservation of earned amounts.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"bad","confidence":0.99,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"Specialty is defined by functional criteria, but the contract lets United control the Specialty Drug List and includes affiliated specialty pharmacies. Specialty pricing is an annual composite AWP discount guarantee with exclusions, not a drug-level ceiling or acquisition-cost invoice rule. United may expressly retain specialty spread, including in its affiliate channel.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 13","evidence_quote":"Confidential Information: Information disclosed or made available by a Party in connection with this Agreement, including without limitation the following, regardless of form or the manner in which it is furnished: (a) pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"The agreement labels pricing, discounts, reimbursement, payment methods, and compensation as confidential and limits disclosure and use. It preserves disclosures legally required under public records law, but otherwise requires strict confidence, notice, and cooperation with efforts to narrow release. That legal-process carveout does not remove the restriction on voluntary sharing with members, the public, lawmakers, or other advisors.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:09:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.93,"page_ref":"Page 26","evidence_quote":"United is not the Plan Administrator of the Plan. Any references in this Agreement to United \"administering the Plan\" are descriptive only and do not confer upon United any responsibilities or duties beyond the claim administration duties set forth herein.","rationale":"United is not the plan administrator. It is a named fiduciary only for initial benefit determinations and first-level appeals. There is no duty of loyalty or care owed solely to the plan for formulary, network, rebate, or pricing decisions. A services warranty uses a prudent claims administrator standard, not a loyalty duty. United may keep spread, affiliate purchase discounts, and other manufacturer revenue, which is the harm the Mark Cuban and collaborators model is meant to stop.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 67","evidence_quote":"United shall on Customer's behalf, administer a fee (\"Consultant Fee\") to be paid to Lockton (\"Consultant\"). The Consultant Fees are included in Customer's pharmacy financial terms. United shall provide Consultant with a monthly payment for all Consultant Fees collected in the amount(s) of $2.00 pmpm.","rationale":"The agreement discloses some compensation, including a $2.00 pmpm Lockton consultant fee built into pharmacy terms, affiliate payment-service fees, 80 percent medical rebate sharing, and claims processor fees collected from pharmacies. It also says United may pursue other manufacturer revenue. There is no named-officer quarterly or annual certification that every dollar of compensation has been disclosed and remitted. That falls short of the Mark Cuban and collaborators model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"No signed ownership exhibit lists owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, or mail and specialty pharmacies with a 30-day refresh. Exhibit E is the Texas Form CIQ ethics questionnaire, not a PBM ownership schedule. Affiliates are mentioned in pharmacy definitions and the account-team clause, but those mentions are not a refreshable ownership exhibit. Looked in Exhibit D definitions, Attachment D-2, Attachment D-5, and Exhibit E.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"Rebate is defined to exclude manufacturer administration fees, group purchasing organization receipts, direct-purchase discounts, and payments for products, services, or analytical tools. Price protection is defined separately and is not treated as a rebate. United may maintain multiple MAC lists and change them in its sole discretion. Brand and generic status follows the Medi-Span labeler. That is the definitional structure the Mark Cuban and collaborators model warns against.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"PASS","verdict":"partial","confidence":0.9,"page_ref":"Page 64","evidence_quote":"Rebate Sharing Percentage 100.0% 100.0% 100.0%","rationale":"The pharmacy exhibit states a 100.0% rebate sharing percentage of defined Rebates, with an annual dollar-for-dollar shortfall payment. Manufacturer administrative fees are excluded from the guarantee. The first rebate payment is due 210 days after the incurred quarter, then 90 days, not 30 days. Other manufacturer revenue and affiliate purchase rebates are retained. If the City ends only pharmacy services without cause, United may keep unremitted rebates.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United or its affiliates, acting as a Home Delivery Pharmacy or a Specialty Pharmacy, purchase Prescription Drugs from Drug Manufacturers and receive certain discounts and purchase rebates from Drug Manufacturers in connection with these purchases. United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"Affiliate home delivery and specialty pharmacies are Network Pharmacies. They buy drugs, keep manufacturer purchase discounts and purchase rebates, and do not invoice the City at acquisition cost. Combined with spread retention on mail and specialty claims, this is the opposite of the Mark Cuban and collaborators acquisition-cost rule.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.87,"page_ref":null,"evidence_quote":null,"rationale":"There is no claim-level ceiling that limits plan cost to a published benchmark such as NADAC, cash, or usual and customary. Pharmacy guarantees are annual average AWP discounts. Lesser-of-three logic applies to participant payments, not to what the plan pays. Looked in Attachment D-2 pricing terms and Attachment D-6 pharmacy financials.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"CASH","verdict":"partial","confidence":0.9,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"Participants pay the lesser of the discounted price, usual and customary charge, or cost share. The contract does not credit cash-pay purchases toward deductibles or out-of-pocket maximums, and it does not let the City elect accumulator treatment. That is weaker than the Mark Cuban and collaborators cash-price model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United's periodic review and modification in its sole discretion.","rationale":"United may keep multiple MAC lists and change them in its sole discretion. There is no single published list, no scheduled disclosure to the City, and no pharmacy appeal path in this agreement. That is the MAC structure the Mark Cuban and collaborators model exists to prevent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"For home delivery, retail, and specialty, United may keep the difference between what it pays the pharmacy and what the City pays. Attachment D-6 repeats that spread applies to mail, specialty, and retail including dispensing fees. That is express spread pricing, which the Mark Cuban and collaborators model exists to prevent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The rebate definition carves out amounts United or a group purchasing organization receives for direct purchase or for products, services, or tools. Affiliate pharmacies keep purchase discounts and purchase rebates and do not pass them to the City. Those purchasing-entity dollars are not passed through as the Mark Cuban and collaborators model requires.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 44","evidence_quote":"United makes the final classification of a Prescription Drug to a certain tier of the PDL by considering a number of factors including, but not limited to, clinical and economic factors.","rationale":"The City adopts United PDL designs and is called the ultimate decision-maker on selecting the design. United still makes the final tier classification using clinical and economic factors, including rebates. Utilization-management criteria are not available to the City, and custom programs need United approval. Plan control is incomplete under the Mark Cuban and collaborators model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.84,"page_ref":null,"evidence_quote":null,"rationale":"There is no lowest-net-cost decision standard for this plan, no annual book of business comparison, and no disclosure of drugs placed above a cheaper equivalent. A D-6 condition lets United reduce or eliminate rebate guarantees if PDL changes made to achieve a lower net drug cost for the City and other ASO customers cut rebate levels. That is a vendor escape hatch, not a formulary standard. Looked in Attachment D-2 section 2.5 PDL and Attachment D-6 rebate conditions.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 42","evidence_quote":"Customer engages United or its affiliate as its exclusive provider of the prescription drug benefit services set forth in this Agreement.","rationale":"The City must use United or its affiliate as exclusive PBM, including retail, mail, and specialty. United may add or remove network pharmacies. Pricing guarantees require exclusive United networks. United collects claims processor fees from pharmacies. There is no any-willing-pharmacy rule, no anti-steering rule, and no claims-final-when-adjudicated rule. That is the network control the Mark Cuban and collaborators model exists to prevent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 66","evidence_quote":"If the market check report validates an annualized savings of greater than three (3) percent between the median of the financial terms for such substantially similar customers and Customer's financial terms for time period that is the subject of the market check, the parties will negotiate in good faith to revise the financial terms.","rationale":"The City may run one market check during the pharmacy pricing term. If the report shows more than three (3) percent annualized savings versus similar customers, the parties negotiate in good faith. There is no automatic meet, credit, or release. That is weaker than the Mark Cuban and collaborators most-favored model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.92,"page_ref":"Page 46","evidence_quote":"Once each calendar year during the term of the Agreement or any applicable runout period, a mutually agreeable entity, on behalf of Customer, may conduct a pharmacy claims audit for purposes of determining if United is administering its claims transactional services in accordance with Plan provisions.","rationale":"The City may run one pharmacy claims audit per calendar year through a mutually agreeable entity after signing a confidentiality agreement. Lookback is 18 months, December and January are off limits, and the period then closes. Rebate audits are limited to the top 5 agreements or 75 percent of rebate revenue, on site, with no copying of contracts. The City pays. That is narrower than the Mark Cuban and collaborators audit model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate's own behalf.","rationale":"The agreement never grants the City sole ownership of plan data. The business associate addendum lets United de-identify PHI and use and disclose it on its own behalf. After termination, post-runout data is provided only at United's discretion and subject to a fee. That permits the reuse the Mark Cuban and collaborators model is meant to stop.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.88,"page_ref":"Page 61","evidence_quote":"With respect to the aspects of United's performance addressed in this exhibit, these Fee adjustments are Customer's exclusive financial remedies.","rationale":"Pharmacy discount, dispensing-fee, and rebate guarantees are customer-specific and pay the annual shortfall in dollars. Medical performance guarantees are capped credits, often measured at the servicing office rather than this plan, and are the City's exclusive financial remedies. Many pharmacy exclusions apply, and United may modify or drop rebate guarantees. There is no quarterly cash settlement of the kind the Mark Cuban and collaborators model calls for.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"There are ordinary termination-for-cause rights with a 30-day cure, and guarantee credits that are exclusive financial remedies. There are no liquidated damages that pay without proving harm, and no two-strikes exit for a second material breach or regulatory integrity failure. Looked in Exhibit B default and termination, Exhibit A special terms, and Attachment D-6 guarantees.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.9,"page_ref":"Page 16","evidence_quote":"The Contract can be modified or amended only by a writing signed by both parties.","rationale":"Exhibit B says the contract can be modified only by a writing signed by both parties. Exhibit A lets the contractor change fees for each renewal with 30 days notice and replace Attachment D-5, and also change fees for plan, law, or enrollment events, including retroactive effective dates. United may specify new guarantee exhibits. Written mutual consent is not the only path.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"TERM","verdict":"partial","confidence":0.9,"page_ref":"Page 11","evidence_quote":"Either party shall have the right to terminate the Contract, in whole or in part, without cause any time upon thirty (120) calendar days' prior written notice following the Initial Term.","rationale":"Either party may terminate without cause after the initial term on thirty (120) calendar days written notice. Failure of appropriations is not a penalty event. If the City ends only pharmacy services without cause, United may keep unremitted rebates, and unused credits are forfeit with clawback if termination is before 12/31/2027. Exit is not clean under the Mark Cuban and collaborators model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"SPEC","verdict":"partial","confidence":0.88,"page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"Specialty drugs are defined by meeting at least 3 listed criteria, which is a functional definition. Pricing is not at acquisition cost. United designates the specialty list, affiliate specialty pharmacies are in network, and United keeps spread on specialty claims. Discount guarantees are annual AWP averages of 21.00 percent listed and 14.00 percent unlisted, not claim-level ceilings.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 13","evidence_quote":"(a) pricing, discounts, reimbursement terms, payment methodologies and payment processes, compensation arrangements, and any similar commercial information","rationale":"Pricing, discounts, reimbursement terms, payment methodologies, and compensation arrangements are Confidential Information. The City may use contractor confidential information only for plan administration, and United may demand a confidentiality agreement before disclosure. The parties must cooperate in seeking a protective order on public-records requests. Fee pages are stamped Proprietary Information of UnitedHealth Group. No pharmacy-to-patient gag was found, but treating pricing as confidential in a way that can block government disclosure is a bad score under the Mark Cuban and collaborators gag item.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 11","evidence_quote":"VENDOR and CITY acknowledge and agree that, except with respect to its fiduciary obligations as specifically delegated and accepted by VENDOR pursuant to this CONTRACT, VENDOR shall not be (i) the administrator of the Plan for any purpose; (ii) a named fiduciary with respect to the Plan for purposes of ERISA or any applicable state law;","rationale":"The vendor agrees to act as a fiduciary only for the narrow job of deciding claims and appeals, and then disclaims fiduciary status and discretionary authority for everything else. That leaves formulary placement, pricing lists and manufacturer money outside any duty of loyalty to the city. The model contract published by Mark Cuban and collaborators requires loyalty and care owed solely to the plan and its members across the whole relationship. Read together with the clause on page 10 that lets the vendor keep manufacturer fees, this is the opposite of the model.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 10","evidence_quote":"may receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies, including, without limitation, administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost","rationale":"The contract does disclose that the vendor and its affiliates take manufacturer money, and it gives a range of one to four percent of wholesale acquisition cost. That is a book of business range, not the amounts actually earned on San Antonio claims, and nothing requires a named officer to certify quarterly or annually that everything has been disclosed and remitted. There is no schedule of consultant or broker payments either. The subject is addressed but far more weakly than the model contract published by Mark Cuban and collaborators.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.6,"page_ref":"Page 21","evidence_quote":"VENDOR agrees to notify CITY of any changes in VENDOR’S ownership interest greater than 50%, or control of its business entity, not less than sixty (60) days in advance of the effective date of such change, or as soon as permitted by applicable law if later.","rationale":"There is no signed exhibit listing the vendor's owners, parents, subsidiaries, affiliates, group purchasing organizations, mail pharmacies or specialty pharmacies. The only ownership disclosure is advance notice of a change of more than fifty percent ownership or control, plus the city ethics disclosure statement referenced on page 28. The contract repeatedly refers to affiliates and to vendor owned mail and specialty pharmacies without naming any of them, so the city cannot check affiliate pricing or steering against a known list.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"Rebates are defined on page 2 as formulary rebates, base and market share only, and page 10 then carves manufacturer fees, other compensation and purchase discounts out of the term entirely and assigns them to the vendor. Brand, generic and specialty drugs are all classified by the vendor using its chosen data source, and the MAC list is set by the vendor. This is exactly the relabeling problem the definitions section of the model contract published by Mark Cuban and collaborators is written to stop. Value that would be plan money under a functional definition stays with the vendor here.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"Page 9","evidence_quote":"Remittance of Rebates. VENDOR will remit to CITY the Rebates received by VENDOR with respect to CITY’s Claims during the prior calendar quarter pursuant to Exhibit B. CITY acknowledges and agrees that it shall not have a right to interest on, or the time value of, any Rebate payments received by VENDOR or monies payable under this CONTRACT.","rationale":"The contract promises only the Rebates as defined, on terms set out in Exhibit B, which is not part of the posted document, so the share and the timing cannot be read. What can be read is that manufacturer administrative fees and purchase discounts are excluded from Rebates and belong exclusively to the vendor, that the city gives up any interest or time value on rebate money, and that remittance can be delayed after termination. That is materially less than the one hundred percent of all manufacturer revenue the model contract requires. Even if Exhibit B promised a full share of Rebates, the definition would keep the fee streams out of it.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.85,"page_ref":"Page 10","evidence_quote":"In addition, VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"Nothing in the contract prices claims filled by CVS owned mail or specialty pharmacies at net acquisition cost plus a stated dispensing fee. Instead the text confirms that purchase discounts earned on drugs bought by vendor affiliated dispensing pharmacies stay with the vendor and its affiliates. The plan pays the discount off list price that the withheld pricing exhibit sets, while the vendor keeps whatever it buys the drug for below that. That is the retained affiliate margin the model contract published by Mark Cuban and collaborators is designed to remove.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.75,"page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be the lowest of the discounted rate, the Participating Pharmacy’s reported U&C price, if applicable, and the VENDOR MAC rate, if applicable), plus the applicable dispensing fee","rationale":"There is a lesser of test on each retail claim, so the plan should not pay more than the pharmacy's reported usual and customary price at a network pharmacy. That is a ceiling of sorts and it is applied claim by claim. It is not the model standard, though, because the benchmark is the pharmacy's own reported price rather than a published transparent cash price, it depends on the pharmacy self reporting, and mail and specialty channels run on rates in the withheld Exhibit B rather than on any stated ceiling.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"The VENDOR’S Participating Pharmacies will dispense prescriptions to CITY plan members according to the CITY’S plan, and shall collect from the Plan Member the lowest of the applicable co-payment, the discounted price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Members at a network pharmacy pay the lowest of the copayment, the discounted price, the vendor MAC rate or the pharmacy's usual and customary price, which stops the most obvious clawback of paying more than the shelf price at that pharmacy. The sentence continues onto page 5 with the usual and customary reference. What is absent is any promise that a cash purchase outside the benefit counts toward the deductible or out of pocket maximum, and there is no accumulator provision at all, so the member who finds a cheaper cash price gets no credit for it.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"partial","confidence":0.8,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR in maintaining its generic pricing program.","rationale":"The city does get the MAC list before signing and again on reasonable request, which is more disclosure than many contracts give. But the vendor sets the prices and may amend the list whenever it likes, there is no update schedule, and nothing requires the list used to bill the city to be the same list used to pay pharmacies. There is also no pharmacy appeal path with deadlines. The model contract published by Mark Cuban and collaborators requires a single disclosed list for both sides of the transaction.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.75,"page_ref":"Page 15","evidence_quote":"CITY acknowledges that, except as expressly set forth herein, it shall not be entitled to audit agreements with vendors, pharmaceutical companies, Participating Pharmacies or other providers of products or services to VENDOR as part of a Claims audit.","rationale":"Nothing in the contract says the city pays exactly what the pharmacy is paid plus a disclosed fee. The city is billed the adjudicated ingredient cost built from discount rates and vendor MAC prices, while pharmacies are paid under separate network agreements that the city is expressly barred from auditing. That combination is what allows a spread to exist and stay invisible, which is the harm the model contract published by Mark Cuban and collaborators is written to prevent. The discount rates themselves are in Exhibit B, which is not in the posting, but no language anywhere in the body prohibits retained spread.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.9,"page_ref":"Page 9","evidence_quote":"CITY’s Authorization. CITY authorizes VENDOR to contract with pharmaceutical companies for Rebates as a group purchasing organization for the Plan.","rationale":"The vendor negotiates with drug makers as the plan's group purchasing organization, so purchase side money runs through it. Page 10 then states that the fees, compensation and purchase discounts collected in that role belong exclusively to the vendor or its affiliates and are not Rebates. The city is separately barred from going around the vendor to negotiate rebates or discounts of its own. So the purchasing entity revenue the model contract sends to the plan is kept by the vendor here.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"bad","confidence":0.8,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"The city adopted the vendor's own drug list as the plan formulary, and the vendor creates, maintains and amends it. The city gets thirty days notice before a drug moves or is removed, and quarterly notice for the specialty list, but notice is not approval and there is no right to reject a change. The model contract published by Mark Cuban and collaborators puts formulary approval in the plan sponsor's hands with lowest net cost support for each change. Here the party that collects the rebates also decides which drugs are preferred.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The formulary sections on pages 8 and 9 list the reasons the vendor may change its drug list, including cost effectiveness, but they set no lowest net cost standard for this plan and require no analysis to be delivered. The performance standards article on pages 13 and 14 covers service metrics, and the audit article on pages 14 to 17 covers claims and rebates, neither of which addresses formulary economics. There is no annual comparison against the vendor's book of business and no requirement to explain why a drug sits above a cheaper equivalent.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.7,"page_ref":"Page 5","evidence_quote":"VENDOR shall have the sole right to audit Participating Pharmacies.","rationale":"The vendor alone audits network pharmacies weekly and pursues recoveries from them, and the contract calls this its sole obligation on discrepancies, so retroactive recoupment against pharmacies is built in rather than barred. There is no any willing pharmacy clause, no bar on steering claims into the vendor's own mail and specialty pharmacies, and the scope of services routes mail and specialty volume to those affiliated pharmacies by design. Claims are also not final when adjudicated. This permits the steering and clawback pattern the model contract published by Mark Cuban and collaborators forbids.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the five year term gives the city pricing at least as good as comparable clients, and there is no market check. The consideration article on page 17 simply points to Exhibit B, the term article on pages 18 and 19 sets a five year term with a two year option and no repricing trigger, and the performance standards on page 13 may be adjusted no more than once a year by mutual agreement, which is not a market check with a meet, credit or release remedy. The city's only real lever is termination on notice.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 15","evidence_quote":"Such audit shall be limited to a review of up to ten (10) pharmaceutical company contracts directly related to CITY’s Rebates as selected by CITY.","rationale":"The city has real audit rights, including an annual claims audit, an annual rebate audit, a post termination audit and delivery of SOC 1 reports and audited financials. Those rights are then narrowed at every turn: one on site audit per plan year, an auditor who must be mutually acceptable and must sign the vendor's confidentiality agreement, no access to the vendor's agreements with pharmacies or drug makers, a ten contract cap on the rebate audit, vendor comment on the draft report, and claims data reissued at vendor cost. The city does get claims data through an online portal and standard reporting. This is narrower than the model, which gives the plan its own auditor, scheduled full claims and financial data, and no proprietary withholding.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"partial","confidence":0.85,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"The city owns information produced solely and exclusively for it, and page 29 says all files are city property and must be delivered at termination. Two carve outs weaken that. The vendor keeps its trade secret rights in material inside city information, and the vendor may use, adapt and even sell deidentified claims and eligibility data, including sharing it with data integration firms. There is also no promise to deliver plan data in machine readable form on request, and files given to a replacement vendor must be scrubbed of the vendor's confidential information.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 13","evidence_quote":"With respect to the aspects of VENDOR’S performance addressed in Exhibit A, these amounts at risk are CITY’S exclusive financial remedies. The Total Dollars at risk will be $175,000 as set forth in Exhibit A.","rationale":"Guarantees exist, they are measured on San Antonio claims only rather than book of business data, and shortfalls are taken out of amounts owed to the vendor within sixty days. But the total at risk is capped at $175,000, that money is the city's exclusive financial remedy for the guaranteed items, settlement happens once a year at reconciliation rather than quarterly, and the guarantee schedule itself sits in Exhibit A, which is not in the posting. Capped and annual is weaker than the dollar for dollar quarterly reconciliation the model contract calls for.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.7,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform as defined in Exhibit A Performance Guarantees (or after the close of any annual audit finding that the reported results were inaccurate).","rationale":"Penalties come off the vendor's invoice without the city having to prove damages, which is a self executing remedy, and misappropriated funds and processing overpayments must be repaid within thirty days. The weakness is that the trigger is the vendor's own reporting of its failure, the amounts are capped and exclusive, and late or missing reports carry no liquidated damages. There is no two strikes exit either: termination for cause requires a thirty day cure and there is no regulatory integrity trigger, while termination for convenience costs the city a pro rata repayment of credits.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"partial","confidence":0.75,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"The amendment clause itself is strong and matches the model: nothing binds unless it is written, dated and signed by both parties, and the entire agreement clause on page 34 repeats it. The problem is elsewhere in the text. The MAC definition on page 2 lets the vendor amend the pricing list that determines what the city pays whenever it chooses, and the formulary sections on pages 8 and 9 let the vendor change the drug list on notice. So economics can move without a signed amendment even though the contract language cannot.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"It is understood that in the event of Termination by Notice initiated by CITY, a pro rata share of any credits disbursed by VENDOR for the calendar year in which the termination occurred as well as a pro rata share of the actual implementation credit amount","rationale":"The city may cancel without cause on ninety to one hundred twenty days notice, and may also stop the contract if funds are not appropriated, which is a genuine exit. It is not penalty free. Leaving early means repaying a pro rata share of credits the vendor disbursed, including the implementation credit spread over the initial term, and the vendor may delay remitting rebates after termination. Record transfer is at the vendor's cost only if the city has completed three years of the term. There is also no regulatory integrity event listed as grounds for termination.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"partial","confidence":0.7,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease, including but not limited to, injectible, infused, or oral medication, or product that otherwise require special handling.","rationale":"Specialty is defined loosely by disease type and handling, and the definition leans on what the vendor uses rather than on a fixed functional test, so the vendor decides what counts as specialty. The plan runs on the vendor's Advance Control Specialty Formulary, specialty prescriptions are filled by the vendor's own specialty pharmacy, and specialty drugs are the one category exempted from the once a year limit on formulary removals. No drug level rate ceiling and no acquisition cost pricing appears in the body, and the specialty rates would sit in Exhibit B, which is not in the posting.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data, trade secrets","rationale":"Costs and pricing data are treated as confidential information, and the vendor asserts that some of the contract itself is confidential. Under the Public Information Act clause on page 36 the city must notify the vendor of any request, give it time to argue exemption to the Texas Attorney General or a court, agree not to oppose that effort, and release only the minimum if ordered. The rebate audit clause on page 15 goes further and says the terms of manufacturer contracts reviewed in an audit may not be revealed to any third party, including the city. The city may share data with its own consultants and auditors under separate confidentiality agreements, but for a taxpayer or a reporter this is a clause set that blocks disclosure of what the plan pays.","model_own_total":21,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 34","evidence_quote":"Customer appoints United a named fiduciary under the Plan with respect to (i) performing initial benefit determinations and payment and (ii) performing the fair and impartial review of first level internal appeals.","rationale":"The only fiduciary role the contract grants United is for claim determinations and first level appeals on the medical side. Everywhere else the contract disclaims the role: Section 5.1 of Exhibit D says United is not the Plan Administrator, and the pharmacy terms let United set MAC lists, classify formulary tiers, and retain spread at its own discretion with no duty of loyalty to the plan. There is no obligation to disclose all direct and indirect compensation, no duty to disclose economic conflicts, and no requirement to give back anything retained in breach. The model contract by Mark Cuban and collaborators makes loyalty, disclosure, and disgorgement the foundation, and this contract permits exactly the self dealing that foundation exists to prevent.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 42","evidence_quote":"Claims Processor Fees. United maintains systems for processing pharmacy claims and may receive access fees and charges for marketing and administrative services as compensation for services United provides to Network Pharmacies.","rationale":"The contract does acknowledge some revenue streams: access fees from network pharmacies on page 42, a 1 to 3 percent transaction fee to a United affiliate on provider payments on page 60, the $2.00 PMPM Lockton consultant fee on page 67, and the spread United retains. But none of these disclosures carry amounts, totals, or a full accounting of direct and indirect compensation, and there is no officer certification that everything has been disclosed and remitted. The City's consultant payment is disclosed, which is more than most contracts show, but the model requires complete certified disclosure and this is piecemeal.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit lists United's owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, mail order pharmacies, or specialty pharmacies, and there is no duty to refresh ownership information on 30 days notice. The only ownership-adjacent document is the Form CIQ on pages 85 to 86, which asks only whether the vendor has conflicts with City officers; United answered that it has no conflict of interest to disclose. The words affiliate and affiliates appear in the service terms, for example in the pharmacy definitions on page 41, but only to confirm that affiliated home delivery and specialty pharmacies participate, never to enumerate them in a signed exhibit.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 41","evidence_quote":"Rebate does not include any discount, price concession , Manufacturer Administration Fees, or other direct or indirect remuneration United or a group purchasing organization receives from a Drug Manufacturer for direct purchase of a Prescription Drug or for the provision of any product or service or tool, including analytical services used in the review of data.","rationale":"The definitions are built around labels rather than economic function. Brand and generic status come from Medi-Span indicator codes, MAC pricing is whatever United puts on lists it controls, and the Rebate definition affirmatively excludes anything a group purchasing organization receives and any payment tied to a product, service, tool, or data analytics. Attachment D-6 on page 66 then confirms manufacturer administrative fees are outside the guaranteed rebate arrangement, so value relabeled as a fee or pushed through a purchasing entity escapes the 100 percent sharing. This is the relabeling loophole the model contract's definitions exist to close.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.87,"page_ref":"Page 64","evidence_quote":"Minimum Rebate Guarantee (Traditional PDL) Rebate Sharing Percentage 100.0%","rationale":"Pharmacy-benefit rebates are shared at 100 percent with per-script minimum guarantees of $730.25 per retail brand script in year one rising to $1,066.98 by year three, reconciled after each contract year. That is the strongest dollar protection in the contract. But it covers only the narrow Rebate definition: manufacturer administrative fees, purchase discounts, GPO remuneration, and United's other manufacturer revenue stay with United, the first payment can arrive 210 days after a quarter instead of within 30 days, and medical-benefit drug rebates pass through at only 80 percent per page 58. One hundred percent of a carved-up definition is not 100 percent of everything.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 45","evidence_quote":"United or its affiliates, acting as a Home Delivery Pharmacy or a Specialty Pharmacy, purchase Prescription Drugs from Drug Manufacturers and receive certain discounts and purchase rebates from Drug Manufacturers in connection with these purchases. United retains these discounts and purchase rebates and does not pass them on to Customer.","rationale":"United's own home delivery and specialty pharmacies not only keep purchase discounts and rebates on drugs they dispense, they also keep the spread between what the pharmacy is paid and what the City is charged, per pages 43 and 67. Nothing prices affiliate-dispensed claims at net acquisition cost plus a disclosed dispensing fee, and there is no documentation default. The model contract's acquisition-cost rule exists to remove the incentive to fill through owned channels; this contract builds the incentive in.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.91,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the document caps the plan's claim cost at a published benchmark or a transparent cash price, and nothing tests cost claim by claim against such a ceiling. The guarantees in Attachment D-6 (pages 61 to 68) are average discounts off average wholesale price measured annually, which can sit far above any cash benchmark, and the only benchmark references on pages 67 and 68 describe circumstances that let United revise or revoke its own guarantees. The lesser-of-three rule on page 67 caps what a member pays at the counter, not what the plan pays United.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"CASH","verdict":"partial","confidence":0.85,"page_ref":"Page 67","evidence_quote":"The lesser of three logic (non-ZBL) will apply to Participant payments. Participants pay the lesser of the discounted price, the usual and customary charge or the cost share amount.","rationale":"Members pay the lesser of the discounted price, the pharmacy's reported usual and customary cash price, or their cost share, so a member should not pay more than the cash price the pharmacy reports. That covers half of what the model asks for. Nothing says a cash purchase counts toward the deductible or out of pocket maximum, and the contract never addresses accumulator adjustment programs at all; the word accumulator appears only in the termination-assistance file transfer clause on page 47. The member protections stop at the point of sale.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"MAC","verdict":"bad","confidence":0.94,"page_ref":"Page 41","evidence_quote":"United may have multiple MAC lists, each of which is subject to United's periodic review and modification in its sole discretion.","rationale":"The MAC definition on pages 40 to 41 is the classic spread-pricing setup: United may run multiple maximum allowable cost lists, each changed at its sole discretion, with no disclosure requirement, no update schedule, and no pharmacy appeals path anywhere in the document. Because the contract also lets United keep the difference between plan-side and pharmacy-side reimbursement, two different MAC lists (one billed to the City, one paid to the pharmacy) are fully permitted. The model contract's single disclosed MAC list with appeal rights is absent in every particular.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"SPRD","verdict":"bad","confidence":0.96,"page_ref":"Page 43","evidence_quote":"For home delivery, retail and specialty pharmacy services, United may retain the difference between the amount which United reimburses the Network Pharmacy and the amount which Customer pays for a Prescription Drug or service.","rationale":"Spread pricing is not just permitted; it is stated twice. Page 43 authorizes United to keep the difference between pharmacy reimbursement and the City's payment in the home delivery, retail, and specialty channels, and page 67 repeats it for mail order, specialty, and retail pharmacy drugs and services including dispensing fees. The discount guarantees in Attachment D-6 are measured against average wholesale price, so they coexist with per-claim spread rather than replacing it. The model contract requires the plan to pay exactly what the pharmacy is paid plus a disclosed fee; this contract is the opposite.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"GPO","verdict":"bad","confidence":0.92,"page_ref":"Page 45","evidence_quote":"Nothing in this Agreement shall preclude United from pursuing, directly or indirectly, other sources of revenue from Drug Manufacturers or engaging in other revenue-producing relationships with Drug Manufacturers.","rationale":"United reserves the right to keep other manufacturer revenue streams, and its affiliates acting as home delivery or specialty pharmacies keep purchase discounts and purchase rebates without passing them to the City. The Rebate definition on page 41 separately excludes anything a group purchasing organization receives for direct purchase or for products, services, or data tools. Together these clauses move exactly the revenue categories the model contract's purchasing-entity pass-through targets outside the City's reach, with no allocation on disclosed drivers.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.86,"page_ref":"Page 44","evidence_quote":"While Customer is the ultimate decision-maker on selecting the design of Customer's PDL(s), Customer has requested that United supply and assist Customer with certain PDL development and management functions including but not limited to drug tiering decisions.","rationale":"The City is named the ultimate decision-maker on formulary design, which is real authority. In practice United makes the final classification of each drug's tier, considering economic factors including available rebates, and the City must stop using the formulary at termination and cannot share it without United's written approval. Utilization management criteria are proprietary and withheld from the City and its vendors, and any customization needs United's approval and may cost extra. Plan control exists on paper but the levers that determine net cost stay with the PBM.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"LNC","verdict":"bad","confidence":0.88,"page_ref":"Page 44","evidence_quote":"Economic factors may include, but are not limited to, the Prescription Drug's acquisition cost including, but not limited to, available Rebates, and assessments on the cost effectiveness of the Prescription Drug.","rationale":"Tier placement expressly weighs the rebates a drug generates, and page 44 also tells the City that United negotiates rebates based on its whole book of business, not this plan. There is no lowest-net-cost standard for this plan, no annual comparison against United's book of business, and no disclosure when a drug is placed above a cheaper equivalent. A formulary that counts available rebates as a reason to favor a drug is the rebate-driven placement the model contract's lowest-net-cost standard is meant to expose.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.87,"page_ref":"Page 67","evidence_quote":"All pricing guarantees require the selection of United's PBM as exclusive provider of pharmacy benefit services, including but not limited to retail, mail order, and specialty networks.","rationale":"The guarantees are conditioned on exclusive use of United's PBM across retail, mail, and specialty, and page 42 makes United the City's exclusive provider of prescription drug benefit services. There is no any-willing-pharmacy right, no bar on steering members to United's affiliated home delivery or specialty pharmacies, and no protection against retroactive claim clawbacks; the medical attachment's cross-plan offset process even lets other plans' overpayment recoveries reduce payments under this plan. United designates and can re-designate the specialty drug list, which controls which pharmacy may fill. The network protections the model contract lists are absent, and exclusivity plus affiliated steerage is affirmatively built in.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 66","evidence_quote":"Customer may conduct one market check during the Pharmacy Pricing Term to confirm its financial terms are competitive with those currently available in the market","rationale":"The City gets one market check during the three-year pharmacy pricing term, run by a mutually agreed third party against at least four substantially similar customers. But there is no most-favored-pricing promise, the remedy triggers only if the report shows more than three percent savings against the median, and even then the parties merely negotiate in good faith, with any change effective the next contract year and requiring a signed amendment 60 days ahead. The model's automatic meet, credit, or release remedy is not here.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.86,"page_ref":"Page 46","evidence_quote":"United will provide Customer's auditor with access to all relevant Customer-specific information reasonably necessary to conduct the audit, including all applicable Prescription Claims, and, in the case of a Rebate audit, access to United's top 5 Rebate agreements or Rebate agreements that account for at least 75% of the Customer's total Rebate revenue generated per year, whichever is less.","rationale":"A real audit right exists: one pharmacy claims audit per calendar year with access to the City's own claims. But the auditor must be mutually agreeable and sign United's confidentiality agreement first, look-back is capped at 18 months, audits are barred in December and January, each period can be audited only once, and rebate-contract review is limited to the lesser of the top five agreements or 75 percent of rebate revenue, on-site only, with no copying and United reviewing the auditor's notes. Ongoing reporting is just United's standard online reports with no pre-adjudication access, and any payment requires a mutually signed settlement. The model's open-data, own-auditor standard is substantially narrowed here.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.82,"page_ref":"Page 50","evidence_quote":"de-identify PHI received or created by Business Associate under this BAA in accordance with the Privacy Rule, which de-identified information does not constitute PHI, is not subject to this BAA and may be used and disclosed on Business Associate's own behalf.","rationale":"The contract never says the City owns its claims, eligibility, accumulator, or rebate data, and there is no right to machine-readable delivery on request; standard online reports and up to twelve transition file transmissions at termination are all the delivery the text promises. Worse, the business associate agreement lets United de-identify the City's health data and use and disclose it for United's own purposes, and page 14 says post-termination information requests are answered at United's discretion for a fee. The City gets working access but not ownership, and the vendor gets a permanent reuse right in de-identified form.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer's Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee.","rationale":"Attachment D-6 contains both operational guarantees and pharmacy financial guarantees, including per-script rebate minimums reconciled to actual receipts, which is more than many contracts offer. But the operational guarantees put only small fixed amounts at risk, $11,000 and $5,500 per metric, measured annually at office or site level and paid as fee credits, and page 61 makes those credits the City's exclusive financial remedies. Measurement is annual rather than quarterly, force majeure and legal-change carve-outs let United escape the guarantees, and United may specify new guarantees each period. Real dollars are guaranteed, but the remedies are capped credits, not cash shortfall payments.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.82,"page_ref":"Page 61","evidence_quote":"The Fees payable by Customer under this Agreement will be adjusted through a credit to Customer's Fees in accordance with the guarantees set forth below unless otherwise defined in the guarantee. Unless otherwise specified, these guarantees are effective for the period beginning January 1, 2025 through December 31, 2025 (\"Guarantee Period\").","rationale":"Missed financial and operational guarantees convert into automatic fee credits without the City proving damages, which is the self-executing half of the model's enforcement design. The other half is missing: there are no liquidated damages for late reports, audit recoveries require a mutually signed settlement agreement, disputes go to confidential arbitration capped at actual damages with no punitive awards, and nothing gives the City a penalty-free exit after a second material breach or a regulatory integrity event. Termination for cause under Exhibit B requires a 30-day cure period every time. Enforcement beyond the guarantee credits depends on litigation the City must initiate.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"AMD","verdict":"partial","confidence":0.84,"page_ref":"Page 16","evidence_quote":"The Contract can be modified or amended only by a writing signed by both parties.","rationale":"Exhibit B Section 48 has the model's core rule: modification only by a writing signed by both parties. But Exhibit A Section 3 lets United change fees on 30 days notice at each renewal, and also at any time when plan terms, law, or enrollment shift by 10 percent, with new fees effective retroactively; the City's only remedy is to terminate. Attachment D-6 separately lets United revise or revoke pricing guarantees and rebate guarantees for a long list of market and legal changes. Economic terms can therefore move by notice even though the contract itself cannot formally be amended unilaterally.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 59","evidence_quote":"if Customer terminates the Pharmacy Benefit Services portion of this Agreement only during the Term of the Agreement and termination is for any reason other than for cause, United may retain all Rebates that have not been remitted to Customer as of the effective date of such termination.","rationale":"Convenience termination is only available after the three-year initial term, on 120 days notice (the text shows an OCR-garbled figure), and the contract auto-renews each year. The decisive problem is forfeiture: if the City exits pharmacy services for any reason other than cause, United keeps all rebates earned but not yet remitted, and page 66 adds that no reconciliation of the minimum rebate guarantee applies either; ending pharmacy services also lets United raise the medical fees. Earned amounts are forfeited and the guarantee vanishes, which is precisely the trap the model contract's termination clause exists to prevent.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"SPEC","verdict":"bad","confidence":0.93,"page_ref":"Page 69","evidence_quote":"On specialty drugs, United will retain the difference between what United reimburses the Network Pharmacy and Customer's payment for a prescription drug product or service.","rationale":"Specialty is defined by a functional criteria list, which is a start, but United designates the specialty drug list, may re-designate drugs from specialty to non-specialty based on market conditions, and keeps the spread on every specialty claim. Specialty drugs dispensed through United's specialty network are excluded from the retail and mail guarantees and get their own aggregate discount target (about AWP less 21 percent for listed drugs), with no drug-level ceiling and no acquisition cost pricing at the affiliate specialty pharmacy. The model's controls on the channel where PBMs earn the most margin are absent.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0006","contract_slug":"city-of-denton-unitedhealthcare-optumrx-2025","entity":"City of Denton","vendor":"United HealthCare Services, Inc. (OptumRx)","model":"Kimi K3","rubric_key":"GAG","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"If a Party is requested or required to disclose Confidential Information by subpoena, legal process, or Law, including public records acts, such Party shall (to the extent permitted by Law) provide the other Party with immediate written notice of that request or requirement.","rationale":"The confidentiality clause on pages 13 to 14 defines pricing, discounts, reimbursement terms, and compensation arrangements as Confidential Information and restricts the City to using United's confidential information only for plan administration, with any further disclosure conditioned on a mutually agreed confidentiality agreement. But it does carve out disclosures required by law including public records acts, subject to notice and cooperation with the vendor's effort to seek a protective order, and Exhibit B Section 35 confirms public nature is judged under the Texas Public Information Act. The SSAE18 security report is separately locked down on pages 53 to 54. Pricing secrecy exists but is limited by the public-records carve-out, so this is a limited gag rather than a full one. Nothing restricts pharmacies from telling patients about cheaper options in this text.","model_own_total":22,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"The contract explicitly limits the PBM's fiduciary duties solely to initial claim adjudication and appeals, denying a broader duty of loyalty or care.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not require full disclosure of all compensation or conflicts, nor does it mandate an officer's certification of compliance. Although \"Exhibit B Administrative Fees\" is missing, the body text does not mention any comprehensive disclosure or officer certification.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include an exhibit listing the PBM's affiliates, mail order pharmacies, specialty pharmacies, or group purchasing organizations. There is no requirement to regularly update a disclosure of all related entities.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"bad","confidence":0.98,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"The contract explicitly excludes administrative fees (up to 4% of WAC) and purchase discounts from the definition of \"Rebates\", ensuring they are not passed through to the plan.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies, including, without limitation, administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost","rationale":"Because the contract lets the PBM or its affiliates retain administrative fees and concurrent or retrospective discounts on purchase prices, 100% of manufacturer revenue is not passed through to the plan sponsor.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not state that the PBM's mail or specialty pharmacies will invoice claims at their net acquisition cost. While there is an \"Administrative Fees\" exhibit (Exhibit B) that is withheld, the body text does not establish acquisition cost pricing as a standard.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The text defines \"Claim costs\" as the lowest of the discounted rate, U&C, and MAC, but this is a standard \"lesser of\" clause. It does not establish a published, transparent benchmark ceiling (like NADAC) checked claim by claim.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no clause guaranteeing that members can pay the cash price if it is lower than their copay, or that any such cash purchases will count toward their deductible and out-of-pocket maximum.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"bad","confidence":0.95,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR","rationale":"The contract allows the PBM to set and amend the MAC list at its own discretion without guaranteeing a single list for both pharmacies and the plan. It also notes the plan's MAC list is specific to the plan, implying separate lists could exist.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not explicitly prohibit spread pricing or state that the plan will pay exactly what the pharmacy is paid plus a disclosed administrative fee. The definition of \"Claim costs\" only dictates what the plan pays, not that it perfectly matches pharmacy reimbursement.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"Instead of passing purchase discounts and supplier payments through to the plan, the contract explicitly states that discounts on products purchased by PBM-affiliated pharmacies belong exclusively to the PBM or its affiliates.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"bad","confidence":0.95,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"The PBM manages the formulary and can change it based on various considerations. The plan sponsor merely adopts the PBM's formulary, giving the PBM control over which drugs are covered and on which tiers.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no requirement for the PBM to make formulary decisions based on a lowest net cost standard, nor is there a provision for an annual book of business comparison to check pricing performance.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"VENDOR shall have the sole right to audit Participating Pharmacies.","rationale":"The contract gives the PBM the exclusive right to audit pharmacies, which is a tool often used to steer claims. There are no protections against retroactive clawbacks, volume-conditioned reimbursement, or steering to PBM-owned channels.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract contains no provision for a market check or a guarantee that the plan sponsor receives pricing at least as favorable as the PBM's comparable clients.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"bad","confidence":0.95,"page_ref":"Page 15","evidence_quote":"CITY acknowledges that, except as expressly set forth herein, it shall not be entitled to audit agreements with vendors, pharmaceutical companies, Participating Pharmacies or other providers of products or services to VENDOR as part of a Claims audit.","rationale":"The contract heavily restricts audit rights. The plan is limited to auditing once per year, the auditor must sign a PBM-approved confidentiality agreement, and the plan is explicitly denied access to the PBM's agreements with pharmaceutical companies and pharmacies.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"While the contract states the plan owns data produced solely for the plan, it permits the PBM to use, disclose, adapt, or sell de-identified claims and eligibility data for its own benchmarking and programs.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"unclear","confidence":0.95,"page_ref":"Page 32","evidence_quote":null,"rationale":"The specific performance guarantees, metrics, and whether shortfalls are paid dollar-for-dollar or as capped credits are located in \"Exhibit A - VENDOR’S Performance Guarantees\", which is listed on Page 32 but omitted from the provided document.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no provisions for automatic remedies or liquidated damages without proving damages, nor is there a two-strikes exit for repeat material breaches or regulatory integrity failures. Standard 30-day cure periods for default apply.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"partial","confidence":0.8,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"The contract nominally requires amendments to be in writing and signed by both parties. However, it allows the PBM to unilaterally alter economic terms like the MAC list and the formulary (PDL).","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"good","confidence":0.95,"page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause upon written notice, provided such notice specifies an effective date of termination, which shall be not less than 90 calendar days nor more than 120 calendar days after the date of receipt of the notice by the other party.","rationale":"The plan sponsor may terminate the contract without cause by providing 90 to 120 days' written notice. There are no apparent penalties for termination, only the requirement to repay a pro rata share of unearned implementation credits.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract defines \"Specialty Drugs\" but it does not establish drug-level rate ceilings, nor does it mandate that specialty claims at affiliate pharmacies be priced at net acquisition cost.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 34","evidence_quote":"costs and pricing data, trade secrets, know-how, processes, plans, designs and other information of or relating to either party’s business. VENDOR asserts that certain information contained in this Contract constitutes Confidential Information.","rationale":"The contract broadly defines pricing, MAC lists, and fee schedules as confidential trade secrets. Disclosures to the plan's own advisors or auditors require them to sign a PBM-approved confidentiality agreement, obstructing transparency.","model_own_total":3.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the\n          purpose of initial Claim adjudication and appeals relating to the coverage of\n          prescription drug benefits.","rationale":"The vendor agrees to be a fiduciary only for initial claim adjudication and appeals. The same section says it is not the plan administrator, not a named fiduciary, and has no discretionary authority over the plan. That contradicts the loyalty and care duty in the model contract published by Mark Cuban and collaborators. The vendor can still put mail, specialty, and manufacturer revenue ahead of the City and its members.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 10","evidence_quote":"administrative fees that range between one percent\n                  (1%) and four percent (4%) of the Wholesale Acquisition Cost\n                  (“WAC”) of the products dispensed across VENDOR’s book\n                  of business.","rationale":"The contract discloses that the vendor and affiliates may receive and keep manufacturer administrative fees of 1 percent to 4 percent of WAC, plus purchase discounts at affiliated pharmacies. There is no named officer certification and no quarterly or annual attestation that every related entity payment was disclosed and remitted. The conflict of interest article on pages 27 to 28 is City ethics, not a full PBM compensation inventory.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no signed exhibit listing owners, parents, subsidiaries, affiliates, GPOs, rebate aggregators, or mail and specialty pharmacies. Section 14.3 on page 21 only requires notice of a greater than 50 percent ownership or control change. The exhibit list on page 32 names performance guarantees, fees, the BAA, SBEDA, the RFP, and the proposal, not an ownership schedule.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 2","evidence_quote":"“Rebates” means the formulary rebates, including base and market share rebates, collected\n    by VENDOR in its capacity as a group purchasing organization for the Plan from various\n    pharmaceutical companies that are attributable to the utilization of brand, prescription\n    drugs by Plan Members.","rationale":"Rebate is limited to formulary base and market share rebates on brand drugs collected as a group purchasing organization. Page 10 then says Rebates do not include administrative fees or affiliated pharmacy purchase discounts, which belong exclusively to the vendor. Brand, generic, MAC, and specialty are identified or set by the vendor, so value can be relabeled and kept.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"term “Rebates” as used in this CONTRACT does not include\n                  the fees, compensation, and concurrent or retrospective\n                  discounts associated with the purchase price of products\n                  described in this Section which belong exclusively to\n                  VENDOR or its affiliates.","rationale":"Page 9 says the vendor will remit Rebates for the prior quarter under Exhibit B, which is not posted. The body already lets the vendor keep 1 percent to 4 percent WAC administrative fees and concurrent or retrospective purchase discounts, and says those sums belong exclusively to the vendor and affiliates. That is not 100 percent pass through of manufacturer revenue of every kind.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.92,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive\n                  concurrent or retrospective discounts from pharmaceutical\n                  companies which are attributable to or based on products\n                  purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The vendor processes claims at its own mail and specialty pharmacies under the same lowest of discounted rate, U&C, and MAC formula on page 4. Affiliates may receive and retain purchase discounts on products those pharmacies buy. There is no net acquisition cost plus dispensing fee invoice and no documentation default if cost records are withheld.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"CEIL","verdict":"partial","confidence":0.82,"page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be\n    the lowest of the discounted rate, the Participating Pharmacy’s reported\n    U&C price, if applicable, and the VENDOR MAC rate, if applicable),\n    plus the applicable dispensing fee","rationale":"Plan claim cost is the lowest of the discounted rate, the pharmacy U&C, and the vendor MAC, plus a dispensing fee. That is a claim level usual and customary check, not a published independent cash benchmark that the plan can never exceed. The City can still pay more through the contract than a transparent cash price at a public benchmark site.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"CASH","verdict":"partial","confidence":0.84,"page_ref":"Page 4","evidence_quote":"shall collect from\n    the Plan Member the lowest of the applicable co-payment, the discounted\n    price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Participating pharmacies collect the lowest of copay, discounted price, MAC, or, as continued on page 5, the pharmacy usual and customary price. That is limited cash price protection at network pharmacies. Nothing credits an outside cash purchase toward the deductible or out of pocket maximum, and nothing bars accumulator adjustment against member assistance.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.93,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by\n    VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the\n    MAC drug list applicable to CITY, which list may be amended from time to time by\n    VENDOR in maintaining its generic pricing program.","rationale":"The vendor establishes the City MAC list and may amend it from time to time while running its generic pricing program. A copy is available before execution and on reasonable request, and the City is told it is not the CMS list. There is no single list for plan payment and pharmacy payment, no update schedule, and no pharmacy appeals path. Vendor discretion over MAC is the classic spread tool.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.9,"page_ref":"Page 4","evidence_quote":"the lowest of the discounted rate, the Participating Pharmacy’s reported\n    U&C price, if applicable, and the VENDOR MAC rate, if applicable),\n    plus the applicable dispensing fee","rationale":"The plan pays an adjudicated ingredient cost of lowest of discounted rate, U&C, and vendor MAC, plus a dispensing fee. The contract never says the City pays exactly what the pharmacy is paid plus a disclosed administrative fee. Page 15 also bars the City from auditing pharmacy network agreements. That structure permits spread in retail, mail, and specialty.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"GPO","verdict":"bad","confidence":0.94,"page_ref":"Page 9","evidence_quote":"CITY authorizes VENDOR to contract\n       with pharmaceutical companies for Rebates as a group\n       purchasing organization for the Plan.","rationale":"The City authorizes the vendor to contract with manufacturers as a group purchasing organization for Rebates. Page 10 then assigns manufacturer administrative fees and affiliated pharmacy purchase discounts exclusively to the vendor and affiliates. Purchase discounts, volume credits, and supplier payments at the GPO or purchasing entity do not flow to the plan.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"FORM","verdict":"bad","confidence":0.93,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL,\n     as in effect from time to time, which the CITY has adopted as\n     part of the Plan design and as CITY’s formulary.","rationale":"The City adopted the CVS Health PDL as its formulary, and the vendor manages that list as in effect from time to time. The vendor gives 30 days notice before adding, removing, or moving a drug, which is notice rather than City approval of each change. Page 9 lets the vendor add or remove drugs on the Advance Control Specialty Formulary with quarterly notice.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Formulary management on pages 8 to 9 lists cost effectiveness as one factor among safety, efficacy, new products, and industry changes. That is not a lowest net cost standard for this plan. There is no annual comparison against the vendor's book of business and no duty to disclose a drug placed above a cheaper equivalent. Account management on page 4 also lacks that standard.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"NET","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Pages 4 to 5 describe vendor contracts with independent participating pharmacies and claims at the vendor mail and specialty pharmacies. Page 5 gives the vendor the sole right to audit pharmacies. Customer service on page 7 helps members locate a retail network pharmacy. Nothing makes claims final at adjudication, forbids steering into vendor pharmacies, forbids volume conditioned pay, or requires any willing pharmacy at the plan's terms.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Consideration and billing on pages 17 to 18, the term article on pages 18 to 19, performance standards on pages 13 to 14, and the exhibit list on page 32 do not contain most favored pricing or an annual market check. There is no meet, credit, or release remedy if another comparable client has better pricing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 15","evidence_quote":"it shall not be entitled to audit agreements with vendors, pharmaceutical\ncompanies, Participating Pharmacies or other providers of products or services to VENDOR as\npart of a Claims audit.","rationale":"The City may run limited annual claims and rebate audits, and page 7 gives portal access to claims data. Audits are one on site review per plan year, need a mutually acceptable auditor who signs the vendor confidentiality form, cannot reach pharmacy or manufacturer contracts, and limit rebate review to 10 contracts. That is weaker than the plan's own auditor, full financial data on a schedule, and no proprietary withholding.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"DATA","verdict":"partial","confidence":0.88,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is\n    deidentified in accordance with HIPAA and other applicable law, and which is not identifiable\n    on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by\n    VENDOR only as allowed by federal or state law.","rationale":"Section 8.1 says the City owns information produced solely and exclusively for the City, and page 29 says files are City property. The same section lets the vendor use, disclose, adapt, or sell deidentified claims and eligibility data and reserves vendor trade secrets. The City is not the sole owner of all claims, rebate, and derived data with a ban on reuse or sale.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.86,"page_ref":"Page 13","evidence_quote":"these amounts at risk are CITY’S\nexclusive financial remedies. The Total Dollars at risk will be $175,000 as set forth in Exhibit A.","rationale":"Performance standards exist and, for claims operations, are measured on City claims. The total dollars at risk are $175,000 under Exhibit A, which is not posted, and those amounts are the City's exclusive financial remedies. Settlement is annual rather than quarterly cash, dollar for dollar. The missing exhibit hides the metrics, but the body already caps and annualizes the remedy.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"ENF","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted\n    from amount due VENDOR no later than 60 days after the reporting by VENDOR of any\n    failure to perform as defined in Exhibit A Performance Guarantees","rationale":"Missed guarantees adjust the amount due the vendor within 60 days, which is an automatic credit of sorts. Those credits are capped at $175,000 and are exclusive remedies, so the City cannot recover more without proving other damages. Termination for cause on page 29 uses a 30 day cure and has no second strike or regulatory integrity exit without penalty.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.84,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the\n       terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent\n       to the date hereof and duly executed by the parties hereto.","rationale":"Amendments must be written, dated after this contract, and signed by both parties, and page 34 repeats that entire agreement rule. The vendor may still change the MAC list from time to time on page 2, change the PDL on 30 days notice on page 8, and change the AWP source after notice on page 1. Economic terms can therefore move without a signed amendment.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"TERM","verdict":"partial","confidence":0.9,"page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause\n         upon written notice, provided such notice specifies an effective date of termination, which\n         shall be not less than 90 calendar days nor more than 120 calendar days after the date of","rationale":"The City may cancel without cause on 90 to 120 days notice, which is a convenience right. On that exit the City must repay a pro rata share of credits and of the implementation credit prorated over the initial term. Page 9 also lets the vendor delay rebate remittance on termination or City breach. Those are penalties and a rebate holdback the model does not allow.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"SPEC","verdict":"bad","confidence":0.88,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are\n     Covered Drugs and that are used by VENDOR, that are used in the management of chronic\n     or genetic disease, including but not limited to, injectible, infused, or oral medication, or\n     product that otherwise require special handling.","rationale":"Specialty is defined as products the vendor uses for chronic or genetic disease and special handling, so the vendor draws the line. The vendor runs mail and specialty pharmacies and an Advance Control Specialty Formulary it can change on page 9. Affiliated pharmacies keep purchase discounts under page 10. There is no acquisition cost pricing and no drug level ceiling in the posted text.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.94,"page_ref":"Page 34","evidence_quote":"costs and pricing\n       data, trade secrets, know-how, processes, plans, designs and other information of or\n       relating to either party’s business. VENDOR asserts that certain information contained in\n       this Contract constitutes Confidential Information.","rationale":"Confidential Information includes costs and pricing data, and the vendor asserts that parts of this contract are confidential. Rebate audit terms on page 15 cannot be revealed even to the City. The Public Information Act clause on page 36 requires the City to notify the vendor and not oppose vendor efforts to block release. Pricing, rebate, and audit material are treated as proprietary in a way that can stop public disclosure.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"partial","confidence":0.85,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"The contract does use the word fiduciary, and Section 5.4(b) adds that the PBM will perform with utmost good faith, loyalty, candor and skill. But the model contract published by Mark Cuban and collaborators requires duties of loyalty and care owed solely to the plan and its members, disclosure of all direct and indirect compensation and conflicts, and disgorgement of anything retained in breach without the plan proving damages. None of those mechanics appear. What ERS got is a general good faith standard, not an enforceable loyalty duty with teeth.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"ERS and PBM agree that PBM shall not receive, charge or seek any administrative fees or any other costs, reimbursements, expenses or fees in connection with the Contract unless they are included in the administrative fees, if any, accepted in writing by ERS.","rationale":"Section 4.1 confines PBM compensation to a written fee schedule and requires manufacturer fees tied to certain management programs to be passed to ERS, which addresses the subject. But there is no named officer certifying quarterly or annually that all compensation has been disclosed and remitted, and no disclosure of payments to consultants or brokers. The audit article lets ERS examine manufacturer contracts, which is a verification right rather than a duty to disclose. The model contract's certification requirement is simply absent.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I looked for a signed exhibit listing every owner, parent, subsidiary, affiliate, group purchasing organization, rebate aggregator, mail order and specialty pharmacy tied to the PBM, and for a duty to refresh it within 30 days of any change. The contract has none. Article 8 only requires notice of mergers or changes of control, and Article 23 restricts assignment. The insurance declaration pages at Exhibit G (pages 55 to 58) happen to list many Express Scripts subsidiaries as named insureds, including Matrix GPO, LLC, but that is an insurance document, not a disclosure exhibit with an update obligation.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The rebate definition is broader than many contracts of its era: it sweeps in price protection dollars, price concessions and any other remuneration from a drug manufacturer, and Article 1.4 defines PBM to include its agents and subsidiaries. Two holes remain. First, the definition only reaches payments related to utilization of drugs on the PBM's own formulary, so value tied to non formulary drugs or other arrangements can escape. Second, value received through group purchasing organizations or other purchasing entities that are not the PBM contracting with the manufacturer is not plainly captured. Specialty Products is used without a functional definition in the base text, and there is no definition closing the relabeling loophole the way the model contract by Mark Cuban and collaborators does.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Federal subsidies, including direct subsidies, coverage gap subsidies and catastrophic re-insurance and all Rebates, as defined in this Contract, to ERS as set forth below and in Exhibit D and/or the Clarifications","rationale":"Section 4.1(h) commits the PBM to pay all Rebates, as defined, to ERS at least quarterly, along with federal subsidies, which is a real pass through promise. It falls short of 100 percent of manufacturer revenue of every kind in two ways: the rebate definition is limited to payments tied to formulary drug utilization received under manufacturer contracts, and the exact rates, exclusions and guarantees are set in Exhibit D and the Clarifications, which are not in the produced text. Whether administrative fees, data fees or other manufacturer revenue streams are retained cannot be verified from what was produced.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"unclear","confidence":0.85,"page_ref":"Page 4","evidence_quote":null,"rationale":"The base agreement defines PBM Mail Pharmacy and PBM Specialty Pharmacy as channels owned by the PBM or its affiliates (pages 3 and 4), so affiliate dispensing plainly exists under this contract. Whether claims at those affiliate pharmacies are invoiced at acquisition cost would be set in the Fee Schedule, which Section 4.1(a) on page 4 incorporates as Exhibit D and which lives in the contract attachment files that were not produced with this text. Because the base text gives no substantive pricing language itself, this item cannot be judged from the produced pages.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the base agreement caps a claim at a published benchmark or a transparent cash price, and nothing tests cost claim by claim. Article 4 on rates and payments discusses administrative fees, a Medi-Span AWP pricing source and MAC pricing limits but contains no ceiling language, and the model contract has no corresponding reference point in the produced exhibits. The subject is simply not addressed in the text available.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"I looked for language guaranteeing members never pay more than the pharmacy cash price, counting cash purchases toward deductibles and out of pocket maximums, and barring accumulator adjustment against member assistance. The base agreement has none of these. The Service addendum implements the Medicare Prescription Payment Plan, which lets Part D members spread cost sharing over monthly payments, but says nothing about cash price protection or deductible credit. The subject is absent from every document read.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"partial","confidence":0.85,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"Section 4.1(d) addresses maximum allowable cost pricing, limiting the PBM to ordinary course changes that would not discourage retail pharmacy participation. That is narrower than the model from Mark Cuban and collaborators, which requires one MAC list covering both what the plan pays and what pharmacies are paid, disclosure of the list, scheduled updates and a pharmacy appeals path with timelines. None of those elements appears, so the clause is a soft guardrail rather than real governance.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"unclear","confidence":0.85,"page_ref":"Page 5","evidence_quote":null,"rationale":"Section 4.1(f) on page 5 shows the claims flow: the PBM pays eligible claims first and is then reimbursed by ERS as provided in the RFP. Whether the reimbursement equals exactly what the pharmacy was paid, with the PBM retaining no difference, would be fixed by the reimbursement schedule in the RFP and the Exhibit D Fee Schedule, which are incorporated by reference and not in the produced text. The base agreement itself contains no statement barring or permitting spread pricing, so the item turns entirely on documents the reader cannot see.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.7,"page_ref":null,"evidence_quote":null,"rationale":"The contract never mentions group purchasing organizations, rebate aggregators, purchasing coalitions or offshore purchasing entities, and no clause routes purchase discounts or volume credits received by such entities to the plan. The rebate definition reaches remuneration received by PBM under a contract with a manufacturer, and although Article 1.4 folds subsidiaries and agents into the definition of PBM, it only covers those involved in performing services under this contract, which a separate purchasing entity generally is not. Notably, the insurance pages list Matrix GPO, LLC as an Express Scripts subsidiary, yet the agreement body is silent about it. Given the audit right reaches PBM arrangements with manufacturers, there is some indirect coverage, but the pass through of GPO value is not addressed.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"ERS holds an approval right over formulary modifications, both in Section 4.1(c) for material plan design changes and in Section 4.1(h) for the formulary itself, so the plan sponsor does control the formulary in a formal sense. The same clause openly names manufacturer rebate arrangements among the factors driving formulary placement, which is exactly the incentive the model contract published by Mark Cuban and collaborators tries to neutralize, and there is no requirement for lowest net cost analysis or quarterly utilization management outcomes by drug. Approval rights without a cost standard leave the rebate driven formulary problem intact.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I looked for a lowest net cost standard governing formulary decisions, an annual comparison of this plan's pricing against the PBM's whole book of business, and disclosure whenever a drug is placed above a cheaper equivalent. None appears in the base agreement, the amendments, the supplement or the service addendum. The Section 31.6 comparative pricing clause concerns aggregate contract pricing across customers, not formulary placement economics, so it does not fill the gap.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"missing","confidence":0.75,"page_ref":null,"evidence_quote":null,"rationale":"The contract contains no protection against retroactive claim clawbacks from pharmacies, no prohibition on steering participants to PBM owned mail or specialty pharmacies, and no any willing pharmacy participation right. The closest text is Section 4.1(d), which merely says MAC changes should not discourage retail pharmacy participation, and Section 5.4(d), where the PBM agrees to cooperate if ERS chooses an alternate retail network. The core network protections in the model contract are not addressed anywhere in the produced documents.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"then this Contract, at ERS¶ sole option, shall be amended to accord equivalent advantage to ERS.","rationale":"Section 31.6 is a genuine most favored pricing clause: if the PBM gives any government or commercial customer of similar size or smaller more generous aggregate pricing, ERS may require equivalent terms, and the PBM must notify ERS and document the determination. It is weaker than the model in two ways. The comparison is measured in the aggregate and made by the PBM itself, and there is no annual market check with a meet, credit or release remedy. Still, an automatic amendment right with a notification duty is more protection than most public contracts contain.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"good","confidence":0.85,"page_ref":"Page 18","evidence_quote":"ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract, and that all ERS-related records (and including, without limiting the foregoing, any arrangements, contracts, or related agreements that PBM has with any Pharmaceutical Manufacturers","rationale":"Article 15 gives ERS an absolute right to audit at times of its choosing, explicitly reaching the PBM's contracts with drug manufacturers and everything needed to check the most favored pricing clause, and Texas Insurance Code Section 1551.067 audit rights are layered on top. ERS gets claims data access through equipment on its own premises, the Texas State Auditor may audit, and Section 15.13 bars the Proposal or Clarifications from narrowing these rights. Two limits keep confidence short of total: audits of rebate agreements go through an approved independent auditor under a confidentiality agreement (Section 15.12), and ERS bears audit costs unless errors exceed $50,000. These are modest carve outs against an otherwise strong scheme.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"good","confidence":0.8,"page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program","rationale":"The confidentiality article makes ERS information, which the definition expressly says includes all records in the claims and membership records of participants, the exclusive property of ERS, and Article 17 bars the PBM from using, selling or disseminating participant data without written consent. On request or at termination the PBM must hand over all ERS related records and data at no cost in a format ERS can use without specialized software (Sections 21.2 and 21.3), and work product created for ERS belongs to ERS. The PBM does reserve ownership of its own systems, methodologies and report templates, so not every derived data set is unambiguously plan owned, but the core ownership, non reuse and portability promises of the model are present.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.9,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Performance guarantees exist under this contract but their content cannot be read. Section 5.5 incorporates them as Exhibit E, and Article 9 lets ERS invoke them alongside liquidated damages, but the exhibit pages in the base document are only a cover sheet. Amendment 2 replaced Exhibit E with the First Amended and Restated Performance Guarantees effective January 1, 2024, and page 4 of Amendment 2, where those guarantees appear, is fully redacted. Whether guarantees are measured quarterly on plan specific data or reconciled in cash is invisible in the produced text.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 12","evidence_quote":"shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform","rationale":"Article 9 gives ERS liquidated damages of up to $10,000.00 per default or per day without proving damages, Section 4.1(g) lets ERS offset sums owed against PBM compensation, and Article 11 makes all remedies cumulative. The weak spots are that assessment is discretionary with ERS rather than truly self executing, each default requires ERS action to collect, and there is no defined two strikes rule allowing penalty free termination after a second material breach or an integrity failure. Termination for cause exists under Section 2.4(a) but is a general remedy, not the model's automatic exit.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 2","evidence_quote":"The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"Section 2.6 requires a written agreement executed by both parties for any amendment, and Article 34 confirms the integrated list of contract documents controls. Section 4.1(b) lets ERS demand rate changes when more favorable pricing becomes available, which runs in the plan's favor rather than the vendor's. The service addendum permits an email response to count as an electronic signature, but that still requires affirmative ERS action. There is no unilateral amendment, portal update or notice based repricing right.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"good","confidence":0.9,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"Section 2.4 allows termination for cause immediately, without cause on 90 days notice, by mutual agreement, and on a funding out, with no termination penalty stated anywhere. Obligations to pay rebates, guarantees and damages survive termination, and prepaid fees must be refunded pro rata within two business days. The service addendum separately lets ERS exit the M3P program without cause by June 1 with year end effect. The one soft spot is that the contract does not expressly say earned rebate amounts are never forfeited, but nothing conditions them on continuation either.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"unclear","confidence":0.8,"page_ref":"Page 4","evidence_quote":null,"rationale":"The base agreement identifies the PBM specialty channel by name, defining PBM Specialty Pharmacy as Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc. and other affiliate pharmacies, but it defines Specialty Products only by reference to what those pharmacies dispense and sets no drug level pricing. Specialty rates and any acquisition cost terms would sit in the Exhibit D Fee Schedule referenced in Section 4.1(a) and in the contract attachments, which were not produced. The specialty pricing controls in the model contract therefore cannot be confirmed or denied from the available text.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"good","confidence":0.9,"page_ref":"Page 15","evidence_quote":"PBM should assume that all reports created by it for ERS may be publicly available records, in accordance with Texas law, and may be subject to the PIA","rationale":"The confidentiality obligations in this contract run one direction: the PBM must protect ERS data. Nothing restricts ERS from releasing pricing, rebate or performance information, and Section 13.11 tells the PBM to assume its reports are public records subject to the Texas Public Information Act, with the Attorney General, not the vendor, deciding what stays secret, and ERS expressly has no duty to advocate for the PBM's confidentiality claims. Supplement 1 has the PBM supporting the federal gag clause prohibition attestation under the Consolidated Appropriations Act, confirming the arrangement is meant to be gag free. No pharmacy gag clause appears in the produced text.","model_own_total":44.4,"model_own_grade":"Concern","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 4","evidence_quote":"Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client.","rationale":"The agreement owes IPM no duty of loyalty to the county or its members. Section 3.8 makes IPM an independent contractor and expressly not an agent of the county, and it disclaims any final discretionary authority, while nothing elsewhere requires IPM to act in the plan's interest or to give up money it keeps improperly. The model contract published by Mark Cuban and collaborators puts a duty of loyalty and care on the pharmacy benefit manager and requires disgorgement of retained amounts. This text does the opposite of that.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no compensation or conflict disclosure anywhere in the seventeen pages. Exhibit A on page 11 lists retail discounts and dispensing fees but no statement of what IPM earns from manufacturers, wholesalers or its own network, and no officer has to certify that everything has been disclosed. The word rebate appears only on page 4, where the county must tell members about rebates, and on page 10 in the tax clause. Nothing requires quarterly or annual disclosure of indirect revenue.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or schedule identifies IPM's owners, parents, subsidiaries, affiliated pharmacies, group purchasing organizations or rebate aggregators. Exhibit A is a one page fee sheet and Exhibit B is a HIPAA business associate agreement, so neither carries ownership information. The only affiliate reference is the cooperation language in the indemnity mechanics on page 8. The county therefore cannot tell which companies in the supply chain are related to its vendor.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.85,"page_ref":"Page 1","evidence_quote":"the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"The definitions article on pages 1 and 2 hands the vendor control of the terms that drive price. IPM picks the pricing benchmark in its sole discretion, decides what counts as a brand name drug, and determines generic status using a combination of data fields it does not have to disclose. There is no definition of rebate, manufacturer revenue, affiliate or specialty drug at all, so there is nothing to stop value from being relabeled. That is the reverse of the function based definitions in the model contract published by Mark Cuban and collaborators.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"PASS","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agreement contains no rebate or manufacturer revenue clause of any kind. Section 5 on pages 4 and 5 covers only what the county pays IPM, and Exhibit A on page 11 lists discounts off average wholesale price and dispensing fees with no rebate terms. Rebates surface only twice, on page 4 where the county must disclose rebates to members and on page 10 where taxes on rebate amounts are made the county's responsibility. Nothing entitles the county to any share of manufacturer money.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the text prices claims filled by IPM related pharmacies at acquisition cost. The recitals on page 1 say IPM has established a network of retail and mail order pharmacies, but Exhibit A sets only retail brand and generic rates and the word acquisition never appears. There is no definition of affiliate pharmacy and no documentation default if cost records are not produced. The county has no protection against retained margin in an IPM owned channel.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.6,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"The generic line in Exhibit A prices claims against usual and customary charge as one of the alternatives, which gives a limited ceiling at the pharmacy's own posted price for generic drugs. Brand drugs get only a discount off average wholesale price with no ceiling, and there is no reference to a published cash benchmark, no mail or specialty channel ceiling, and no claim by claim test. The model contract published by Mark Cuban and collaborators would cap plan cost at a transparent cash price in every channel. What is here is much narrower than that.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no cash price protection for members. Section 5.7 on page 5 stops pharmacies from billing members beyond copayments and deductibles, but that is balance billing protection, not a promise that the member pays no more than the shelf cash price. The word cash does not appear anywhere in the document, and nothing says a cash purchase counts toward the deductible or out of pocket maximum. Accumulator adjustment is not addressed either.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"MAC","verdict":"bad","confidence":0.7,"page_ref":"Page 11","evidence_quote":"Brand: AWP less 16% plus $2.00 dispensing fee Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"A generic maximum allowable cost list is used to price what the county pays, but the phrase Generic MAC appears only in this fee line and nowhere else in the agreement. The list is never defined, never disclosed, never put on an update schedule, and it is not tied to what network pharmacies are actually paid, since pharmacy payment sits in IPM's separate pharmacy agreements described in Section 5.8 on page 5. There is no pharmacy appeals path with timelines. That is exactly the arrangement that allows one list for the plan and another for pharmacies.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.85,"page_ref":"Page 5","evidence_quote":"Client understands that IPM ' s agreements w ith Network Pharmacies may allow etwork Pharmacies to review payments made by IPM related to the Covered Pharmacy Services.","rationale":"The county pays discounts off average wholesale price under Exhibit A while pharmacies are paid under separate IPM contracts the county never sees, and nothing requires the two amounts to match. Section 5.8 confirms that pharmacy payment terms live in IPM's own agreements, and it makes the county remit any additional payment a pharmacy later requests. There is no clause saying the county pays exactly what the pharmacy is paid plus a disclosed administrative fee, and no reconciliation of the difference. Retained spread is permitted in every channel.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No group purchasing organization, purchasing entity, volume credit or supplier payment is mentioned in the agreement. Section 5 on pages 4 and 5 addresses only invoices and payment timing, and Exhibit A on page 11 is limited to retail discounts and dispensing fees. Because there is no rebate clause at all, there is likewise nothing covering money that moves through an affiliated purchasing entity. The county has no claim on any of it.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.7,"page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans.","rationale":"The county keeps overall authority over its plan and supplies the benefit design and the description of coverage that IPM adjudicates against, which is a real measure of control. But the word formulary never appears, so there is no approval right over formulary placement or changes, no lowest net cost analysis, and no quarterly utilization management reporting by drug. Section 2.1 on page 2 also lets IPM change the Services from time to time on its own. The control the county has is over plan design, not over the drug list economics.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard appears anywhere in the text. There is no formulary article to attach such a standard to, no annual comparison against IPM's book of business, and no requirement to explain why a drug sits above a cheaper equivalent. The reporting clause in Section 2.7 on page 3 promises only standard IPM reports that IPM may amend at will. Nothing lets the county see the rebate versus net cost trade off.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.85,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"Network composition is entirely IPM's choice and IPM promises nothing about which pharmacies or how many will participate, so there is no any willing pharmacy right and no anti steering protection. Section 5.8 on page 5 goes further and requires the county to immediately remit additional payment whenever a network pharmacy asks for more after the fact, which is the opposite of claims being final when adjudicated. Reimbursement terms for pharmacies are not disclosed to the county at all. Members and independent pharmacies have no protection here.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement has no most favored pricing promise and no market check. Section 5.3 on page 4 addresses pricing changes only in the direction of IPM raising fees after the initial term, and Exhibit A fixes rates with no benchmarking mechanism. The phrase market check does not appear, and there is no meet, credit or release remedy. Because the term renews automatically every year, pricing can drift out of market with no test.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.75,"page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement.","rationale":"The only audit right in the file sits in the HIPAA business associate agreement at Exhibit B, and it covers compliance with that privacy agreement and records of protected health information uses, not claims pricing or vendor revenue. The main agreement gives the county no right to audit claims, no pre adjudication access, and only standard IPM reports that IPM may amend from time to time under Section 2.7 on page 3. Worse, Section 3.6 on page 3 deems reports and statements accurate if the county does not object within forty five days, and Section 5.5 on page 5 requires payment in full even while a charge is disputed. The county can audit privacy practices but not the money.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 6","evidence_quote":"the format of all reports, printouts, and copies thereof, and any prior and future versions thereof by any name, are the property ofIPM and are protected by copyright which shall be owned by !PM .","rationale":"Section 6.5 assigns IPM ownership of its databases, the compilations produced by its adjudication system and the format of all reports, which is the opposite of the county owning its own claims data. Section 7.1 on page 6 then lets IPM use, reproduce or adapt covered person information in any manner it deems appropriate, including product research and development, and Section 7.2 lets IPM use de identified data as it sees fit. Nothing requires delivery of claims data in machine readable form on request or at termination, and nothing bars resale. On this text the county would struggle to take its own data to a new vendor.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"PERF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There are no performance guarantees in the agreement. Exhibit A on page 11 states discounts and dispensing fees but sets no guaranteed discount to be reconciled, no service level standards, and no annual true up. The word guarantee does not appear anywhere in the seventeen pages. Nothing is measured quarterly on county specific data and nothing is settled in cash.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"ENF","verdict":"bad","confidence":0.9,"page_ref":"Page 7","evidence_quote":"!PM's maximum liability to Cl ient, regardless of the for m of action and whether for damages, indem nification or otherwise, shall not exceed the Administrative Fee paid by Cl ient over the previous six (6) months .","rationale":"Instead of automatic credits or liquidated damages, Section 9.6 caps everything IPM can ever owe the county at the administrative fee paid over the previous six months, and it bars claims raised more than ninety days after the county should have known of them. There are no self executing remedies for missed guarantees or late reports, because there are no guarantees or report deadlines. Termination for breach requires a thirty day cure and can be blocked if IPM merely starts a cure, and there is no two strikes exit or regulatory integrity trigger. A county pursuing money here would have to litigate for a capped amount.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.85,"page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"Section 18 on page 9 says amendments require mutual written consent, but Section 5.3 lets IPM change the fees or other pricing on its own after the first year, with only documentation delivered before the county budget cycle. Section 2.1 on page 2 also lets IPM change the Services from time to time, and the business associate agreement at Exhibit B provides that HIPAA related changes take effect without a signed amendment. The economics of the deal can therefore move without the county signing anything. That is the harm the model amendment clause exists to prevent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"TERM","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"The county can walk away for convenience on ninety days notice and no termination fee is stated, and the fiscal funding clause in Section 27 on page 12 lets the county stop when the commissioners court has not appropriated funds. The catch is that a convenience termination only takes effect at the end of the current term, so a late decision means another full year, and the exclusivity clause on page 8 blocks the county from lining up another manager in the meantime. There is no regulatory integrity trigger and no protection for earned amounts because no rebates or credits are ever owed. Useful but weaker than a clean exit on notice.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Specialty drugs are not addressed anywhere in the agreement. The word specialty does not appear, there is no specialty definition, no specialty rate sheet in Exhibit A on page 11, and no ceiling for specialty claims in any channel. Exhibit A prices only retail brand and generic fills for the indigent population. The largest and fastest growing part of drug spend is left entirely to the vendor.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"Section 6.1 defines confidential information to include pricing information and the agreement itself together with all exhibits, which sweeps in the Exhibit A fee schedule. Section 6.2 then bars either party from revealing that information without the other party's written consent, which may be withheld for any reason, and the only stated escape in Section 6.3 is a subpoena. There is no carve out for the Texas Public Information Act, for the county's own auditors or advisors, or for elected officials. On its face this clause is aimed at keeping what taxpayers pay out of public view.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"bad","confidence":0.99,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"The fiduciary role is expressly limited to initial claim adjudication and appeals. The contract then disclaims fiduciary status for the rest of plan administration, so it does not impose loyalty and care across formulary, network, rebate, and pricing decisions as the model requires.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.96,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may have a financial relationship with such pharmaceutical companies and may receive and retain fees or other compensation from pharmaceutical companies","rationale":"The contract identifies some manufacturer compensation and affiliate purchase discounts, which is meaningful disclosure. It does not require disclosure of every direct and indirect revenue stream, affiliate ownership touching claims, broker or consultant payments, or quarterly and annual officer certification.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.94,"page_ref":"Page 21","evidence_quote":"VENDOR agrees to notify CITY of any changes in VENDOR’S ownership interest greater than 50%, or control of its business entity, not less than sixty (60) days in advance of the effective date of such change","rationale":"The City receives notice of a change exceeding 50 percent ownership or control. There is no signed exhibit listing every parent, subsidiary, affiliate, purchasing entity, mail pharmacy, and specialty pharmacy, and the notice threshold would miss smaller ownership changes.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"Rebates are narrowly defined as certain formulary payments attributable to brand drug utilization. The contract then expressly removes fees, compensation, and affiliate purchase discounts from that definition, allowing manufacturer value to be relabeled and retained.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 10","evidence_quote":"The term “Rebates” as used in this CONTRACT does not include the fees, compensation, and concurrent or retrospective discounts associated with the purchase price of products described in this Section which belong exclusively to VENDOR or its affiliates.","rationale":"The contract promises remittance only of the defined Rebates and directs the detailed remittance terms to absent Exhibit B. It expressly permits the vendor and affiliates to retain other manufacturer fees and discounts, contradicting a pass-through of all manufacturer revenue.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.94,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The contract acknowledges purchase discounts tied to vendor-affiliated dispensing pharmacies and assigns that value exclusively to the vendor or affiliates. It does not invoice affiliate pharmacy claims at documented net acquisition cost plus a stated dispensing fee, and it permits retained affiliate economics that the model would eliminate.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"partial","confidence":0.94,"page_ref":"Page 4","evidence_quote":"Claim costs shall consist of the adjudicated ingredient cost (which shall be the lowest of the discounted rate, the Participating Pharmacy’s reported U&C price, if applicable, and the VENDOR MAC rate, if applicable), plus the applicable dispensing fee","rationale":"The claim formula uses the lowest of three contract measures, including the pharmacy's reported usual and customary price. It does not impose an external published cash-price benchmark or clearly require a claim-by-claim ceiling based on the cheapest lawful option in every channel.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.94,"page_ref":"Page 4","evidence_quote":"The VENDOR’S Participating Pharmacies will dispense prescriptions to CITY plan members according to the CITY’S plan, and shall collect from the Plan Member the lowest of the applicable co-payment, the discounted price, the VENDOR MAC rate, if applicable, or the Participating","rationale":"Members receive a point-of-sale protection tied to the lowest of copayment, discounted price, MAC, or pharmacy usual and customary price. The contract does not say that an outside cash purchase counts toward the deductible and out-of-pocket maximum, and it contains no protection against accumulator adjustments.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"bad","confidence":0.98,"page_ref":"Page 2","evidence_quote":"“Maximum Allowable Cost” or “MAC” means the unit price that has been established by VENDOR for a multi-source drug (i.e., a drug with more than two sources) included on the MAC drug list applicable to CITY, which list may be amended from time to time by VENDOR","rationale":"The vendor establishes and may amend the City's MAC list. The City can request a copy, but the contract does not require one identical list for plan billing and pharmacy reimbursement, a fixed update schedule, or a defined pharmacy appeal process.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The claim-cost formula on pages 4 to 5 and billing terms on pages 17 to 18 do not require the City to pay exactly what the pharmacy receives plus a disclosed fee. The audit provisions on pages 14 to 17 also do not give the City pharmacy-payment data needed to test for spread, and no no-spread covenant appears in the produced text.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.98,"page_ref":"Page 10","evidence_quote":"VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The vendor acts as a group purchasing organization for the plan, but related purchase discounts may remain with the vendor or its affiliates. The contract does not pass through supplier payments received through every related purchasing entity or require allocation on disclosed drivers.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"bad","confidence":0.99,"page_ref":"Page 8","evidence_quote":"VENDOR shall provide CITY with thirty (30) days notice prior to the addition, removal or movement within tiers of a drug on the PDL","rationale":"The City adopted the vendor's PDL, but the vendor manages it and can add, remove, or move drugs with notice rather than City approval. Specialty formulary changes similarly require only quarterly notice, so the sponsor does not control every formulary change.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"partial","confidence":0.9,"page_ref":"Page 8","evidence_quote":"Changes made by VENDOR to the PDL, may be based upon, among other things, the introduction of new products, customer safety, clinical appropriateness, efficacy, cost effectiveness","rationale":"Cost effectiveness is one of several factors the vendor may consider in formulary changes. There is no binding lowest-net-cost standard for this City plan, annual whole-book comparison, or disclosure when a more expensive drug is placed above a cheaper equivalent.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"missing","confidence":0.91,"page_ref":null,"evidence_quote":null,"rationale":"The pharmacy network and claim-processing provisions on pages 4 to 6 describe participating pharmacies and vendor mail and specialty pharmacies, but they do not prohibit steering, retroactive clawbacks, or volume-conditioned reimbursement. They also do not grant any willing pharmacy participation at the City's terms.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"The pricing, performance, and term provisions on pages 4, 13 to 18, and 29 to 31 contain no most-favored pricing promise. They also contain no annual market check with a meet, credit, or release remedy.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.99,"page_ref":"Page 15","evidence_quote":"CITY, or a mutually acceptable independent third party retained by CITY, may conduct an annual Claims audit and such audit shall be limited to the prior Contract Year of VENDOR data that directly relates to Claims billings.","rationale":"The City has annual claims and rebate audit rights and can obtain prior-year claims data. Those rights are limited to mutually acceptable auditors, confidentiality agreements, narrow periods and samples, selected manufacturer contracts, and no general access to vendor agreements, so they are substantially weaker than the model.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 19","evidence_quote":"Claims, as well as eligibility information which is deidentified in accordance with HIPAA and other applicable law, and which is not identifiable on a CITY or Plan member basis, may be used, disclosed, reproduced, adapted or sold by VENDOR only as allowed by federal or state law.","rationale":"The City owns information produced solely and exclusively for it and receives some access and transfer rights. The vendor nevertheless may use, disclose, adapt, or sell deidentified claims and eligibility information, directly contradicting the model's ban on reuse, licensing, or sale of plan data.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"bad","confidence":0.96,"page_ref":"Page 13","evidence_quote":"The settlement of penalties will be performed on an annual basis at the time of the year-end reconciliation. With respect to the aspects of VENDOR’S performance addressed in Exhibit A, these amounts at risk are CITY’S exclusive financial remedies.","rationale":"The contract uses City claims for claims-operations measures and provides performance amounts at risk, but settlement is annual rather than quarterly. The remedy is expressly exclusive and capped in aggregate, while the detailed standards in Exhibit A are withheld from the posting, so it is not a dollar-for-dollar cash reconciliation.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.95,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform","rationale":"A failed performance standard produces an adjustment against amounts due without a separate damages lawsuit. The adjustment depends on the withheld Exhibit A, is an exclusive capped remedy, and the contract has no defined two-strikes exit for repeated material breach or regulatory integrity failure.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"good","confidence":0.99,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"Amendments must be later-dated writings duly executed by both parties. The produced text does not permit the vendor to change economic terms through notice, a portal update, or an unilaterally revised exhibit.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.99,"page_ref":"Page 29","evidence_quote":"in the event of Termination by Notice initiated by CITY, a pro rata share of any credits disbursed by VENDOR for the calendar year in which the termination occurred as well as a pro rata share of the actual implementation credit amount disbursed by VENDOR (prorated over the initial term of the Contract) would be repaid by CITY to VENDOR.","rationale":"The City may terminate without cause on 90 to 120 days notice. It must repay prorated annual credits and the prorated implementation credit, which functions as an exit cost, and there is no express regulatory integrity termination right beyond a law that makes performance prohibited.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"partial","confidence":0.86,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease, including but not limited to, injectible, infused, or oral medication, or product that otherwise require special handling.","rationale":"The contract gives a functional, though awkward, definition of specialty drugs and applies a general lowest-of claim formula to claims processed through vendor specialty pharmacies. It does not require drug-level ceiling schedules or net acquisition cost pricing for affiliate specialty claims, and the vendor controls the specialty formulary.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data","rationale":"The confidentiality definition expressly covers costs and pricing data, and disclosure is generally barred without consent. Advisors and auditors can receive information only under confidentiality restrictions, while the Public Information Act clause lets the vendor seek to block release and limits disclosure to what is legally compelled.","model_own_total":18,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:19:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.97,"page_ref":"Page 11","evidence_quote":"VENDOR agrees to be a fiduciary solely for the purpose of initial Claim adjudication and appeals relating to the coverage of prescription drug benefits.","rationale":"The contract limits any fiduciary role to initial claim adjudication and appeals, and the same paragraph expressly states the vendor is not a named fiduciary, has no discretionary authority over the plan, and is not deemed a fiduciary under ERISA or any applicable state law. There is no duty of loyalty to the plan and its members, no requirement to disclose all direct and indirect compensation, and no disgorgement obligation. This is the opposite of what the model contract published by Mark Cuban and collaborators calls for.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"DISC","verdict":"bad","confidence":0.85,"page_ref":"Page 10","evidence_quote":"administrative fees that range between one percent (1%) and four percent (4%) of the Wholesale Acquisition Cost (“WAC”) of the products dispensed across VENDOR’s book of business.","rationale":"The contract does disclose, in general terms, that the vendor and its affiliates may receive and retain manufacturer fees of one to four percent of WAC, and section 21.3 adds a warranty that no broker was paid a contingent fee to win this contract. But there is no complete disclosure of all compensation, no obligation to report what was actually received, and no officer certification that everything has been disclosed and remitted. The disclosure functions mainly to authorize retention rather than to let the city verify it.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or clause lists the vendor's owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, or mail and specialty pharmacies. Section 14.3 on page 21 requires only 60 days notice of a change in ownership interest greater than 50 percent, and section 21.2 on page 28 requires an ethics disclosure statement about city officers, not about the vendor's corporate family. The word affiliate appears in the compensation clause on page 10 and the assignment clause on page 21, but no ownership exhibit exists anywhere in the 37 pages.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.95,"page_ref":"Page 2","evidence_quote":"“Rebates” means the formulary rebates, including base and market share rebates, collected by VENDOR in its capacity as a group purchasing organization for the Plan","rationale":"Rebates are defined by label as formulary rebates only, and page 10 then carves manufacturer administrative fees, other compensation, and purchase price discounts out of the definition entirely, declaring they belong exclusively to the vendor or its affiliates. Generic Drug and Brand Drug are defined as whatever the vendor identifies using Medi-Span, and Maximum Allowable Cost is a unit price established and amended by the vendor alone. These definitions let value be relabeled to escape pass-through, which is exactly the loophole the model contract's functional definitions are meant to close.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"may receive and retain fees or other compensation from pharmaceutical companies for services rendered and property provided to pharmaceutical companies","rationale":"The vendor remits only 'Rebates' as narrowly defined, and the same section states that fees, compensation, and concurrent or retrospective discounts associated with purchase prices belong exclusively to the vendor or its affiliates. The city also waives any right to interest or the time value of rebate payments on page 9. This expressly permits the retention of manufacturer revenue, the harm the model contract's 100 percent pass-through clause exists to prevent. The remittance schedule itself is in Exhibit B, which is not in the posted PDF, but the retention language in the base text is decisive.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"NAC","verdict":"unclear","confidence":0.8,"page_ref":"Pages 4 and 17","evidence_quote":null,"rationale":"Page 4 says claim costs are the lowest of the discounted rate, the pharmacy's reported usual and customary price, and the vendor MAC rate, plus a dispensing fee, and page 17 points to Exhibit B for administrative fees, but Exhibit B is not in the posted PDF. Nothing in the base text requires claims dispensed by the vendor's own mail and specialty pharmacies to be invoiced at net acquisition cost with no retained margin. Because the rates that would answer this question live only in the withheld fee exhibit, the item cannot be decided from the readable text.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the 37 pages caps the city's claim cost at a published benchmark such as a transparent cash price, in any channel, checked claim by claim. The pricing language on page 4 only applies a lowest of logic among the discounted rate, the pharmacy's usual and customary price, and the vendor MAC rate, none of which is an external public benchmark. No market benchmark or ceiling provision appears anywhere in the contract.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"Pages 4 and 5 say the pharmacy collects from the member the lowest of the copayment, the discounted price, the vendor MAC rate, or the pharmacy's usual and customary price, which is a partial member level protection, but that is all. There is no provision crediting cash purchases toward deductibles or out of pocket maximums and no mention of accumulator adjustment programs anywhere in the text. Most of what this rubric item requires is simply not addressed in the produced pages.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"MAC","verdict":"bad","confidence":0.92,"page_ref":"Page 2","evidence_quote":"which list may be amended from time to time by VENDOR in maintaining its generic pricing program","rationale":"The MAC list is created and amended at the vendor's sole discretion, with no update schedule, no pharmacy appeals path, and no statement that the same MAC list governs what the plan pays and what pharmacies are paid. The list is provided to the city before execution and thereafter only on reasonable request. This is the classic single sided MAC structure the model contract's MAC governance clause is written against.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"SPRD","verdict":"unclear","confidence":0.75,"page_ref":"Pages 4 and 17","evidence_quote":null,"rationale":"The base text never states that the city pays exactly what the pharmacy is paid plus a disclosed administrative fee. Page 4 defines claim cost as the lowest of the discounted rate, usual and customary price, or MAC rate plus a dispensing fee, which is silent on whether the discounted rate equals the pharmacy's reimbursement, and page 17 sends all administrative fees to Exhibit B, which is not in the posted PDF. Whether spread exists cannot be verified from the readable text because the pricing exhibit is withheld.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"GPO","verdict":"bad","confidence":0.95,"page_ref":"Page 10","evidence_quote":"In addition, VENDOR or its affiliates may receive concurrent or retrospective discounts from pharmaceutical companies which are attributable to or based on products purchased by VENDOR affiliated dispensing pharmacies.","rationale":"The vendor acts as the group purchasing organization for the plan, and the contract expressly allows the vendor and its affiliates to keep purchase related discounts and manufacturer fees rather than passing them through. There is no requirement that purchasing entity revenue of any kind flow to the plan; the same page states this money belongs exclusively to the vendor or its affiliates. That directly contradicts the model contract's GPO pass-through clause.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"FORM","verdict":"bad","confidence":0.95,"page_ref":"Page 8","evidence_quote":"VENDOR shall manage at its own cost the CVS Health PDL, as in effect from time to time, which the CITY has adopted as part of the Plan design and as CITY’s formulary.","rationale":"The city's formulary is the vendor's own Performance Drug List, created, maintained and amended by the vendor and approved by the vendor's Pharmacy and Therapeutics Committee per the definition on page 2. The city receives 30 days notice of changes but has no approval right over the formulary or any change to it, and the specialty formulary works the same way with quarterly notice. This is PBM control of the formulary, the arrangement the model contract's plan approval clause exists to prevent.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard for this plan appears anywhere in the text, and there is no annual comparison of the city's drug costs against the vendor's book of business. Page 8 lists cost effectiveness as one of many factors the vendor may consider in formulary changes, but that is not an enforceable standard and no disclosure of above cost placements is required. The performance section on page 13 deals with service accuracy, not net cost.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"NET","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"The text contains no any willing pharmacy clause, no anti-steering language, and no prohibition on retroactive claim clawbacks. Page 5 gives the vendor the sole right to audit network pharmacies and authority to reconcile discrepancies, which implies recoupment power without any claim finality protection for pharmacies. Mail order appears in the plan design as a 90 day channel on page 4, but nothing governs steering into the vendor's own mail and specialty pharmacies.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the 37 pages gives the city pricing at least as good as comparable clients, and there is no annual market check with a meet, credit or release remedy. Searches of the full text for most favored and market check language return nothing. The five year term on page 18 runs without any mechanism to reprice to market.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 14","evidence_quote":"Pharmacy claims audits may be conduct at the discretion of CITY, but (i) are limited to one (1) on site audit per plan year and the audit must be completed within two years of the end of","rationale":"The city may audit claims annually and may audit rebates through review of up to ten pharmaceutical company contracts per year, which is a real right. But audits are limited to one per year, the auditor must be mutually acceptable and must sign the vendor's confidentiality agreement, rebate audit findings may not be revealed to any third party including the city, and the city may not audit the vendor's pharmacy or manufacturer agreements beyond that. Data access is through an online portal rather than scheduled delivery of full claims level files, so the rights are weaker than the model contract.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.78,"page_ref":"Page 19","evidence_quote":"VENDOR recognizes that CITY shall own any and all information in whatsoever form and character produced and/or maintained in accordance with this CONTRACT that is produced solely and exclusively for CITY","rationale":"The ownership clause is meaningful but narrow: it covers only information produced solely and exclusively for the city, and the vendor keeps the right to protect confidential trade secret information within it and may use and sell deidentified claims and eligibility data with data integration firms. Section 22.5 on page 29 adds that all files are the property of the city and must be delivered at termination, though scrubbed of the vendor's confidential information and at the vendor's cost only after three years. There is no machine readable delivery obligation on request and no blanket ban on reuse, so this is weaker than the model contract's data ownership clause.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.82,"page_ref":"Page 13","evidence_quote":null,"rationale":"The base text establishes that performance standards exist, that total dollars at risk will be $175,000 as set forth in Exhibit A, that only city claims are used for measurement, and that amounts at risk are adjusted within 60 days. But page 13 itself says the guarantees live in Exhibit A, which is not in the posted PDF, so whether the guarantees are quarterly, cash reconciled, and paid dollar for dollar cannot be determined. The $175,000 cap on total dollars at risk is visible and suggests limited remedies, but the substance is withheld with the exhibit.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 14","evidence_quote":"Any amount at –risk due because of failure to meet performance standards shall be adjusted from amount due VENDOR no later than 60 days after the reporting by VENDOR of any failure to perform","rationale":"Missed performance standards produce an automatic adjustment against amounts due the vendor within 60 days without the city proving damages, which is a self executing remedy of the kind the model contract favors. However the amounts at risk are capped at $175,000 total per Exhibit A and are the city's exclusive financial remedies, and there is no liquidated damages clause for late reports and no two strikes termination right for repeated material breach. Termination for cause on page 29 requires only a single uncured default, so enforcement is present but limited.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 20","evidence_quote":"No amendment, modification or alteration of the terms of this CONTRACT shall be binding unless the same be in writing, dated subsequent to the date hereof and duly executed by the parties hereto.","rationale":"Amendments require a written document signed by both parties, and there is no clause letting the vendor change economic terms by notice, portal update, or updated exhibit. Section 31.1 on page 34 reinforces that no other agreements bind the parties unless in writing and duly executed. This matches the model contract's amendment clause.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"TERM","verdict":"partial","confidence":0.85,"page_ref":"Page 29","evidence_quote":"This CONTRACT may be canceled by CITY without cause upon written notice, provided such notice specifies an effective date of termination, which shall be not less than 90 calendar days","rationale":"The city may cancel without cause on 90 to 120 days notice, which is a genuine convenience termination right. It is weakened by the requirement to repay a pro rata share of credits and the implementation credit disbursed by the vendor, by page 9's allowance that the vendor may delay rebate remittance on termination for final adjustments, and by the absence of a regulatory integrity event trigger. The record transfer at termination is at the vendor's cost only if the city completed at least three years of the initial term.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"SPEC","verdict":"partial","confidence":0.7,"page_ref":"Page 3","evidence_quote":"“Specialty Drugs” means certain pharmaceuticals, biotech or biological drugs, that are Covered Drugs and that are used by VENDOR, that are used in the management of chronic or genetic disease","rationale":"Specialty drugs are defined by function, though loosely and with the vendor doing the identifying, and the city adopts the vendor's Advance Control Specialty Formulary which the vendor may change from time to time with quarterly notice. There is no drug level rate ceiling and no acquisition cost pricing requirement for specialty claims at affiliate pharmacies in the base text; any specialty rates would sit in the withheld Exhibit B. What is visible addresses the definition and formulary notice only, so the item is addressed but far weaker than the model.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0009","contract_slug":"city-of-san-antonio-caremarkpcs-2016","entity":"City of San Antonio","vendor":"CaremarkPCS Health, L.L.C. (CVS Health)","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 34","evidence_quote":"The term “Confidential Information” includes, but is not limited to, any information of either CITY or VENDOR (whether oral, written, electronic, visual or fixed in any tangible medium of expression) relating to either party’s inventions, techniques, suppliers, customers and prospective customers, contractors, costs and pricing data, trade secrets","rationale":"Costs and pricing data are expressly classified as Confidential Information that neither party may disclose without the other's written consent, and the vendor asserts that information in this contract is confidential. The Public Information Act carve out on page 36 does not free the city to release pricing; it obligates the city to notify the vendor of any request, to give the vendor time to claim exemptions, and not to oppose the vendor's effort to block release through the Texas Attorney General or the courts. Audit confidentiality clauses on page 15 further bar disclosure of audited contract terms to any third party, including the city itself for rebate audit details. This is a gag structure on pricing and audit material, and the posted file's missing fee exhibits are consistent with it.","model_own_total":13.1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"partial","confidence":0.9,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall perform its obligations and duties under this Contract with utmost good faith, loyalty, candor and skill.","rationale":"The agreement states that the PBM will act as a fiduciary and perform its duties with good faith and loyalty. However, it does not mandate that these duties are owed solely to the plan and its members, nor does it include a provision for disgorgement of retained amounts.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include a requirement for a named officer to certify quarterly and annually that all compensation and conflicts have been fully disclosed and remitted.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The list of contract exhibits in Article 37 on page 34 covers the RFP, proposal, clarifications, fee schedule, performance guarantees, business associate agreement, insurance, data security, implementation plan, and incumbency certificate. There is no mention of an ownership and affiliate disclosure exhibit.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"partial","confidence":0.8,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"The contract defines Rebates broadly by economic function to include any manufacturer remuneration, which is strong. However, definitions for other key terms like generic or specialty are either missing or potentially located in the absent Exhibit D.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"good","confidence":0.9,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Rebates to ERS as set forth herein and in Exhibit D based on each Pharmaceutical Manufacturer's drugs or products dispensed","rationale":"The agreement requires the PBM to pay all manufacturer rebates to the plan on a quarterly basis. The broad definition of Rebates covers all types of manufacturer remuneration.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"Pricing terms are incorporated by reference from the Fee Schedule (Exhibit D). Because this exhibit is missing from the provided text, it is unclear whether affiliate pharmacies are priced at acquisition cost.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"The base agreement relies on the absent Exhibit D for the compensation and reimbursement schedule. Therefore, it is impossible to determine if a benchmark ceiling or cheapest lawful option requirement is present.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not contain any provisions addressing cash price protection, deductible credits for cash purchases, or accumulator adjustments. The text is completely silent on this subject.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"While the base agreement mentions on page 4 that the PBM may modify MAC pricing in the ordinary course of business, it does not mandate a single disclosed MAC list for both the plan and pharmacies or establish an appeals path with defined timelines.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"The contract indicates that the PBM's administrative fees and reimbursement schedule are exclusively governed by Exhibit D. Since this fee schedule is missing, the presence or absence of spread pricing cannot be evaluated.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not address group purchasing organizations (GPOs) or mandate the pass-through of purchase discounts, volume credits, or supplier payments received by related purchasing entities.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 4","evidence_quote":"ERS must approve in writing any material modification of the Plan design or program specifications, including the formulary in place for ERS, prior to any implementation thereof.","rationale":"The plan sponsor retains control by approving the formulary and any material modifications in writing. However, the contract does not require the PBM to deliver a lowest-net-cost analysis or utilization management outcomes each quarter.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a lowest net cost standard for formulary decisions. It also lacks any requirement for an annual comparison against the PBM's entire book of business.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no pharmacy network protections in the text. The agreement does not prohibit retroactive clawbacks, condition reimbursement on volume, prevent steering to PBM-owned pharmacies, or guarantee any willing pharmacy's right to participate.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 29","evidence_quote":"PBM warrants and represents that if, during the term of this Contract, PBM enters into any agreement with any other governmental customer or any commercial customer not affiliated with PBM, of a similar size or smaller (the Comparative Agreement), by which PBM agrees to perform, deliver or provide equivalent Services, coverages, benefits, supplies or products that PBM is providing in accordance with this Contract for more generous pricing terms","rationale":"The contract includes a robust most favored nation clause that requires the PBM to amend the contract if it offers better pricing to comparable clients. However, it lacks an annual market check with a distinct meet, credit, or release remedy.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 18","evidence_quote":"PBM specifically understands, acknowledges and agrees that ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract, and that all ERS-related records","rationale":"The plan sponsor has strong audit rights, including the ability to audit rebate agreements with pharmaceutical manufacturers using an independent representative. However, the clause does not grant pre-adjudication claims access or provide full claims-level data on a schedule without asking.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"partial","confidence":0.8,"page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program (the ³GBP´) as applicable","rationale":"The contract designates confidential information (which includes participant and plan data) as the exclusive property of the plan sponsor. While this protects plan information, it does not explicitly declare ownership over every derived data set or rebate data in the manner of the model contract.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"unclear","confidence":0.9,"page_ref":"Page 40","evidence_quote":null,"rationale":"Performance guarantees are detailed in Exhibit E, which is referenced in the base agreement but not provided in the text. Thus, it cannot be determined if the guarantees are measured on plan-specific data or rely on capped credits.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"partial","confidence":0.9,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline","rationale":"The contract features strong self-executing enforcement mechanisms, allowing the plan to collect up to $10,000 per day in liquidated damages for default without proving actual damages. However, it does not establish a defined two-strikes exit for repeat material breaches.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 2","evidence_quote":"The Contract may be altered, extended, modified or amended only by written agreement properly executed by the duly authorized representatives of ERS and PBM","rationale":"The agreement strictly requires that any alterations or amendments be made through a written agreement signed by authorized representatives of both parties, preventing unilateral updates by the PBM.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"partial","confidence":0.9,"page_ref":"Page 2","evidence_quote":"In addition to and without restricting or waiving any other legal, contractual or equitable remedies otherwise available to ERS, ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"The plan sponsor has the right to terminate the contract for convenience without penalty by providing 90 days' written notice. However, the contract does not explicitly state that earned amounts are never forfeited upon termination.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"unclear","confidence":0.9,"page_ref":"Page 4","evidence_quote":null,"rationale":"Because the pricing terms are incorporated from the absent Fee Schedule (Exhibit D), the contract's specialty drug pricing controls cannot be evaluated. The base agreement only defines a PBM Specialty Pharmacy.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"partial","confidence":0.8,"page_ref":"Page 15","evidence_quote":"ERS and, subject to a non-disclosure agreement with PBM, its auditors, advisors, consultants, and custodians, if applicable, are entitled to use and retain copies of all written materials generated by PBM under this Contract.","rationale":"The confidentiality provisions permit the plan sponsor to share materials with its auditors and advisors, provided an NDA is signed, and acknowledge that records may be subject to the Public Information Act. However, the PBM retains the right to label materials as proprietary to seek to block their public release.","model_own_total":38.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FID","verdict":"partial","confidence":0.92,"page_ref":"Page 2","evidence_quote":"PBM agrees to act as a fiduciary by acting in good faith, with candor and due diligence in connection with the performance of the Contract and any negotiations related thereto.","rationale":"Express Scripts agrees to act as a fiduciary, and later warrants utmost good faith, loyalty, candor and skill. That is more than silence, but it is not the duty of loyalty and care owed solely to the plan and members in the model contract published by Mark Cuban and collaborators. There is no duty to disclose every economic conflict or to disgorge amounts retained in breach without ERS proving damages.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 4","evidence_quote":"PBM's administrative fees, if any, and the compensation and/or reimbursement schedule that PBM will in any way receive for or in connection with the Services, coverages, benefits, Equipment, supplies and products that PBM is required to perform, deliver or provide in connection with, arising out of or related to its performance of this Contract shall be only those specifically agreed to and accepted by ERS and that are reflected in the Fee Schedule attached hereto and fully incorporated herein as Exhibit D.","rationale":"Compensation is supposed to be only what Exhibit D lists, and manufacturer fees from extra management programs are pulled into the Rebate definition. Article 16 requires disclosure of procurement conflicts, not a full map of affiliate compensation. No named officer certifies quarterly or annually that everything has been disclosed and remitted. Exhibit D itself is only a title page in this file.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"OWN","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"PBM Specialty Pharmacy´ means Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc., or another pharmacy or home health agency owned or operated by PBM or its affiliates that primarily dispenses Specialty Products.","rationale":"The contract names Accredo and Express Scripts Specialty Distribution as owned specialty pharmacies and requires notice of merger, acquisition, or change of control. Exhibit G insurance pages list many subsidiaries, including MATRIX GPO, LLC and mail pharmacies. That is not a signed ownership exhibit that must be refreshed within 30 days of any ownership or control change, and it does not identify rebate aggregators as such.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 5","evidence_quote":"The term \"Rebates\" is intended to include any rebates, price protection dollars, price concessions, discounts, or any other payments or remuneration received by PBM","rationale":"Rebate is defined more broadly than a label, covering price protection, concessions, discounts, and other manufacturer remuneration. Page 6 then limits that bag to amounts received under a pharmaceutical manufacturer contract and related to Formulary utilization by Participants. Affiliate, specialty, and generic are not defined by economic function, so value can still be moved into GPO, data, or non-formulary payments.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PASS","verdict":"partial","confidence":0.88,"page_ref":"Page 5","evidence_quote":"PBM shall pay all Federal subsidies, including direct subsidies, coverage gap subsidies and catastrophic re-insurance and all Rebates, as defined in this Contract, to ERS as set forth below and in Exhibit D and/or the Clarifications for the Contract Term and any extension or renewal thereof.","rationale":"Express Scripts must pay all defined Rebates and listed federal subsidies to ERS, promptly and no later than quarterly. That is pass-through of Rebates as defined, not 100 percent of manufacturer revenue of every kind. The definition is limited to manufacturer contracts and Formulary utilization, timing is not within 30 days of quarter end, and the actual rates live in Exhibit D, which is not in this file.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Pages 3 to 4 define PBM Mail Pharmacy and PBM Specialty Pharmacy as owned or operated by Express Scripts or affiliates, so the contract knows those channels exist. Article 4 rates and payments, the Exhibit D cover, Amendment 2, and the Service addendum never require those pharmacies to invoice at net acquisition cost plus a stated dispensing fee. There is no documentation default if cost records are not produced.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Article 4 on rates, the Exhibit D fee schedule cover, Article 31.6 comparative pricing, and the Service addendum do not cap any claim at a published cash or other public benchmark. Nothing requires a claim by claim cheapest lawful option test.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Articles 3 through 5, the Business Associate Agreement, and the Service addendum have no cash price, usual and customary, deductible credit, or accumulator language. The Medicare Prescription Payment Plan addendum spreads Part D cost share over monthly invoices. It does not stop a member from paying more than the pharmacy cash price or make a cash purchase count toward the deductible.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MAC","verdict":"partial","confidence":0.9,"page_ref":"Page 4","evidence_quote":"PBM may only modify MAC pricing to the extent it is done in the ordinary course of business, so long as any such changes would not reasonably be expected to discourage retail pharmacy participation in the Network.","rationale":"MAC lists are acknowledged and cannot be changed in a way expected to drive retailers out of the network. There is no single MAC list for both plan cost and pharmacy pay, no disclosure schedule, and no pharmacy appeals path with timelines. Ordinary course updates can still move prices without a signed amendment.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPRD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Article 4 says Express Scripts pays claims and then seeks reimbursement from ERS, and that extra fees must sit in the administrative fee if they exist. Nowhere in Articles 4 or 15, the Exhibit D cover, or the Service addendum does the text say the plan pays exactly what the pharmacy is paid plus a disclosed fee. Spread is simply not addressed in the produced text.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"The Rebate definition on pages 5 to 6 covers manufacturer contract payments tied to Formulary use, not purchase discounts or supplier payments received by a related purchasing entity. Exhibit G insurance pages list MATRIX GPO, LLC among named insureds, but there is no pass-through of GPO or aggregator revenue and no allocation method.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 5","evidence_quote":"the drugs included on the PBM's Formulary may be modified by PBM, with prior approval by ERS' authorized representatives, from time-to-time as a result of factors including, but not limited to, medical appropriateness, manufacturer rebate arrangements and patent expirations.","rationale":"ERS must approve formulary changes, and material plan design changes also need written ERS approval. The formulary is still described as the PBM's list, and manufacturer rebate arrangements are an express reason to change it. There is no lowest net cost analysis and no quarterly utilization management report by drug.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Formulary language on pages 4 to 5 requires ERS approval and even lists manufacturer rebate arrangements as a modification factor. Articles 4, 5, and 31 never impose a lowest net cost standard for this plan, never require an annual book of business comparison, and never require disclosure when a drug is placed above a cheaper equivalent.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NET","verdict":"partial","confidence":0.85,"page_ref":"Page 7","evidence_quote":"PBM warrants and represents that it shall cooperate in utmost good faith with ERS if ERS, in its sole discretion, chooses to implement any alternate retail pharmacy network referenced in the RFP or that may hereafter be requested by ERS.","rationale":"The contract defines a Network and lets ERS ask for an alternate retail network. Participating pharmacies are called independent contractors. There is no ban on steering to mail or specialty affiliates, no any willing pharmacy rule, no bar on volume conditioned reimbursement, and no statement that claims are final when adjudicated.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MFN","verdict":"partial","confidence":0.92,"page_ref":"Page 29","evidence_quote":"PBM shall determine whether the pricing terms offered under the Comparative Agreement are more generous in the aggregate than the pricing terms provided to ERS in this Contract","rationale":"If Express Scripts gives more generous aggregate pricing to a similar or smaller government or unaffiliated commercial customer, ERS may take equivalent terms. That is a most favored pricing clause, but it is not automatic, Express Scripts itself measures the comparison, and there is no annual market check with a meet, credit, or release remedy.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 18","evidence_quote":"ERS has an absolute right to conduct compliance reviews and/or audits of PBM in connection with PBM's duties and obligations under the Contract","rationale":"ERS may audit with its own representatives, may reach manufacturer contracts, and Texas Insurance Code 1551.067 gives an independent auditor access to facilities, records, and subcontractor agreements. Rebate audits can be narrowed to portions of confidential manufacturer agreements and require an NDA. Page 16 also lets Express Scripts withhold Third-Party IP that a supplier contract forbids sharing, so data is not fully un-withholdable as proprietary.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DATA","verdict":"partial","confidence":0.88,"page_ref":"Page 14","evidence_quote":"The items designated herein as confidential information are the exclusive property of ERS and the Texas Employees Group Benefits Program (the ³GBP´) as applicable","rationale":"Confidential information, including claims and membership records, is ERS and GBP property, Work Product is owned by ERS, and records must be delivered on termination in a usable format. The Business Associate Agreement still lets Express Scripts de-identify PHI and keep it indefinitely, and the data security exhibit treats further processing for historical, statistical or other business purposes as compatible. That is not sole ownership with a ban on reuse.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PERF","verdict":"unclear","confidence":0.9,"page_ref":"Amendment 2, page 4","evidence_quote":null,"rationale":"Article 5.5 on page 7 puts performance guarantees in Exhibit E. Amendment 2 replaces Exhibit E with a First Amended and Restated Performance Guarantees document, then Amendment 2 page 4 is fully redacted. The produced text does not show whether guarantees are measured quarterly on plan data, paid in cash, or capped as credits, so PERF cannot be scored from what is readable.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"ENF","verdict":"partial","confidence":0.88,"page_ref":"Page 12","evidence_quote":"The amount of such liquidated damages, as referred to herein, shall be up to and including $10,000.00 (Ten Thousand Dollars) for each Default or each calendar day beyond the Notice Period or deadline, as applicable, that PBM delays or fails to perform its obligations under this Contract","rationale":"Missed performance can draw liquidated damages after notice, and ERS may terminate for cause immediately in its sole opinion. Those are real remedies, but they are not self executing without ERS choosing to invoke them, and there is no two strikes exit for a second material breach or regulatory integrity failure. The detailed performance guarantee credits themselves are in the redacted Exhibit E replacement.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.86,"page_ref":"Service addendum, page 2","evidence_quote":"ESI shall provide ERS with a minimum of thirty (30) calendar days written notice prior to effecting any material modifications or changes to the pricing structure of the M3P program.","rationale":"Article 2.6 says the main contract may be amended only by written agreement of authorized representatives. The Service addendum still lets Express Scripts change M3P pricing structure on 30 days notice, and Article 4.1(d) lets MAC prices move in the ordinary course without a signed amendment. That is weaker than a rule that economic terms cannot change by notice or updated lists.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"TERM","verdict":"good","confidence":0.93,"page_ref":"Page 2","evidence_quote":"ERS may terminate the Contract without cause by giving PBM ninety (90) days written notice","rationale":"ERS may walk away without cause on 90 days written notice, may terminate for cause immediately, and may terminate if the Board does not approve funds. Prepaid fees must be refunded within two business days after a termination under section 2.5. No termination penalty or forfeiture of earned amounts appears in the produced text.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPEC","verdict":"partial","confidence":0.88,"page_ref":"Page 4","evidence_quote":"PBM Specialty Pharmacy´ means Accredo Health Group, Inc., Express Scripts Specialty Distribution Services, Inc., or another pharmacy or home health agency owned or operated by PBM or its affiliates that primarily dispenses Specialty Products.","rationale":"Owned specialty pharmacies are named, so the contract knows specialty is a distinct channel. Specialty Products is not defined by clinical or economic function, there is no drug level rate ceiling in every channel, and affiliate specialty claims are not priced at acquisition cost. Those controls, if they exist, would have to live in Exhibit D, which is not in this file.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0002","contract_slug":"ers-express-scripts-2022","entity":"Employees Retirement System of Texas","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GAG","verdict":"partial","confidence":0.85,"page_ref":"Page 15","evidence_quote":"If ERS receives a PIA request for information labeled as confidential and/or proprietary, ERS will notify PBM in accordance with the PIA of the PBM¶s right to submit written comments to the Office of the Attorney General as to why the information should not be released.","rationale":"ERS is subject to the Public Information Act, and advisors and auditors may see materials under a non-disclosure agreement. Express Scripts may still stamp materials confidential or proprietary and ask the Attorney General to block release, and the Service addendum is labeled Confidential Information. Nothing in the produced text stops pharmacies from telling patients about cheaper options. Supplement 1 is CAA gag clause attestation support, not a gag on ERS.","model_own_total":37.2,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish any fiduciary duty or duty of loyalty. In Section 3.8 on page 4, the contract explicitly states that IPM operates as an independent contractor and has no final discretionary authority or responsibility for the administration of the plans.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The document does not require IPM to disclose all compensation, conflicts of interest, affiliate ownership, or broker payments. There is no requirement for quarterly or annual officer certifications regarding financial disclosures.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no signed exhibit or any other provision listing the PBM's owners, parents, subsidiaries, affiliates, or associated pharmacies. The contract does not mandate that the PBM refresh such an exhibit upon any change in ownership or control.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"bad","confidence":0.8,"page_ref":"Page 1","evidence_quote":"\"Generic Drug\" will mean a multisource generic drug as determined by IPM using a combination of data fields .","rationale":"Definitions for key terms like Generic Drug and Brand Name Drug are not based on objective economic functions. Instead, the contract allows IPM to determine these classifications in its sole discretion or using its own combination of data fields, which permits the PBM to relabel drugs to its advantage.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not require the pass-through of manufacturer revenue. In fact, rebates and manufacturer payments are not substantively addressed anywhere in the claims pricing terms or Exhibit A.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no requirement to price claims dispensed by PBM-owned or affiliated pharmacies at net acquisition cost. The contract does not address affiliate pharmacy pricing at all.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not establish a published benchmark ceiling or require that plan claim costs never exceed the cheapest lawful cash price.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There are no cash price protections for members. The text does not guarantee that a member will pay the lesser of their copay or the cash price, nor does it mandate that cash purchases count toward the deductible.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Although Generic MAC is mentioned in the Exhibit A fee schedule, there are no governance provisions dictating a single MAC list, update schedules, or appeals processes for pharmacies.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not contain any language prohibiting spread pricing. Exhibit A sets the rates the plan pays to the PBM but does not stipulate that these rates must exactly match the reimbursement paid to pharmacies.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Group purchasing organizations and related entity purchasing agreements are not mentioned. There is no provision requiring GPO pass-through of discounts or supplier payments to the plan.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract lacks any language giving the plan sponsor control over formulary decisions, nor does it require the PBM to provide lowest-net-cost analysis or utilization management outcomes.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no lowest net cost standard for formulary design in this agreement, nor is there any requirement for an annual book of business comparison.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not include pharmacy network protections. There are no clauses prohibiting retroactive clawbacks, preventing volume-conditioned reimbursement, or guaranteeing an any willing pharmacy policy.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The agreement does not provide the plan with most favored pricing rights, and there are no provisions allowing for an annual market check.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The main agreement lacks any audit rights allowing the plan to inspect financial or claims-level data. The only audit provision is located in the Business Associate Agreement (Exhibit B) and is strictly limited to verifying HIPAA compliance.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"bad","confidence":0.9,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"Instead of affirming that the plan sponsor solely owns all plan data, the contract explicitly grants the PBM the right to reproduce and adapt covered person information for its own product research and development. Additionally, Section 6.5 designates the databases containing this information as the PBM's copyrighted property.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There are no performance guarantees or service level agreements (SLAs) with measurable financial remedies outlined anywhere in the contract or exhibits.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The contract does not feature self-executing enforcement mechanisms, liquidated damages, or a two-strikes exit policy for repeat material breaches.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"bad","confidence":0.9,"page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"While the general amendments clause requires mutual written consent, Section 5.3 creates a major loophole by allowing the PBM to unilaterally change fees and pricing after the initial term merely by providing advance documentation.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"The contract allows either party to terminate with ninety days notice, but restricts this termination to only take effect at the end of the current one-year term. This effectively prevents the plan from terminating for convenience without penalty at any point during the year.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There are no specific pricing controls, transparent definitions, or acquisition cost requirements outlined for specialty drugs.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits","rationale":"The confidentiality provision explicitly defines pricing information and the agreement's exhibits as confidential. This restricts the government entity's ability to freely share pricing and contract terms with auditors, lawmakers, or the public.","model_own_total":1,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"FID","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The definitions on pages 1 to 2, IPM duties on pages 2 to 3, Client duties including section 3.8 on page 4, the independent contractor clause in section 16 on page 9, and the ERISA sentence in section 19.1 on page 9 do not impose any duty of loyalty or care on IPM. Section 3.8 says IPM is an independent contractor with no final discretionary authority over the Plans, which is not a loyalty duty to the County or members. There is no conflict disclosure and no disgorgement remedy of the kind in the model contract published by Mark Cuban and collaborators.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"DISC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Compensation is limited to the fees in Exhibit A on page 11 and the billing article on pages 4 to 5. Nothing requires IPM to disclose affiliate ownership, related-entity compensation, or payments to consultants or brokers. There is no named officer certification quarterly or annually. Section 3.7 on pages 3 to 4 tells the County to disclose copays and rebates to members, which is not PBM compensation disclosure.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"No ownership exhibit appears in the 17-page file. Affiliates are mentioned only in the indemnity cooperation language on page 8. Section 20 on page 10 lets IPM assign the agreement to a wholly owned subsidiary without consent, but it does not list owners, parents, GPOs, mail order pharmacies, or specialty pharmacies, and it does not require a refresh within 30 days of a change in control.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"DEF","verdict":"partial","confidence":0.9,"page_ref":"Page 1","evidence_quote":"\"Brand Name Drug\" will mean a prescription drug specified as a single-source drug or multi-source brand name drug as determined by IPM.","rationale":"Pages 1 to 2 define Administrative Fee, AWP, Brand, Generic, Claims, Network, and PHI, so there is a definitions article. Brand and Generic are whatever IPM determines, and IPM picks the AWP source in its sole discretion. There is no definition of rebate, manufacturer revenue, affiliate, or specialty, so value can still be relabeled. That is weaker than the closed, function-based definitions in the model contract published by Mark Cuban and collaborators.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"PASS","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The word rebate appears in section 3.7 on page 4, where the County must disclose rebates or other discounts to members, and in section 24 on page 10, where taxes on rebate amounts are the County's cost. Neither clause requires 100 percent of manufacturer revenue to be paid to the plan. There is no rebate definition, no quarterly remittance, and no closed list of excludable claims.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"NAC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The recitals on page 1 mention a network of retail and mail order pharmacies. Exhibit A on page 11 prices only retail pharmacy claims at AWP discounts plus dispensing fees. Nothing prices PBM-owned or economically related pharmacies at net acquisition cost, and there is no documentation default if acquisition records are not produced.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 sets AWP discounts for retail brand and generic claims. Sections 5.1 to 5.8 on pages 4 to 5 describe invoicing and pharmacy payment. No clause caps any claim at a published cash or benchmark price, and there is no claim-by-claim test against the cheapest lawful option.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 uses U&C as one generic pricing option for what the County pays, not as a member cash-price cap. Section 5.7 on page 5 bars IPM and network pharmacies from balance billing members except for copays, deductibles, and non-covered services. Nothing says a member never pays more than the pharmacy cash price, nothing credits cash purchases to a deductible, and nothing addresses accumulator adjustment.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"MAC","verdict":"partial","confidence":0.86,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"Exhibit A prices generics at AWP less 80 percent, U&C or Generic MAC plus a $2.50 dispensing fee, so a MAC list is part of what the County pays. The contract never says one MAC list applies to both plan payment and pharmacy payment, never requires disclosure or a refresh schedule, and never gives pharmacies an appeals path with timelines. That is MAC as a pricing label without the governance the model requires.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.88,"page_ref":"Page 5","evidence_quote":"Furthermore, if in accordance with IPM's agreement with a Network Pharmacy there was an underpayment for Covered Pharmacy Services to a Covered Person, such etwork Pharmacy may seek reimbursement for such underpayment(s) .","rationale":"The County is billed at the AWP rates in Exhibit A on page 11, while IPM pays pharmacies under separate network agreements described in sections 5.2 and 5.8. Section 5.8 lets a pharmacy seek more money if IPM underpaid it relative to the pharmacy contract, and the County must remit that difference. Nothing requires the County to pay exactly what the pharmacy was paid plus a disclosed administrative fee, so IPM may keep a spread.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"No GPO, group purchasing organization, volume credit, or supplier-payment pass-through appears in the definitions on pages 1 to 2, the compensation article on pages 4 to 5, Exhibit A on page 11, or the remainder of the 17-page file.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.84,"page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans. Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client.","rationale":"Section 3.8 says the County has sole authority to control and administer its Plans and that IPM has no final discretionary authority over plan terms. Sections 3.1 and 3.2 on page 3 make the County furnish the benefit design that IPM uses to adjudicate claims. The word formulary never appears, and IPM need not deliver lowest-net-cost analysis or quarterly utilization management outcomes by drug.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Benefit design language on pages 3 to 4, reporting in section 2.7 on page 3, and Exhibit A on page 11 contain no lowest net cost standard for this plan, no annual comparison against IPM's book of business, and no duty to disclose when a drug is placed above a cheaper equivalent.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.91,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"Section 2.3 lets IPM add or drop network pharmacies in its sole discretion and makes no warranty that any specific pharmacy will remain. There is no any-willing-pharmacy right, no ban on steering claims into mail order or other IPM channels, and no rule that claims are final when adjudicated. Section 5.8 on page 5 even lets pharmacies reopen payment after the fact.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Pricing lives in Exhibit A on page 11 and in section 5.3 on page 4, which lets IPM change fees after the first year. Nothing grants the County pricing at least as good as any comparable client, and nothing creates an annual market check with a meet, credit, or release remedy.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 3","evidence_quote":"IPM wi ll provide Client records and reports, including standard !PM reports as amended from time to time, relating to Covered Persons. Client may request additional reports, which may be provided upon the mutual written agreement of the parties .","rationale":"Section 2.7 gives the County standard IPM reports as amended from time to time, and extra reports only by mutual written agreement. Section 3.6 on page 3 deems reports accurate if the County does not object within 45 days. Exhibit B section 7 on page 16 allows an audit after 10 business days, but only to verify HIPAA compliance, not claims-level financial data. There is no pre-adjudication feed and no rule that data cannot be withheld as proprietary.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"DATA","verdict":"bad","confidence":0.93,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development, except that each party and its agents, employees and contractors shall maintain the confidentiality of this information to the extent required by applicable Law","rationale":"Section 7.1 lets IPM use, reproduce, or adapt member information in any manner it deems appropriate, including product research and development. Section 6.5 on the same page says IPM owns the databases and the format of reports. Section 7.2 lets IPM de-identify PHI and use that information as it deems appropriate. The County is not the sole owner, and IPM may reuse plan data.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"PERF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"No performance guarantees, quarterly measurement on plan-specific data, cash reconciliation, or dollar-for-dollar shortfall payments appear in the services article on pages 2 to 3, Exhibit A on page 11, or the liability and termination sections on pages 4 and 7.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Section 4 on page 4 allows termination for an uncured material breach, but if the breach cannot be cured in 30 days the non-breaching party may not terminate if the other party has started a cure. Section 9.6 on page 7 caps IPM's liability at the Administrative Fee paid over the previous six months and bars consequential damages. There are no automatic credits, liquidated damages, or a two-strikes exit after a repeat failure.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"AMD","verdict":"partial","confidence":0.9,"page_ref":"Page 9","evidence_quote":"Except as otherwise set forth herein, this Agreement may be amended , modified , or supplemented on ly by mutual consent set forth in writing duly signed by the parties hereto .","rationale":"Section 18 requires mutual consent in a writing signed by both parties, except as otherwise set forth. Section 5.3 on page 4 lets IPM change fees and other pricing after the initial term by notice timed to the County budget cycle. Section 2.1 on page 2 lets IPM change services that do not materially alter the agreement. That is weaker than a hard ban on unilateral economic changes.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"TERM","verdict":"partial","confidence":0.92,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"Either party may give 90 days written notice, but termination is effective only at the end of the then expiring term, and the deal renews automatically for one-year periods. There is no mid-term termination for convenience and no regulatory integrity exit. No termination penalty or forfeiture of earned amounts is stated, and section 27 on page 12 adds a fiscal funding limit.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"SPEC","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 lists only retail pharmacy fees. The recitals on page 1 mention mail order pharmacies. Specialty is never defined, and there is no drug-level specialty ceiling or acquisition-cost rule for affiliate specialty pharmacies anywhere in the 17 pages.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.94,"page_ref":"Page 5","evidence_quote":"pricing information, the Agreement and all exhibits, addenda and alterations hereto, Network Pharmacy coverage information, trade secrets and innovations","rationale":"Confidential Information includes pricing information and the Agreement and all exhibits. Neither party may reveal it without prior written consent, which may be withheld for any reason. The only extra-contract disclosure path is a bona fide subpoena with notice so the other party can object. There is no Texas public information carve-out, so this would stop the County from sharing pricing terms with the public or lawmakers.","model_own_total":12,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The responsibilities provisions on pages 2 to 4 and the relationship clause on page 9 do not impose duties of loyalty or care on IPM. The agreement contains no fiduciary duty, conflict disclosure duty, or disgorgement remedy.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"The compensation and fee provisions on pages 4, 5, and 11 do not require disclosure of IPM or affiliate compensation, consultant payments, or economic conflicts. The interested-party filing language on page 12 is a general government contracting requirement, not quarterly and annual officer-certified disclosure of PBM revenue.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.91,"page_ref":"Page 12","evidence_quote":"Bidder agrees to provide Grayson County Purchasing Age nt, and/or requesting department, the \" Certificate ofrnterested Parties,\" Form 1295 as required, within ten (10) business days fro m notification of pending award, renewal , amended or extended contract.","rationale":"The agreement requires a Texas Certificate of Interested Parties around award, renewal, amendment, or extension. This is narrower than the signed ownership and affiliate exhibit contemplated by the model because it does not list every parent, affiliate, purchasing entity, mail pharmacy, and specialty pharmacy or require updates within 30 days of ownership changes.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.94,"page_ref":"Page 1","evidence_quote":"\"Average Wholesale Price\" or \"A WP\" will mean the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"The definitions give IPM sole discretion to select the AWP source and let IPM determine brand and generic status. They omit rebate, manufacturer revenue, affiliate, specialty, and purchasing-entity definitions, leaving the core economic terms open rather than closing relabeling and classification loopholes.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The compensation sections on pages 4 and 5, Exhibit A on page 11, and the brief rebate references on pages 4 and 10 do not require any manufacturer revenue to be paid to the county. There is no percentage, payment schedule, or closed list of excluded claims.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit A on page 11 states only retail AWP, U&C, and Generic MAC formulas. No provision identifies an IPM-owned or related pharmacy or requires any affiliate pharmacy claim to be invoiced at acquisition cost plus a stated dispensing fee.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"The retail fee schedule on page 11 mentions U&C only as one component of the generic formula. It does not cap every claim in every channel at a published cash benchmark or require a claim-by-claim cheapest lawful price test.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.98,"page_ref":null,"evidence_quote":null,"rationale":"The member payment language on pages 2, 4, and 5 addresses copayments, deductibles, and balance billing but never compares member cost with the pharmacy cash price. It also does not credit cash purchases to deductibles or out-of-pocket limits and does not address accumulator adjustments.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"partial","confidence":0.94,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee;","rationale":"Exhibit A uses Generic MAC as a possible retail pricing basis. The agreement does not disclose the MAC list, require the same list for county billing and pharmacy reimbursement, set an update schedule, or provide a pharmacy appeal process with deadlines.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":0.9,"page_ref":"Page 11","evidence_quote":"Retail Pharmacy Fees: Brand: AWP less 16% plus $2.00 dispensing fee","rationale":"The county is charged under an AWP-based retail formula, while the agreement never ties that charge to the amount IPM pays the dispensing pharmacy. This structure permits IPM to retain a difference instead of limiting compensation to the pharmacy payment plus a disclosed administrative fee.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The definitions on pages 1 and 2, compensation provisions on pages 4 and 5, and Exhibit A on page 11 do not identify a group purchasing organization or related purchasing entity. No clause passes through purchase discounts, volume credits, or supplier payments.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.87,"page_ref":"Page 4","evidence_quote":"Client acknowledges that it has the so le authority to control and admi ni ster its Plans.","rationale":"The county retains sole authority to control and administer its plans, which gives it general authority over benefit design. The agreement does not expressly require county approval of the formulary and every formulary change, nor does it require lowest-net-cost analysis or quarterly drug-level utilization management outcomes.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The benefit design provisions on pages 3 and 4 and Exhibit A on page 11 contain no lowest-net-cost standard. They also require no comparison with IPM's book of business and no explanation when a costlier drug is placed above a cheaper equivalent.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"bad","confidence":0.97,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time.","rationale":"IPM has sole discretion to add or remove network pharmacies and promises no access to any particular pharmacy. The agreement provides no any-willing-pharmacy right, anti-steering protection, ban on retroactive clawbacks, or volume-neutral reimbursement standard.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The fee schedule on page 11 and renewal and pricing provisions on page 4 contain no most-favored pricing promise. The county also receives no annual market check or meet, credit, or release remedy.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.95,"page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement.","rationale":"Exhibit B gives either party and its representative an audit right, but the right verifies compliance with the business associate agreement and focuses on PHI practices. It does not grant a full PBM financial and claims audit, routine claims-level delivery, pre-adjudication access, or protection against proprietary-data withholding.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.99,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"The agreement expressly permits IPM to reuse covered-person information broadly, including for product research and development. It also says IPM owns its databases and compilations, while never making the county sole owner of claims, eligibility, accumulator, rebate, and derived data or requiring machine-readable delivery.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"Neither the service provisions on pages 2 and 3 nor the fee exhibit on page 11 states measurable performance guarantees. There is no quarterly plan-specific measurement, cash reconciliation, or dollar-for-dollar shortfall payment.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.93,"page_ref":"Page 4","evidence_quote":"If there is a material breach of any provision of this Agreement, and that breach remains uncured for thirty (30) days after the breaching party receives written notice of the breach , the non-breaching party may terminate this Agreement","rationale":"The agreement allows termination after an uncured material breach, so it provides a conventional enforcement path. It does not impose automatic credits or liquidated damages for missed guarantees or reports, and it has no two-strikes exit or defined regulatory-integrity trigger.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":0.98,"page_ref":"Page 4","evidence_quote":"After the initial term of the Agreement, !PM may change the Fees or other pricing under th is Agreement.","rationale":"Although page 9 generally calls for mutually signed amendments, this express exception lets IPM change fees or other pricing after the initial term by advance documentation. That unilateral economic change right contradicts the model's requirement that both parties sign every amendment.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.96,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof.","rationale":"The county may give 90 days' notice without a stated termination fee, but termination becomes effective only at the end of the current one-year term or renewal. The agreement lacks a general midterm convenience exit and does not make a regulatory-integrity event an express ground for termination.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The definitions on pages 1 and 2 and Exhibit A on page 11 do not define specialty drugs or state specialty rates. No clause imposes drug-level specialty ceilings or acquisition-cost pricing at an affiliated specialty pharmacy.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":0.99,"page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"The confidentiality clause expressly treats pricing information and the entire agreement and exhibits as confidential. Disclosure requires consent or a subpoena process, with no clear carveout for Texas public records, the county's advisors or auditors, members, the public, or lawmakers, so it can obstruct disclosure of contract economics.","model_own_total":11.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:08:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.85,"page_ref":"Page 4","evidence_quote":"Client further acknowledges that !PM is engaged to perform the Services as an independent contractor and not as an employee or agent of Client","rationale":"The model contract published by Mark Cuban and collaborators makes the PBM owe duties of loyalty and care to the plan and its members. This agreement does the opposite: it frames IPM as an arm's length independent contractor, states that IPM has no discretionary authority or responsibility for plan administration, and nowhere imposes any duty of loyalty, care, or disclosure of conflicts. IPM also disclaims liability for its drug utilization review and network pharmacy decisions. There is no fiduciary obligation of any kind in the text.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The compensation article (Section 5, pages 4 and 5) covers only the fees in Exhibit A and invoicing mechanics. Nothing requires IPM to disclose its full compensation, revenue from manufacturers or pharmacies, affiliate interests, or payments to brokers and consultants, and there is no officer certification of disclosure anywhere in the agreement or its exhibits. The only compensation visible is the Exhibit A fee schedule on page 11.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or clause lists IPM's owners, parents, subsidiaries, affiliates, group purchasing organizations, or owned pharmacies. The only exhibits are Exhibit A (fees, page 11) and Exhibit B (a HIPAA business associate agreement, pages 13 to 17). Section 20 on assignment (page 10) even contemplates affiliates and subsidiaries of IPM without ever identifying them, and there is no duty to refresh ownership information.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.88,"page_ref":"Page 1","evidence_quote":"\"Average Wholesale Price\" or \"A WP\" will mean the benchmark price established by Medi Span, or another nationally reporting service of pharmaceutical prices as selected by IPM , in its sole discretion","rationale":"The definitions article (Section 1, pages 1 and 2) is short and vendor controlled. IPM picks the AWP pricing source in its sole discretion and decides unilaterally what counts as a brand or generic drug. There are no definitions of rebate, manufacturer revenue, affiliate, specialty drug, or MAC at all, so there is nothing to stop value from being relabeled or moved outside the county's view. The model contract from Mark Cuban and collaborators defines these terms by economic function precisely to close those loopholes.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The word rebate appears only twice in the entire document: Section 3.7 (page 3) requires the county to disclose rebates or other discounts to members as required by law, and Section 24 (page 10) makes the county responsible for taxes on the payment of rebate amounts. Neither clause passes any manufacturer revenue to the county. There is no rebate definition, no pass through percentage, no payment schedule, and no exclusion list, so the largest dollar item in most PBM contracts is simply not addressed.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the agreement acknowledges that IPM may own or be economically related to any pharmacy, and there is no acquisition cost pricing for any channel. The recitals mention that IPM has a network of retail and mail order pharmacies, but Exhibit A prices only retail claims on an AWP discount basis, and mail order pricing does not appear anywhere. Because no affiliate pharmacy pricing rule exists, the model requirement of net acquisition cost plus a dispensing fee is absent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No clause caps plan claim cost at a published benchmark or a transparent cash price, in any channel or for any drug. Exhibit A (page 11) sets AWP discount rates, which the agreement itself concedes do not represent a true wholesale price, and nothing tests any claim against an external ceiling. I checked the compensation article and both exhibits and found no ceiling of any kind.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"There is no cash price protection for members, no rule that a member never pays more than the pharmacy's cash price, and no provision crediting cash purchases toward deductibles or out of pocket maximums. The words accumulator, cash price, and usual and customary protections do not appear; the only member payment terms are co-payments and deductibles as defined in Section 1 and the balance billing protection in Section 5.7. The model's cash price and accumulator provisions are entirely absent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"partial","confidence":0.6,"page_ref":"Page 11","evidence_quote":"Generic: A WP less 80%, U&C or Generic MAC plus $2.50 di spensing fee","rationale":"Exhibit A applies a Generic MAC to generic pricing, so a MAC list exists and affects what the county pays. But the agreement says nothing about how that list is built, whether the same list governs what pharmacies are paid, whether it is disclosed to the county, how often it is updated, or whether pharmacies have any appeal path. The subject is touched by the pricing exhibit but none of the governance the model contract requires is present.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Nothing states that the county pays what the pharmacy is paid plus a disclosed fee, and nothing prohibits IPM from retaining a difference between the two. Section 5.2 (page 4) has IPM paying network pharmacies only out of funds received from the county and says those funds are not an asset of the county's plan, which leaves the actual pharmacy reimbursement invisible to the county. Exhibit A prices claims on AWP discounts rather than pharmacy cost, a structure in which spread can live, but the contract never addresses it, so the item is not addressed rather than contradicted in words.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The agreement never mentions a group purchasing organization, rebate aggregator, purchasing entity, or any purchase discounts or volume credits received by IPM or its affiliates. With no rebate pass through and no affiliate disclosure, there is no mechanism for GPO derived revenue to reach the county. I searched the full text for these terms and they do not appear.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The word formulary does not appear anywhere in the 17 pages. There is no formulary approval right for the county, no lowest net cost analysis, and no utilization management reporting by drug. The county's only levers are the benefit design it furnishes under Section 3.1 and prior authorization criteria referenced in Section 2.5, neither of which is formulary control.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"Because the agreement contains no formulary provisions at all, it also contains no lowest net cost standard, no annual comparison of this plan against IPM's book of business, and no disclosure when a drug is placed above a cheaper equivalent. I confirmed there is no formulary, net cost, or book of business language anywhere in the document.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.88,"page_ref":"Page 2","evidence_quote":"Additions or deletions to the Network shall be in IP M ' s sole discretion and !PM makes no warranty that any specific pharmacy or number of pharmacies will be in the Network at any time","rationale":"Network composition is entirely in IPM's sole discretion with no any willing pharmacy right, no anti steering provision, and no promise that claims are final once adjudicated. Worse, Section 5.8 (page 5) obligates the county to immediately remit money to IPM whenever a network pharmacy claims it was underpaid, which passes retroactive pharmacy payment risk to the county, and Section 10 (page 8) makes IPM the county's exclusive PBM. The model contract from Mark Cuban and collaborators requires the opposite protections, so this contradicts the model.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"There is no most favored pricing clause and no annual market check with a meet, credit or release remedy. Pricing is fixed by Exhibit A for the initial term and thereafter IPM may change fees and other pricing under Section 5.3, so drift out of market is governed entirely by the vendor. I found no most favored or market check language anywhere in the text.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.75,"page_ref":"Page 16","evidence_quote":"Either Party, or its representative, shall be entitled after ten (10) business days' prior written notice to the other Party, to audit that Party to verify their compliance with the terms of th is Agreement","rationale":"The only audit right in the document is in Exhibit B, the HIPAA business associate agreement, and it covers compliance with privacy and security obligations, not claims pricing, rebates, or fees. The main agreement gives the county only IPM's standard reports as amended from time to time (Section 2.7, page 3), with additional reports requiring mutual written agreement, and Section 3.6 deems reports accurate if not disputed within 45 days. There is no claims level data schedule, no pre adjudication access, and no financial audit right, so the county can see very little of what it needs to verify.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"bad","confidence":0.92,"page_ref":"Page 6","evidence_quote":"IPM may use, reproduce, or adapt Covered Person information in any manner it deems appropriate, including product research and development","rationale":"The county is never named the owner of its claims, eligibility, or rebate data. Instead Section 7.1 lets IPM use Covered Person information however it deems appropriate, including product research and development, and Section 6.5 (page 6) states that IPM's databases, adjudication logic, and the format of all reports are IPM's property. De identified information may also be used and disclosed by IPM as it deems appropriate under Section 7.2. This contradicts the model contract requirement that the plan sponsor own all plan data and control its reuse.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The agreement contains no performance guarantees of any kind: no pricing or rebate guarantees, no service level standards with remedies, and no quarterly reconciliation. Exhibit A lists rates but guarantees nothing, and Section 9.3 expressly disclaims warranties and even the accuracy of the prices and reports IPM produces. The word guarantee does not appear in the document.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"There are no liquidated damages, automatic credits, or self executing remedies for missed obligations, and no two strikes exit. Enforcement runs entirely through the termination clause (Section 4, page 4), which requires 30 day cure periods, and litigation under Section 14, while Section 9.6 (page 7) caps IPM's total liability at six months of administrative fees and bars claims asserted more than twelve months after the event. Nothing triggers a remedy without the county proving its case.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"partial","confidence":0.8,"page_ref":"Page 9","evidence_quote":"this Agreement may be amended , modified , or supplemented on ly by mutual consent set forth in writing duly signed by the parties hereto","rationale":"Section 18 matches the model by requiring written, mutually signed amendments. But the protection is carved out in practice: Section 5.3 (page 4) lets IPM change the fees or other pricing after the initial term by giving documentation ahead of the county budget cycle, and Exhibit B (page 17) adopts HIPAA driven amendments automatically without a signed amendment. Economic terms can therefore move without the county's signature, which is exactly the risk the model clause exists to prevent.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"partial","confidence":0.8,"page_ref":"Page 4","evidence_quote":"Either party may terminate this Agreement upon ninety (90) days prior written notice to the other party, which shall become effective only at the end of the then expiri ng term or extension thereof","rationale":"The county can terminate without penalty on 90 days notice, and there are no termination fees or forfeiture of earned amounts in the text. However the termination only takes effect at the end of the then current term, and the agreement auto renews for successive one year periods, so the practical exit window is narrow. The fiscal funding clause (Section 27, page 12) gives the county an additional out if budget approval fails. This is weaker than the model's clean convenience termination but not punitive.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The word specialty does not appear anywhere in the document. Exhibit A prices only retail brand and generic claims, and there is no specialty definition, no drug level rate ceiling, and no channel pricing for specialty. Given that specialty drugs drive the majority of spend in most plans, this is a significant gap for the county.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0008","contract_slug":"grayson-county-integrated-prescription-management-2022","entity":"Grayson County","vendor":"Integrated Prescription Management, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 5","evidence_quote":"\" Confidential Information\" includes, but is not limited to, proprietary business and technical information, patient and third-party payor lists, statistical data, computer programs, pricing information, the Agreement and all exhibits, addenda and alterations hereto","rationale":"Section 6 treats pricing information, the agreement itself, and all exhibits as confidential information that neither party may reveal without the other's prior written consent, with only a subpoena carve out that requires notice so the other party can object. There is no carve out for the Texas Public Information Act, for the county's advisors or auditors, or for disclosure to lawmakers, and Section 6.6 backs the restriction with injunctive relief. For a Texas county this would position the vendor to resist public release of what taxpayers pay, which is exactly the harm this red flag item tracks.","model_own_total":7.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment mentions Aetna acts as a fiduciary for ERISA claim determinations, but does not address broad fiduciary duties of care or loyalty for PBM services.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not address the disclosure of compensation, conflicts of interest, or require officer certifications.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not include an exhibit listing the PBM's owners, affiliates, or related entities.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment relies on the missing Prescription Drug Services Schedule for defined terms like rebate and specialty.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 47","evidence_quote":"Rebates for Specialty Products that are administered and paid through the Plan Participant’s medical benefit rather than the Plan Participant’s pharmacy benefit will be retained by Aetna as compensation","rationale":"The contract explicitly permits Aetna to retain manufacturer payments for certain specialty products and value-based rebate contracting arrangements, allowing the exact harm the model clause exists to prevent.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment includes pricing schedules for retail and mail order but does not price affiliate pharmacy claims at net acquisition cost.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"partial","confidence":0.9,"page_ref":"Page 39","evidence_quote":"Cost Share will be calculated on the basis of the rates charged to the Customer by Aetna for Covered Services, except for fixed copays or where required by law to be otherwise.","rationale":"The amendment addresses pricing logic but lacks a comprehensive benchmark ceiling for plan costs. It only specifies that member cost shares are based on negotiated rates or fixed copays.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"partial","confidence":0.9,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy’s Usual and Customary Charge","rationale":"The amendment provides cash price protection for the member at the point of sale. However, the base agreement is missing, and the amendment is silent on whether these cash purchases count toward the member's deductible.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment states that MAC pricing applies at mail order but does not establish governance rules, disclosure requirements, or an appeals process for the MAC list.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference","rationale":"The amendment explicitly defines a Traditional or Lock-In pricing arrangement that allows spread pricing, permitting Aetna to charge the plan sponsor more than it pays the pharmacy and keep the difference.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not mention pass-through of discounts or payments received by group purchasing organizations.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"The amendment gives the sponsor the authority to accept or reject the formulary. However, it does not require lowest-net-cost analysis or utilization management outcomes.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not contain a lowest net cost standard for formulary decisions or require an annual book of business comparison.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not address pharmacy network protections, anti-steering provisions, or any willing pharmacy requirements.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms","rationale":"The amendment allows for an annual market check. However, if savings are found, the parties are only obligated to discuss revisions in good faith, lacking a mandatory meet, credit, or release remedy.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"partial","confidence":0.95,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"Audit rights are addressed but severely restricted. The plan is explicitly limited to one annual rebate audit and one claim audit, falling short of the unrestricted access in the model.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not state that the plan sponsor solely owns all claims, eligibility, and rebate data, nor does it address data portability.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not outline comprehensive performance guarantees with dollar-for-dollar cash remedies.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The base agreement is not in the file. The amendment does not provide self-executing enforcement mechanisms or a two-strikes termination right for material breaches.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"The contract allows Aetna to unilaterally amend the agreement with just 30 days written notice, avoiding the model requirement for mutual written consent.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"bad","confidence":0.95,"page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna’s arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an “Early Termination”) Aetna shall retain any earned but unpaid rebates","rationale":"Although termination for convenience is mentioned elsewhere, terminating early triggers a massive penalty requiring the sponsor to forfeit all earned but unpaid rebates, contradicting the model.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"partial","confidence":0.9,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The amendment sets specific AWP discounts for specialty drugs but mandates the use of CVS Specialty Pharmacies, failing to price affiliate pharmacy claims at acquisition cost.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"Aetna and Contract Holder shall not disclose or make use of any Confidential Information except as permitted under this Group Agreement without the prior written consent of the non-disclosing party","rationale":"The amendment defines Confidential Information to include pricing data and strictly prohibits the plan sponsor from disclosing it without Aetna's prior written consent, restricting data sharing.","model_own_total":11,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.93,"page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA. Aetna has complete authority to determine whether and to what extent eligible individuals and beneficiaries are entitled to coverage and to construe any disputed or doubtful terms under this Group Agreement.","rationale":"The attached Medicare Group Agreement names Aetna a fiduciary only for ERISA claims review and gives it complete coverage authority unless it acts arbitrarily and capriciously. The same packet says the parties are independent contractors, not agents of one another. That is the opposite of the loyalty and care duty to the plan and members in the model contract published by Mark Cuban and collaborators. The 2023 base agreement is not in the file, so no broader PBM fiduciary clause appears here either.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"DISC","verdict":"partial","confidence":0.88,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"The Pharmacy Service and Fee Schedule does tell the county that manufacturer administrative fees, other manufacturer payments, and pharmacy network transmission fees are kept by Aetna or CVS Caremark, and the rate exhibit says broker commissions are excluded. That is some compensation disclosure. There is no named-officer quarterly or annual certification that every related-entity payment has been disclosed and remitted. The 2023 base agreement is not in the file, so a fuller disclosure exhibit may exist there and is not available to score.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"OWN","verdict":"partial","confidence":0.86,"page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"The amendment names SilverScript as a CVS affiliate, CVS as parent of Aetna and SilverScript, CaremarkPCS Health L.L.C. as the affiliated PBM, and CVS Specialty and CVS Caremark Mail as the mail and specialty channels. That is useful affiliate identification, not a signed ownership exhibit listing every owner, GPO, rebate aggregator, and related pharmacy with a 30-day refresh. The 2023 base agreement is not in the file, so no such exhibit appears here.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"DEF","verdict":"bad","confidence":0.94,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"Rebate is defined by label, not by economic function. Administrative fees, other manufacturer payments, and network transmission fees are carved out of Rebates and stay with Aetna. The pricing charts even say capitalized terms are not defined except in the Prescription Drug Services Schedule, which is not attached. That is the loophole the model contract published by Mark Cuban and collaborators exists to close.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"PASS","verdict":"bad","confidence":0.95,"page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates. These payments are generally for one of two purposes: (i) to compensate Aetna for bona fide services it performs, such as the analysis or provision of aggregated data or (ii) to reimburse Aetna for the cost of various educational and other related programs","rationale":"The fee schedule advertises the greater of 100 percent or a per-brand-script dollar floor, but that 100 percent applies only to Rebates as narrowly defined. Manufacturer administrative fees, other manufacturer payments, medical-benefit specialty rebates, and value-based contracting payments are kept by Aetna. Rebate collections are paid 180 days after quarter end, not within 30 days. That is not 100 percent of manufacturer revenue of every kind.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.95,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Mail and specialty claims are priced at AWP discounts, not at net acquisition cost plus a stated dispensing fee. Mail order is CVS Caremark Mail Service and specialty is exclusive CVS Specialty, both affiliates, under Traditional lock-in pricing that lets Aetna keep a spread. There is no documentation default if acquisition-cost records are not produced. The 2023 base agreement is not in the file and does not change what this fee schedule actually prices.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The Pharmacy Service and Fee Schedule on pages 36 to 44 and the Caremark Cost Saver note on page 57 never cap plan claim cost at a published cash benchmark checked claim by claim. Lesser-of usual and customary language on page 39 governs what the member pays at a network pharmacy, not what the county may be charged. The 2023 base agreement is not in the file, so no ceiling clause from that agreement can be scored.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"CASH","verdict":"partial","confidence":0.84,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall give the Plan Participant the benefit of the lesser of (i) the Participating Pharmacy’s Usual and Customary Charge, (ii) MAC (where applicable) or (iii) discounted AWP cost.","rationale":"At participating pharmacies the member is supposed to pay the lesser of cost share, usual and customary, MAC, or discounted AWP, which is some cash-price protection inside the network. The text does not credit an out-of-plan cash purchase toward the deductible or out-of-pocket maximum. PrudentRx copay optimization is included as a savings program and requires exclusive specialty and a true accumulation design, which is narrower than the model cash and accumulator rules.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.9,"page_ref":"Page 40","evidence_quote":"MAC: Certain dosage forms and strengths may not be included on the MAC list and shall be priced at the Specialty Product default rate.","rationale":"MAC is used at mail and for some specialty products, but the county is on Traditional lock-in pricing, so the amount charged to the plan can differ from the amount paid to the pharmacy. That is the two-list problem. There is no single disclosed MAC list that applies to both sides, no update schedule, and no pharmacy appeals path with timelines in this amendment. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"SPRD","verdict":"bad","confidence":0.98,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"The fee schedule states that Discounts and Dispensing Fees reflect a Traditional or Lock-In pricing arrangement and then defines that arrangement as Aetna keeping the difference between what the county and members are charged and what the pharmacy is paid. That is spread pricing in every network channel covered by those discounts. The model contract published by Mark Cuban and collaborators requires the plan to pay exactly what the pharmacy is paid plus a disclosed administrative fee.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"GPO","verdict":"bad","confidence":0.92,"page_ref":"Page 47","evidence_quote":"Customer further agrees that the amounts described above belong exclusively to Aetna or it’s affiliate, CVS Caremark, and Customer has no right to, or legal interest in, any portion of the aforesaid amounts received by Aetna or CVS Caremark.","rationale":"The fee schedule does not name a GPO, but it does say other payments from drug manufacturers and other organizations, manufacturer administrative fees, and pharmacy network transmission fees are not Rebates and belong exclusively to Aetna or CVS Caremark. Those are the supplier and purchasing-entity dollars the model would pass through. The 2023 base agreement is not in the file, so no GPO pass-through from that agreement can be scored.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.87,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"The county is said to have sole discretion to accept or reject the formulary Aetna offers. Rebate guarantees require the Aetna Standard Formulary and Advanced Control Specialty Formulary, and Aetna may propose modifications based on market conditions, clinical information, cost, and rebates. The SilverScript summary also says the formulary may change at any time. That is weaker than plan approval of every change with lowest-net-cost analysis.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Formulary management on page 46 lists cost and rebates among reasons Aetna may propose changes, and a paid custom-formulary option on page 53 includes net cost analysis as an extra $100,000 service. Neither clause sets a lowest net cost standard for this plan, requires an annual book-of-business comparison, or requires disclosure when a higher-net-cost drug is placed above a cheaper equivalent. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.96,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Specialty is exclusive to CVS Specialty with no retail fills, and Aetna is the exclusive specialty provider except for the HIV class. The P1 preferred network charges higher member cost share at standard pharmacies, and Maintenance Choice and CVS Caremark Mail are core services. That is steering into affiliated pharmacies, not any-willing-pharmacy at the plan's terms. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"MFN","verdict":"partial","confidence":0.9,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"There is an annual market check against similar employers, which is more than silence. The trigger is a 2 percent net-cost gap, the remedy is a good-faith discussion, and any change needs a later amendment effective the following January 1. There is no automatic most-favored pricing and no meet, credit, or release right. That is weaker than the model.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.88,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"The county gets one annual rebate audit and one annual electronic claim audit, at its own expense unless otherwise agreed, and a small general allowance can be used for audit invoices. Audit terms live in the Prescription Drug Services Schedule, which is not attached. There is no right to full claims-level and financial data on a schedule without asking, no pre-adjudication access, and extra fees for older audit files. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"DATA","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Privacy language on page 10 is HIPAA only. Pages 15 to 16 and 27 grant a limited license to Aetna intellectual property in reporting systems and say nothing grants the county ownership of that IP. Historical claims, accumulator, and refill files are billed extras on pages 54 to 55. No clause makes the county the sole owner of claims, eligibility, rebate, or derived data or bars Aetna from reusing it. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.9,"page_ref":"Page 42","evidence_quote":"Rebate guarantees are measured individually by component and reconciled in the aggregate on an annual basis within 12 months following the end of the Plan year; a surplus in one or more component Rebate guarantees may be used to offset shortages in other component Rebate guarantees.","rationale":"Discount, dispensing-fee, and rebate guarantees exist and are reconciled, which is more than nothing. They are annual rather than quarterly, rebate components may offset each other, discount reporting is due 180 days after the period, and the PrudentRx savings guarantee is a future billing credit capped at 30 percent of program cost. That is not dollar-for-dollar quarterly cash on plan-specific results without caps.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Guarantee reconciliation on pages 39 to 42 is a performance true-up, not a self-executing penalty for missed reports or a second material breach. Early termination on page 47 imposes liquidated damages on the county, including retained rebates, rather than giving the county an automatic exit. The Medicare Group Agreement termination article on pages 8 to 9 has no two-strikes clause. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"The Medicare Group Agreement lets Aetna amend on 30 days written notice and says all amendments, other than automatic mandate changes, must be approved and executed by Aetna. The Pharmacy Service and Fee Schedule also lets Aetna make Equitable Adjustments to financial terms and amend individual specialty drug discounts to manage its guarantee. That is unilateral change of economic terms, which the model forbids.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"TERM","verdict":"bad","confidence":0.93,"page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna’s arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an “Early Termination”) Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein.","rationale":"The Medicare Group Agreement allows either party to end that group agreement without cause on 90 days notice. The pharmacy fee schedule, which runs through December 31, 2028, treats an earlier exit as Early Termination: Aetna keeps earned unpaid rebates, pharmacy guarantees become void, and allowances must be refunded, labeled liquidated damages. Earned amounts are forfeited, which is how plans get trapped. The 2023 base agreement is not in the file.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"SPEC","verdict":"bad","confidence":0.95,"page_ref":"Page 40","evidence_quote":"Aetna may amend the individual Specialty Drug discounts to manage the financial guarantee.","rationale":"Specialty is defined by Aetna's product list and exclusive CVS Specialty network, priced at AWP minus 22.75 percent in 2026 on the blended guarantee and at drug-level AWP discounts, including some at 0.00 percent, not at acquisition cost. Aetna may change individual specialty discounts to manage its guarantee, and medical-benefit specialty rebates are retained. That is not a claim-level acquisition-cost ceiling in every channel.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.96,"page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna’s prior written consent.","rationale":"Confidential Information includes the Group Agreement and costs and pricing data. The financial conditions bar Harris County from releasing the proposal to any third party without Aetna's prior written consent. The public records clause on page 22 only requires the county to warn Aetna and not oppose Aetna's effort to block release, which does not cure a gag. Nothing in this amendment frees pharmacies to tell members about cheaper options.","model_own_total":13.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"A&M System acknowledges and agrees that, except for the limited purpose set forth in Section 2.3(c) of this Exhibit G, neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"Section 4.2 of Exhibit G is an express fiduciary disclaimer negotiated in what the contract calls an arm's length fashion, and the same page reserves ESI's right to stop services in any state that would require a PBM to act as a fiduciary. The only fiduciary acceptance anywhere is ESI's narrow agreement, for appeals work only, to accept fiduciary status with respect to the performance of an appeal. The model contract from Mark Cuban and collaborators instead asks the PBM to owe loyalty and care solely to the plan and to disgorge anything retained in breach. This contract is an explicit statement of the opposite posture.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries or affiliates derive revenue in one or more of the ways as further described in the Financial Disclosure to ESI PBM Clients set forth in the Proposal (“Financial Disclosure”), as updated by ESI from time to time","rationale":"Section 4.3 of Exhibit G does disclose that ESI and its affiliates earn revenue beyond the administrative fees, and it points to a Financial Disclosure document in the Proposal, which is itself incorporated into the contract. That is more disclosure than silence. But the same section declares those revenues are not compensation from the plan, says ESI acts on its own behalf in negotiating them, and states the plan has no right to or beneficial interest in any of them, and the actual Financial Disclosure is not in the posted text and can be updated by ESI at will. There is no named officer certifying completeness of disclosures quarterly or annually, so the clause falls well short of the model's certified full disclosure.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"I looked in the exhibit list on page 17, the subcontracting clause on page 14 and the definitions in Exhibit G. There is no signed exhibit listing ESI's owners, parents, subsidiaries, affiliates, group purchasing organizations, rebate aggregators, mail order pharmacies or specialty pharmacies, and no duty to refresh any such list on a change in control. The text names Accredo, Express Scripts Specialty Distribution Services and Medco Containment Life Insurance Company only inside operational definitions, and acknowledges affiliates perform mail and specialty services, without any ownership or affiliate inventory. The change of ownership clause on page 6 only requires advance notice of a merger and gives A&M a termination election.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DEF","verdict":"unclear","confidence":0.8,"page_ref":"Pages 110 to 112","evidence_quote":null,"rationale":"Whether the definitions close labeling loopholes cannot be decided because the decisive definitions are individually blacked out. The Exhibit G definition list on pages 110 to 112 skips items 1.4, 1.15, 1.17, 1.18, 1.22, 1.26 and 1.29, rendered only as black-bar artifacts in the OCR. Alphabetically, item 1.26 sits exactly where Rebate belongs, between Prescription Drug Claim and Set-Up Forms, and items 1.17 and 1.18 sit where Manufacturer Administrative Fee belongs. The definitions that survive, such as Formulary and MAC List, are vendor friendly, but the core pass-through definitions are unreadable, so redaction, not ambiguity, is the reason this cannot be settled.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PASS","verdict":"unclear","confidence":0.8,"page_ref":"Pages 35 to 37","evidence_quote":null,"rationale":"The rebate exhibit, Exhibit C-3 on pages 35 to 37, is where pass-through percentages and payment terms live, and it is blacked except for headings and one surviving clause on page 38 noting that Rebate and Manufacturer Administrative Fee amounts paid to A&M are intended to be treated as discounts under the federal anti-kickback statute. The readable text cuts both ways: page 114 says only that ESI will pay the amounts set forth on Exhibit C, and section 4.3 on page 115 says ESI and its affiliates keep all other manufacturer related revenue, which would contradict the model's 100 percent pass-through, but the actual contractual share owed to A&M is behind the black bars. Because the exhibit that decides this is redacted, the read is redaction blocked rather than missing.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NAC","verdict":"unclear","confidence":0.85,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Pricing for ESI's own mail order and specialty pharmacies is exactly what the fully blacked Exhibit D and the blacked ESI Mail Pharmacy guarantee section on page 25 contain. Definitions on pages 110 and 111 confirm ESI Mail Pharmacy and ESI Specialty Pharmacy are ESI or affiliate owned, and section 4.3 reserves affiliate revenue to ESI, so nothing readable promises acquisition cost pricing with no retained margin. In the readable text there is no net acquisition cost commitment at all; the phrase acquisition cost appears nowhere. The standard cannot be judged because the pages where it would live are blacked.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CEIL","verdict":"unclear","confidence":0.75,"page_ref":"Pages 27 to 29","evidence_quote":null,"rationale":"A benchmark ceiling or cheapest lawful option commitment would have to appear in the general pricing terms of Exhibit C-2, section 5, on pages 27 to 29, and those are essentially fully blacked. What little is readable shows guarantees framed as average aggregate annual guarantees on page 24, not claim level ceilings, so the visible architecture leans against the model, which asks that no claim ever exceed a published benchmark. Because the actual ceiling terms, if any, sit behind the redaction, I treat this as redaction blocked rather than missing.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"CASH","verdict":"unclear","confidence":0.75,"page_ref":"Pages 27 to 29","evidence_quote":null,"rationale":"Nothing readable anywhere in the contract addresses a member paying no more than the cash price, crediting cash purchases toward the deductible, or accumulator adjustment programs; the word accumulator does not appear and cash price does not appear outside the usual and customary definition. Such protections could in principle sit inside the blacked general pricing terms of Exhibit C-2 on pages 27 to 29, since that section is said to apply to all pricing in the contract. Because I cannot rule out that the subject is addressed behind the black bars, redaction rather than absence is the reason I cannot decide.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MAC","verdict":"unclear","confidence":0.8,"page_ref":"Pages 27 to 29","evidence_quote":null,"rationale":"The surviving definition on page 111 lets ESI develop or select the MAC list, which is vendor discretion, not shared governance. Whether one list applies to both plan and pharmacy sides, whether the list is disclosed, and whether pharmacies have an appeal path would be set out in the general pricing terms of Exhibit C-2, and those pages are blacked. Some sections even within that blacked run, such as the vaccine claim pricing on page 29, remain partially visible, so I cannot confirm the subject is simply absent. Redaction is the reason this cannot be settled.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPRD","verdict":"unclear","confidence":0.8,"page_ref":"Pages 24 to 33","evidence_quote":null,"rationale":"The readable text hints at a pass-through retail arrangement: page 4 defines a billing dispute as A&M being billed other than the amount reimbursed to the pharmacy, and the audit protocol on page 127 describes verifying an existing Pass-Through pricing arrangement for participating pharmacy claims. But the claims reimbursement rates on pages 24 to 33 are blacked, and the mail and specialty pricing in Exhibit D is fully blacked, so I cannot confirm whether the plan pays exactly what the pharmacy is paid plus a disclosed fee in any channel. Because the pages that decide spread pricing are withheld, this is redaction blocked rather than a finding that spread pricing exists.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GPO","verdict":"unclear","confidence":0.8,"page_ref":"Pages 35 to 37","evidence_quote":null,"rationale":"No readable passage anywhere mentions a group purchasing organization, a rebate aggregator, or purchase discounts received by a related purchasing entity, and section 4.3 on page 115 broadly reserves affiliate revenue to ESI. If rebate aggregation economics are addressed at all, it would be in the rebate exhibit on pages 35 to 37 or in the individually blacked definitions on pages 110 to 112, both of which ESI has designated proprietary. Since the pages where a GPO pass-through would live are redacted, I treat this as redaction blocked, noting that the visible retention language points against the model.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 110","evidence_quote":"“Formulary” means the list of FDA-approved prescription drugs and supplies developed by ESI’s Pharmacy and Therapeutics Committee and/or customized by Sponsor, and which is selected and/or adopted by Sponsor","rationale":"The sponsor selects or adopts the formulary, but it is developed by ESI's pharmacy and therapeutics committee and ESI modifies it from time to time with additions and deletions automatically adopted unless the sponsor opts out through Set-Up Forms. That is opt-out control rather than the model's standard that the sponsor approve every change. Nothing readable requires a lowest net cost analysis or quarterly utilization management outcomes by drug. The EGWP formulary on page 120 is even further from sponsor control since Medicare rules restrict changes.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"LNC","verdict":"bad","confidence":0.8,"page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The formulary definition states on its face that manufacturer rebate arrangements are a reason ESI moves drugs on and off the formulary, which is the rebate driven placement the model's lowest net cost standard exists to prevent. The phrases lowest net cost and book of business appear nowhere in the produced text, so there is no stated lowest net cost standard, no annual comparison against ESI's whole book of business, and no duty to disclose drugs placed above cheaper equivalents. Because the contract affirmatively elevates rebate arrangements as a formulary factor, this contradicts the model rather than merely falling short of it.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"NET","verdict":"partial","confidence":0.8,"page_ref":"Page 112","evidence_quote":"ESI maintains multiple networks and subnetworks, and periodically consolidates networks or migrates clients to other networks and subnetworks","rationale":"The network clause lets ESI consolidate networks and migrate the plan between networks, and the mail pharmacy clause has ESI marketing its own mail channel to members with cost savings messaging, plus the right to suspend a member's mail service over an unpaid copay, all of which sits uneasily with the model's anti-steering and any willing pharmacy principles. On the protective side, page 4 commits ESI to return pharmacy audit overpayments to A&M, keeping only 15 percent for running the audit program, and nothing readable mentions retroactive claim clawbacks or volume conditioned reimbursement. The protections are narrower than the model's, so this is addressed but weaker.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"MFN","verdict":"unclear","confidence":0.7,"page_ref":"Pages 21 to 29","evidence_quote":null,"rationale":"The phrases most favored and market check appear nowhere in the readable text, and no annual market check with a meet, credit or release remedy is described in the base agreement or the audit protocol. A pricing adjustment of that kind could conceivably sit in the blacked billing and general pricing terms of Exhibit C-1 and C-2 on pages 21 to 29, where section 5 states terms applicable to all pricing. Since I cannot exclude the subject living behind the black bars, redaction is the reason I cannot decide, though the visible text gives no hint the protection exists.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AUD","verdict":"bad","confidence":0.9,"page_ref":"Page 3","evidence_quote":"Auditing representatives selected by the A&M System (the “Auditor’) and approved by ESI, whose approval shall not be unreasonably withheld, shall be allowed access to A&M System specific records","rationale":"The audit right is fenced in on every side: one audit a year, a rolling 24 months of data, an auditor ESI must approve, a six month ban on the auditor later working for anyone in proceedings against ESI, and extra audits at ESI's standard cost. The rebate audit in Exhibit I is on site only, restricted to a mutually agreed CPA firm, covers only fifty percent of rebate payments for two quarters, and ESI may review the auditor's notes. The bright spots, State Auditor access under Texas law and a right to audit rebate agreements for Exhibit C compliance, do not offset the fact that the plan cannot freely choose its auditor or take away copies. This is the classic restricted audit the model clause exists to prevent.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"DATA","verdict":"partial","confidence":0.85,"page_ref":"Page 8","evidence_quote":"anonymized claims data (de-identified in accordance with HIPAA); ESI Specialty Pharmacy and ESI Mail Pharmacy data","rationale":"The plan gets real but incomplete data rights: page 4 makes A&M specific records and reports the property of the A&M System with delivery on request at termination, page 12 bars ESI from selling member identifiable data, and page 130 bars PHI sales under Texas law. But the confidentiality clause on page 8 lists anonymized claims data and specialty and mail pharmacy data as ESI property, and the business associate agreement lets ESI use and disclose de-identified data. There is no clause making the plan sole owner of claims, rebate and derived data sets, no machine readable delivery duty, and no ban on ESI reusing anonymized plan data, so the subject is addressed but materially weaker than the model.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"PERF","verdict":"unclear","confidence":0.75,"page_ref":"Pages 39 to 51","evidence_quote":null,"rationale":"Performance guarantees and their reconciliation mechanics would be set with the pricing in Exhibit C, and pages 39 to 51 covering administrative services fees and EGWP administrative fees are blacked, as are the guarantee values on pages 24 to 25. The readable headings show the guarantees are average aggregate annual ingredient cost and dispensing fee guarantees, which already leans toward book averaging rather than the model's quarterly, plan specific, cash reconciled standard. Because the measurement and remedy terms themselves are behind the redaction, this is redaction blocked.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"ENF","verdict":"partial","confidence":0.8,"page_ref":"Page 127","evidence_quote":"To the extent the mutually accepted audit results demonstrate claims errors, ES! will reprocess the claims and make corresponding adjustments to Sponsor through credits to a future invoice(s).","rationale":"Enforcement is not self executing: audit corrections arrive as credits against future invoices, and only after both parties accept the audit results, with no liquidated damages, interest, or automatic credit for missed guarantees or late reports anywhere in the readable text. A second material breach carries no special consequence beyond the ordinary 45 day cure and termination right on page 5. The stronger pieces are statutory: page 9 allows termination if ESI knowingly violates the contracting information duties of Subchapter J of the Texas Public Information Act, and page 6 lets A&M terminate immediately on an ESI change of control. That is meaningful but short of the model's automatic remedies and two strikes exit.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"AMD","verdict":"good","confidence":0.95,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The amendment clause is clean and bilateral, and it is reinforced by page 2, where ESI agrees not to revise the Exhibit C pricing terms during the term except as required by law or by written agreement of the parties. Nothing readable gives ESI a right to change economic terms by notice, portal update or updated exhibit. The one caution is section 4.3 of Exhibit G, which lets ESI update its Financial Disclosure document from time to time without an amendment, but that document discloses revenue rather than setting plan pricing. This meets the model's requirement.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"TERM","verdict":"good","confidence":0.85,"page_ref":"Page 5","evidence_quote":"the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice","rationale":"The plan holds a straightforward 90 day convenience termination with no stated penalty, plus loss of funding termination on page 12, immediate termination on an ESI merger or acquisition on page 6, and EGWP auto-termination if CMS ends MCLIC's Part D contract. The caveats that keep confidence below full are on pages 123 to 125 of the EGWP addendum, where MCLIC may delay final rebate and CMS reimbursement payments to allow for final reconciliation, and on page 4 where A&M specific records are delivered only on written request. The core model requirement, convenience exit without penalty and without express forfeiture, is present.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"SPEC","verdict":"unclear","confidence":0.85,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Specialty pricing is the single most blacked out subject in the contract: the Specialty Product Pricing heading on page 25 has no surviving text, the specialty rebate amounts on page 35 are blacked, and the entire fifty three page Exhibit D on specialty drugs under the mail order pharmacy program is fully blacked. The specialty definition itself appears to sit at item 1.29 of the Exhibit G definitions, which is also individually blacked. Whether specialty is defined by function, whether drug level rates act as ceilings, and whether affiliate specialty claims price at acquisition cost simply cannot be seen.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 109","evidence_quote":"The Contract, Exhibit C (Program Pricing Terms), Exhibit D (Specialty Drugs Under the Mail Specialty Drugs Under the Mail Order Pharmacy Program), and Exhibit E (Clarifications)","rationale":"Exhibit F is ESI's designation of what it considers confidential and proprietary, and it sweeps in the entire pricing exhibit, the entire specialty exhibit and the clarifications, while page 8 separately lists rebate contracts, manufacturer administrative fees and drug pricing information as ESI confidential property. The Public Information Act clause then obliges A&M to notify ESI of requests so ESI can advocate that the information be withheld, and the blacked out pages in this very posting are the practical result of that machinery. The contract does acknowledge Texas public records law, under which ESI can only seek to block release, but treating all pricing and rebate material as proprietary trade secret material is exactly the gag the model flags. No pharmacy gag clause appears in the readable text, but the pricing confidentiality is enough.","model_own_total":34,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"FID","verdict":"partial","confidence":0.75,"page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA. Aetna has complete authority to determine whether and to what extent eligible individuals and beneficiaries are entitled to coverage and to construe any disputed or doubtful terms under this Group Agreement.","rationale":"The only fiduciary language in the file is narrow, covering claim determinations under Section 503 of ERISA, and it is paired with complete discretionary authority and a deferential standard of review. Nothing extends a duty of loyalty to the financial side of the arrangement, and page 47 states that manufacturer payments belong exclusively to Aetna and its affiliate with no legal interest for the county. A model style duty to act solely in the interest of the plan and its members would need to cover formulary, network and pricing discretion, not just benefit appeals.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.7,"page_ref":"Page 85","evidence_quote":"Aetna has various programs for compensating producers (agents, brokers and consultants). If you would like information regarding compensation programs for which your producer is eligible, payments (if any) which Aetna has made to your producer, or other material relationships your producer may have with Aetna","rationale":"Disclosure here is category level and reactive rather than a standing certified accounting. Page 46 tells the county that categories of manufacturer administrative fees, other manufacturer payments and network transmission fees exist, and this application page offers producer compensation information only if the county asks. There is no annual certified statement of all revenue Aetna and CVS Caremark derive from the county business, and no officer certification requirement anywhere in the file.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"OWN","verdict":"partial","confidence":0.75,"page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"The file does disclose the main affiliate relationships, naming CVS as parent of Aetna and SilverScript and naming CaremarkPCS Health as the affiliated pharmacy benefit manager on page 36, with CVS Caremark mail and CVS Specialty as the dispensing channels. What is absent is any ongoing obligation to disclose new affiliate relationships, any arm's length pricing standard for affiliate transactions, or any disclosure of affiliate margins. Disclosure of the corporate family is present but the protections that should follow it are not.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"DEF","verdict":"bad","confidence":0.9,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"The definition of rebates is built by exclusion rather than by capturing all manufacturer value. Administrative fees, other manufacturer payments and network transmission fees are each defined out of the rebate pool, which is the exact carve out pattern the model contract from Mark Cuban and collaborators is written to close. The controlling definition itself sits in the Prescription Drug Services Schedule, which is referenced but not attached, so the county has agreed to exclusions from a definition that is not in the file.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"Page 47","evidence_quote":"Customer further agrees that the amounts described above belong exclusively to Aetna or it's affiliate, CVS Caremark, and Customer has no right to, or legal interest in, any portion of the aforesaid amounts received by Aetna or CVS Caremark.","rationale":"Instead of full pass through of manufacturer value, the county gets minimum per script rebate guarantees and an express disclaimer of any interest in the rest. Guaranteed amounts are floors, not a share of what is actually collected, and the surplus above the floor stays with Aetna along with the carved out fee categories. Rebates for specialty drugs paid under the medical benefit and value based contracting recoveries are also retained by Aetna on this same page.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"NAC","verdict":"bad","confidence":0.85,"page_ref":"Page 40","evidence_quote":"Aetna may amend the individual Specialty Drug discounts to manage the financial guarantee. The financial guarantee is measured and reconciled annually across all specialty drugs dispensed by CVS Specialty Pharmacy, including through the Specialty Connect process","rationale":"Nothing in the file prices any drug at the acquisition cost of the dispensing pharmacy plus a stated markup. Every channel, including the affiliate mail and specialty pharmacies, is priced as a discount off average wholesale price, and Aetna reserves the right to move the individual specialty discounts to protect its own aggregate guarantee. The result is a benchmark based price for affiliate purchases with no visibility into what CVS actually pays for the drug.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"partial","confidence":0.8,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall give the Plan Participant the benefit of the lesser of (i) the Participating Pharmacy's Usual and Customary Charge, (ii) MAC (where applicable) or (iii) discounted AWP cost.","rationale":"There is a lesser of test, so the plan and the member are protected against paying more than usual and customary or the maximum allowable cost at the counter. It is not a true ceiling against outside benchmarks, because it never references acquisition cost, a national average price, or any published cash program. Specialty drugs dispensed at retail are excluded from the discount guarantees, and Aetna may re-evaluate pricing when assumptions change, so the effective ceiling is contingent.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"CASH","verdict":"partial","confidence":0.7,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy's Usual and Customary Charge, (iii) MAC (where applicable) or (iv) discounted AWP cost.","rationale":"Member cost share is capped at the pharmacy usual and customary charge, which prevents the classic clawback where a member pays more than the cash price. The file goes no further, since nothing lets a member buy at an outside cash price and have it credited to the deductible or out of pocket maximum, and page 79 confirms that certain drug costs do not apply toward the deductible or the true out of pocket threshold. The Caremark Cost Saver description on page 57 is framed as a plan pricing tool rather than a member right.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"MAC","verdict":"partial","confidence":0.75,"page_ref":"Page 40","evidence_quote":"MAC: Certain dosage forms and strengths may not be included on the MAC list and shall be priced at the Specialty Product default rate.","rationale":"Maximum allowable cost appears only as an input to pricing and to the lesser of test, with a note that items off the list default to a different rate. The file never requires the list to be disclosed to the county, never sets update timing or sourcing standards, and gives no appeal path for pharmacies or the plan. Because the arrangement is lock in pricing, nothing requires the list used to bill the county to be the same list used to pay the pharmacy.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"bad","confidence":0.95,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"This is an explicit spread pricing arrangement, described in the contract as traditional or lock in pricing. The county pays one amount, the pharmacy is paid another, and the vendor keeps the difference as part of its compensation on top of the stated administrative and per claim fees. A traditional pricing auxiliary fee of 1.50 dollars per retail claim on page 52 sits on top of that retained spread.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"GPO","verdict":"bad","confidence":0.85,"page_ref":"Page 46","evidence_quote":"Aetna may also receive network transmission fees from our network pharmacies for services we provide for them. These amounts are not considered Rebates and are not shared with Customers.","rationale":"The file confirms that revenue flows to Aetna and its affiliates from manufacturers and from network pharmacies and then removes all of it from what the county sees or shares in. There is no obligation to disclose or pass through amounts collected by any group purchasing or rebate aggregation entity, and no audit right reaching those entities. This is the aggregator leakage the model contract is designed to prevent, stated affirmatively in the vendor's favor.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"FORM","verdict":"partial","confidence":0.75,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"The county can accept or reject a formulary, but only from options Aetna proposes, and the pricing on page 40 assumes the Aetna standard formulary and the choose generics program. Aetna may propose modifications based on rebates and other factors, treats the formulary as its own confidential business information, and charges 100,000 dollars for a custom formulary per page 53. Nothing requires formulary placement decisions to be made on a lowest net cost basis or disclosed with their rebate drivers.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"I looked at the formulary management section on page 46, the rebate terms on pages 41 and 42, the market check language on page 43 and the additional services list on pages 53 through 57. Nothing states a lowest net cost standard for coverage or placement decisions, and nothing gives the county a comparison of its pricing against the vendor book of business. A net cost analysis appears only as a feature of the priced custom formulary service, not as a contractual standard, and the base agreement that would ordinarily hold such a standard is not in the file.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"Members are steered into pharmacies owned by the vendor's parent, with retail fills barred for specialty and an exclusive specialty arrangement stated on the same page. There is no any willing pharmacy provision, no protection for independent pharmacies against differential reimbursement, and no limit on effective rate reconciliation or pharmacy clawbacks. Network composition and pricing are controlled entirely by the vendor, with a stated right to amend pricing if retail leakage rises.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"MFN","verdict":"partial","confidence":0.8,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"There is an annual market check, which is more than many contracts give, but it is not a most favored nation guarantee. It only triggers a good faith discussion, requires a 2 percent net savings threshold before anything happens, and any change must be mutually agreed and applied prospectively from a future January. The reviewer must be a mutually agreed third party under a non-disclosure agreement, so the county cannot unilaterally choose its benchmark or force a price reset.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule. Customer is entitled to an annual electronic claim audit subject to standard pharmacy benefit audit practices","rationale":"Audit rights exist but are rationed and expensive. The county gets one rebate audit and one electronic claim audit a year, audits are at the county's own expense unless otherwise agreed, and the governing terms sit in a Prescription Drug Services Schedule that is not attached to this file. The fee schedule on page 54 charges 5,000 dollars per file for audit claim files covering data older than 24 months, and there is no stated right to reach manufacturer contracts or affiliate pharmacy records.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"DATA","verdict":"bad","confidence":0.8,"page_ref":"Page 54","evidence_quote":"Refill Transfers upon termination $4,500 Per file Precertification history $3,500 Per file Accumulator files $1,000 Per file Historical claims data $1,000 Per file","rationale":"The county is charged per file for its own historical claims, accumulator and transition data, including at termination, which is inconsistent with plan sponsor ownership of plan data. No clause anywhere in the file states that the county owns the data or restricts the vendor from using or monetizing it, while page 46 describes payments to Aetna for the analysis or provision of aggregated data and page 84 gives Aetna inspection rights over county data. The base agreement is not in the file, but the fee schedule in this amendment affirmatively prices access to the county's own information.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 42","evidence_quote":"Rebate guarantees are measured individually by component and reconciled in the aggregate on an annual basis within 12 months following the end of the Plan year; a surplus in one or more component Rebate guarantees may be used to offset shortages in other component Rebate guarantees.","rationale":"There are real financial guarantees for discounts, dispensing fees and rebates, and page 39 keeps discount and dispensing fee components from offsetting one another. The rebate side is weaker, since surpluses offset shortfalls in the aggregate and reconciliation can take a full year after the plan year ends. Long exclusion lists for compounds, limited distribution drugs, coordination of benefits, vaccines and 340B claims further shrink the base on which any guarantee is measured.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"ENF","verdict":"partial","confidence":0.65,"page_ref":"Page 43","evidence_quote":"CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"Some remedies are self executing, since guarantee shortfalls and program savings misses produce credits against future billing without the county having to prove damages. Those remedies are capped, the drug savings review credit on page 56 is limited to the fees paid for the program, and there is no two strikes exit, no penalty interest and no fee at risk for compliance failures. The strongest liquidated damages provision in the file runs the other way, as an early termination fee payable to Aetna.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"AMD","verdict":"bad","confidence":0.95,"page_ref":"Page 14","evidence_quote":"by Aetna upon 30 days' written notice to the Contract Holder. The parties agree that an amendment does not require the consent of any Member or other person.","rationale":"Section 9.17 lets Aetna amend the group agreement unilaterally on 30 days written notice, without county consent. The pharmacy schedule adds further one sided change rights, including equitable adjustment of pricing on stated triggers effective 30 days after notice on page 44 and the right to amend individual specialty discounts on page 40. A public plan sponsor should have mutual written amendment only, with a right to terminate if terms change.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 47","evidence_quote":"prior to December 31, 2028 (an \"Early Termination\") Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein","rationale":"Although section 5.1 allows either party to end the group agreement on 90 days notice, the pharmacy terms attach heavy penalties to leaving before December 31, 2028. Aetna keeps earned but unpaid rebates, the pharmacy guarantees become null and void and are not reconciled, unused allowances must be refunded, and an early termination fee is payable as liquidated damages. Transition of data is also priced per file on page 54, which raises the practical cost of exit further.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"partial","confidence":0.8,"page_ref":"Page 39","evidence_quote":"Only Specialty Products dispensed by a Specialty Pharmacy are included in the Specialty Pharmacy Discount guarantee listed above. Specialty Products dispensed by Participating Retail Pharmacies are not included in any Discount guarantee listed above.","rationale":"Specialty pricing is unusually detailed, with a drug level discount table across pages 59 through 71 and a stated default rate of 17.00 percent with a zero dispensing fee on page 71. The protections are still weak, because the guarantee only covers drugs dispensed by the affiliate specialty pharmacy, discounts are set off average wholesale price rather than acquisition cost, and Aetna may change individual drug discounts to protect its own aggregate result. Specialty is defined by an Aetna maintained product list, so the vendor controls which drugs fall under which economics.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Claude Opus 5","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna's prior written consent.","rationale":"A Texas county is told that pricing and financial terms cannot be released to any third party without vendor consent, which cuts directly against public accountability for public money. Section 9.20 of the group agreement sweeps the agreement itself, costs and pricing data into confidential information, page 22 requires the county to notify Aetna of public records requests and not to oppose Aetna efforts to obtain a declaratory judgment blocking disclosure, and pages 17 through 21 carry a not for distribution trade secret legend. This is a broad gag on a public body rather than a narrow trade secret protection.","model_own_total":24,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"partial","confidence":0.95,"page_ref":"Page 12","evidence_quote":"Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA.","rationale":"Aetna accepts fiduciary status only for ERISA claim determinations. The clause does not impose loyalty and care solely to the plan and members, require conflict disclosure, or require disgorgement. It also grants Aetna broad interpretive discretion, so it is substantially narrower than the model protection.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.94,"page_ref":"Page 47","evidence_quote":"Rebates for Specialty Products that are administered and paid through the Plan Participant’s medical benefit rather than the Plan Participant’s pharmacy benefit will be retained by Aetna as compensation","rationale":"The exhibits disclose several retained revenue categories, including medical-benefit specialty rebates, value-based rebate payments, administrative fees, and network fees. That is useful conflict information, but the amendment does not require disclosure of all direct and indirect compensation, consultant payments, or affiliate ownership. No named officer must certify completeness quarterly or annually.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"partial","confidence":0.97,"page_ref":"Page 72","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"The rate exhibit identifies CVS as parent of Aetna and SilverScript, and other pages identify CVS Caremark and Aetna Rx Home Delivery. There is no signed exhibit listing every owner, subsidiary, affiliate, purchasing entity, rebate aggregator, mail pharmacy, and specialty pharmacy. The amendment also lacks a duty to refresh the disclosure within 30 days after a change.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"bad","confidence":0.99,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers","rationale":"The rebate definition expressly excludes manufacturer administrative fees. The same section excludes other manufacturer payments, data-related payments, educational payments, and network transmission fees from rebate sharing. These labels create the precise loophole that the model's economic-function definitions are intended to close.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"bad","confidence":0.99,"page_ref":"Page 46","evidence_quote":"These payments are not considered Rebates and are not included in Rebate sharing arrangements with Customers.","rationale":"The schedule promises minimum rebate guarantees but excludes multiple streams of manufacturer and other organization revenue from sharing. It also allows Aetna to retain medical-benefit specialty rebates and value-based rebate payments. Payments occur 180 days after quarter end, much later than the model's 30-day standard.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"bad","confidence":0.98,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The contract requires use of CVS-owned specialty pharmacies but prices specialty drugs through AWP discount schedules. It does not invoice affiliate claims at documented net acquisition cost plus a stated dispensing fee. The traditional pricing disclosure also allows Aetna to retain a spread, directly contradicting the model's affiliate cost rule.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"partial","confidence":0.9,"page_ref":"Page 57","evidence_quote":"If the price is lower through a non-Aetna contracted network (including an administrative fee paid to the third-party that contracts the network), the Claim will be processed through that network.","rationale":"Caremark Cost Saver compares an Aetna network price with an available non-Aetna network price and uses the lower option. That is a limited claim-price comparison, but it is not a ceiling tied to a published cash benchmark. It does not apply to every drug and channel or guarantee the cheapest lawful option claim by claim.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"partial","confidence":0.94,"page_ref":"Page 39","evidence_quote":"Participating Pharmacy shall collect and retain from the Plan Participant at the time of dispensing the lesser of (i) the Cost Share; (ii) the Participating Pharmacy’s Usual and Customary Charge, (iii) MAC (where applicable) or (iv) discounted AWP cost.","rationale":"The member receives a useful lesser-of protection against the pharmacy's usual and customary charge, MAC, and discounted AWP. The amendment does not say that an outside cash purchase counts toward the deductible and out-of-pocket maximum. It also conditions the PrudentRx guarantee on a true accumulation design without requiring a written sponsor election for accumulator treatment.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"partial","confidence":0.88,"page_ref":"Page 39","evidence_quote":"MAC Pricing applies at Mail Order.","rationale":"The pricing terms use MAC at mail order and in the member lesser-of calculation, and the service list mentions third-party pharmacy appeals. The amendment does not require one disclosed MAC list for both plan billing and pharmacy reimbursement. It also omits update schedules and defined appeal timelines, while the base agreement is not in the file.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"bad","confidence":1,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference","rationale":"The schedule expressly defines traditional or lock-in pricing to permit different plan and pharmacy amounts. Aetna keeps the difference in addition to other fees. This is spread pricing and directly contradicts the model.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"bad","confidence":0.93,"page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates.","rationale":"The schedule permits Aetna to receive payments from manufacturers and other organizations outside rebate sharing. It contains no requirement that a related purchasing entity or rebate aggregator pass purchase discounts, volume credits, or supplier payments to the plan. Because the base agreement is not in the file, there is no broader related-entity pass-through provision to cure this exclusion.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.96,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan.","rationale":"Harris County may accept or reject the formulary, which provides some sponsor control. Aetna determines which formulary options are available and may propose modifications based on cost, rebates, and other factors. The amendment does not require sponsor approval of every change, lowest-net-cost analysis, or quarterly drug-level utilization management outcomes.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The formulary terms on pages 40 and 46 do not require decisions based on lowest net cost for Harris County or an annual comparison with Aetna's whole book of business. Page 53 lists net cost analysis only as part of an optional custom formulary service, not as a governing standard. The underlying base agreement is not in the file, so any broader formulary standard that might be there cannot be scored.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"bad","confidence":1,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The amendment mandates CVS Specialty and prohibits retail fills for the Specialty Performance Network. It also conditions pricing on Aetna being the exclusive specialty provider, with only a stated HIV exception. This is direct affiliate steering and contradicts the model's network protections.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"partial","confidence":0.98,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs","rationale":"The schedule allows an annual market check against comparable employers. It does not automatically give Harris County the best comparable pricing, and a qualifying result only leads to good-faith discussion. There is no mandatory meet, credit, or release remedy if Aetna declines a revision.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"partial","confidence":0.97,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule.","rationale":"The amendment grants one annual rebate audit and an annual electronic claim audit at the customer's expense. Both rights are subject to terms in the Prescription Drug Services Schedule, which is not in this file. Reporting tools and quarterly aggregate reports are offered, but there is no full scheduled financial data, pre-adjudication access, or unrestricted sponsor-selected auditor right.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"bad","confidence":0.98,"page_ref":"Page 54","evidence_quote":"Accumulator files                                      $1,000                  Per file\n\n             Historical claims data                                 $1,000                  Per file","rationale":"The service schedule charges separate per-file fees for accumulator and historical claims data, as well as other transition files. The amendment never grants Harris County sole ownership of claims, eligibility, accumulator, rebate, and derived data or prohibits Aetna from reusing it. Charging for core plan data creates the switching and audit barrier the model provision is designed to prevent.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"bad","confidence":0.98,"page_ref":"Page 43","evidence_quote":"CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"The PrudentRx savings remedy is an annual future billing credit capped at 30 percent of program cost. Discount guarantees are also annual and may take 180 days to reconcile, while rebate guarantee components may offset one another. These are capped or delayed credits rather than quarterly plan-specific cash remedies.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"partial","confidence":0.91,"page_ref":"Page 43","evidence_quote":"CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"The PrudentRx provision supplies a defined credit without requiring proof of damages, which is a limited self-executing remedy. The credit is delayed, capped, and usable only against future billing. The amendment has no automatic damages for late reports and no penalty-free two-strikes termination right for repeated breach or integrity failure.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"bad","confidence":1,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder.","rationale":"The Medicare Group Agreement lets Aetna amend the agreement unilaterally on 30 days' notice. It also allows automatic amendments for mandates. The unilateral notice right directly contradicts the model requirement that both parties sign every amendment.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"bad","confidence":0.99,"page_ref":"Page 47","evidence_quote":"Aetna shall retain any earned but unpaid rebates as of the Early Termination date","rationale":"Although the Medicare Group Agreement permits termination without cause on 90 days' notice, the pharmacy schedule penalizes termination before December 31, 2028. Aetna keeps earned but unpaid rebates, voids plan-year pharmacy guarantees, and may recover prorated allowances as an Early Termination Fee. Forfeiting earned rebates and imposing termination costs contradict the model.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"bad","confidence":0.99,"page_ref":"Page 40","evidence_quote":"Aetna being the exclusive provider of Specialty Services with the exception of the HIV class","rationale":"The contract includes drug-level specialty AWP discounts but makes Aetna the exclusive specialty provider except for the HIV class. It does not price CVS affiliate specialty claims at net acquisition cost. The mandatory affiliate channel and AWP methodology contradict the model's core specialty pricing control.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"bad","confidence":1,"page_ref":"Page 14","evidence_quote":"The term “Confidential Information” includes, but is not limited to, this Group Agreement or any information of either Contract Holder or Aetna","rationale":"The confidentiality clause covers the agreement, costs, and pricing data and restricts disclosure without consent. Pricing exhibits are repeatedly marked proprietary, confidential, and not for further distribution. A public-records clause requires notice to Aetna and an opportunity to seek protection, so it does not remove the gag on voluntary public disclosure.","model_own_total":21.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:30:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"FID","verdict":"bad","confidence":0.9,"page_ref":"Page 10","evidence_quote":"The relationship between the Parties is a contractual relationship between independent contractors. Neither Party is an agent or employee of the other in performing its obligations pursuant to this Group Agreement.","rationale":"The Group Agreement expressly frames Aetna as an independent contractor, not a fiduciary to the County or its retirees. The only fiduciary statement anywhere in the file is that Aetna is a fiduciary for the purpose of Section 503 of Title 1 of ERISA for claims decisions, with an abuse of discretion standard, which is the narrow claims administrator role and nothing like the duty of loyalty over formularies, networks and pricing that the model contract published by Mark Cuban and collaborators requires. The base agreement, where a broader duty might theoretically sit, is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.8,"page_ref":"Page 46","evidence_quote":"The term Rebates as defined in the Prescription Drug Services Schedule does not mean or include any manufacturer administrative fees that may be paid by pharmaceutical manufacturers to cover the costs related to the reporting and administration of the pharmaceutical manufacturer agreements. Such manufacturer administrative fees are not shared with Customer hereunder.","rationale":"To its credit, the fee schedule affirmatively discloses several revenue streams Aetna keeps, including manufacturer administrative fees, data and education payments, and network transmission fees. But it discloses them only to retain them, not to remit them, and there is no officer certification, quarterly or annual, that all compensation has been disclosed and remitted as the model contract of Mark Cuban and collaborators contemplates. Broker compensation disclosure on page 29 says only that rates exclude broker commissions.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"OWN","verdict":"partial","confidence":0.8,"page_ref":"Page 31","evidence_quote":"SilverScript is a CVS affiliate and is contracted with CMS for 2026. CVS is the parent company of both Aetna and SilverScript.","rationale":"There is no signed ownership exhibit, but the documents do disclose the corporate chain in plain text: SilverScript Insurance Company issues the drug plan, CVS Caremark administers the pharmacy benefit, CVS Specialty fills the specialty drugs, and CVS is the parent of Aetna and SilverScript. That is more than silence, but it is a narrative disclosure with no completeness duty and no obligation to refresh it within 30 days of an ownership change, which is what the model exhibit requires.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"DEF","verdict":"bad","confidence":0.85,"page_ref":"Page 46","evidence_quote":"Aetna may also receive other payments from drug manufacturers and other organizations that are not Rebates. These payments are generally for one of two purposes: (i) to compensate Aetna for bona fide services it performs, such as the analysis or provision of aggregated data or (ii) to reimburse Aetna for the cost of various educational and other related programs","rationale":"The definitions in this text open loopholes rather than close them. Rebates are defined elsewhere, in the Prescription Drug Services Schedule that is not in the file, and this document then excludes manufacturer administrative fees, data and education payments, network transmission fees, and medical benefit specialty rebates from that definition of Rebates, letting value be relabeled as fees to escape the 100 percent pass through. Specialty is defined by Aetna's own Specialty Product List, that is, by label rather than economic function.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"PASS","verdict":"partial","confidence":0.85,"page_ref":"Page 37","evidence_quote":"Customer will receive the following minimum rebate guarantees: 01/01/2026 01/01/2027 01/01/2028 Greater of 100%or Greater of 100%or Greater of 100%or Retail $406.62 Per Brand $406.62 Per Brand $406.62 Per Brand Script Script Script","rationale":"The rebate numbers look strong: the County receives the greater of 100 percent of rebates or fixed per brand script minimums, paid quarterly. But the definition of Rebates excludes manufacturer administrative fees and several other payment streams, which stay with Aetna or CVS Caremark, and payment comes 180 days after quarter end rather than within 30 days as the model contract of Mark Cuban and collaborators requires. Guarantees are also reconciled in the aggregate annually, letting surpluses on one component offset shortfalls on another. One hundred percent of a shrunken definition is not 100 percent of everything.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"NAC","verdict":"bad","confidence":0.88,"page_ref":"Page 36","evidence_quote":"Brand Discount AWP - 19.50% AWP - 19.50% AWP - 19.50% Generic Discount AWP - 92.00% AWP - 92.20% AWP - 92.40% Dispensing Fee $0.00 per Script $0.00 per Script $0.00 per Script","rationale":"The mail order channel is run by CVS Caremark Mail Service Pharmacy and the specialty channel by CVS Specialty, both affiliates of the vendor. Claims through these owned pharmacies are priced at AWP discounts, for example brand drugs at AWP minus 19.50 percent at mail, not at net acquisition cost plus a dispensing fee, and under traditional pricing the vendor can retain margin on those channels. That leaves the incentive to route retirees into the vendor's own pharmacies fully intact.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the produced text caps what the plan pays at a published benchmark on a claim by claim basis. The lesser of language on page 39 limits only what the pharmacy collects from the member at the counter, the lesser of cost share, usual and customary charge, MAC or discounted AWP, not what the plan itself is charged. A plan level benchmark ceiling would live in the pricing articles of the base agreement, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"I searched the amendment body, the Group Agreement, the fee schedule and the Summary of Benefits for any promise that a member never pays more than the pharmacy cash price, that cash purchases count toward the deductible and out of pocket maximum, or any language on accumulator adjustment. None exists. This kind of member protection would ordinarily sit in the base agreement or plan documents, which are not in the file. The file does mention the PrudentRx copay optimization program and true accumulation as a plan design assumption, but that is a vendor program condition, not a member cash price right.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"MAC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The text references MAC pricing in passing: page 39 says MAC Pricing applies at Mail Order and retail guarantees exclude claims priced at usual and customary rates, and some specialty drugs are priced at MAC in the list on pages 59 to 71. But there is no MAC list governance: no disclosure obligation, no update schedule, no single list for plan and pharmacy sides, and no pharmacy appeal path with timelines. The only appeal related item is a pass through fee per review for retail network pharmacy third party appeals on page 52. MAC governance would live in the Prescription Drug Services Schedule, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"SPRD","verdict":"bad","confidence":0.96,"page_ref":"Page 44","evidence_quote":"charged to the Customer and Plan Participants for network claims may differ from the amount paid to Participating Pharmacy and Aetna retains the difference, in addition to any other fees or charges agreed upon by Aetna and Customer, as compensation for the pharmacy benefit management services provided to the Customer.","rationale":"This is a written admission of spread pricing. The County chose a Traditional pricing arrangement under which what the plan is charged for a claim can exceed what the pharmacy is paid, and Aetna keeps the difference as compensation. The model contract published by Mark Cuban and collaborators exists to eliminate exactly this undisclosed markup.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"Group purchasing organizations and rebate aggregators are never mentioned in the 87 pages. The closest language is page 47, where the County agrees that payments Aetna receives from manufacturers for aggregated data and book of business activities belong exclusively to Aetna or CVS Caremark, which is precisely the kind of purchasing entity revenue a GPO clause should capture but does not. If a GPO pass through clause exists, it would be in the base agreement or the Prescription Drug Services Schedule, neither of which is in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"FORM","verdict":"partial","confidence":0.85,"page_ref":"Page 46","evidence_quote":"Customer acknowledges and agrees that it has sole discretion and authority to accept or reject the Formulary that will be used in connection with the Plan. Customer further understands and agrees that from time to time Aetna may propose modifications to the drugs and supplies included on the Formulary as a result of factors, including but not limited to, market conditions, clinical information, cost, rebates and other factors.","rationale":"The County formally retains sole discretion to accept or reject the formulary, which is the right starting point. But the pricing is conditioned on adopting the Aetna Standard Formulary, the Choose Generics program and the Advanced Control Specialty Formulary, and the Financial Conditions document reserves the right to restructure the plan design or formulary in response to regulatory events, so the County's control is exercised within guardrails set by the vendor's economics. There is no right to receive lowest net cost analysis or quarterly utilization management outcomes by drug.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No lowest net cost standard for this plan appears anywhere in the file, and no annual comparison of the County's formulary results against Aetna's whole book of business is promised. Page 46 says formulary modifications may be driven by market conditions, clinical information, cost, rebates and other factors, which names rebates as a placement factor without any offsetting net cost test. Such a standard might be in the base agreement, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"NET","verdict":"bad","confidence":0.9,"page_ref":"Page 40","evidence_quote":"Specialty Performance Network means that Plan Participants are required to use CVS Specialty Pharmacies (no fills at retail allowed).","rationale":"The network design steers specialty patients into the vendor's own channel: retirees must use CVS Specialty pharmacies and retail fills are not allowed, with only the HIV class excepted, and specialty retail leakage of 10 percent or more lets Aetna amend pricing. Nothing in the text protects pharmacies from retroactive clawbacks, promises any willing pharmacy access, or bars steering into affiliate pharmacies. Mail order is likewise run by CVS Caremark Mail Service Pharmacy.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"MFN","verdict":"partial","confidence":0.88,"page_ref":"Page 43","evidence_quote":"Should the comparison demonstrate that the current market conditions would yield a savings of 2%or more in net costs (i.e. gross costs net of administration fees and rebate guarantees), then the parties will discuss in good faith a revision to the current pricing terms and other applicable contract provisions.","rationale":"There is an annual market check in the second quarter of each contract year, which is a real protection many contracts lack. But there is no most favored pricing promise that the County automatically receives pricing as good as comparable clients, and even when the check shows savings of 2 percent or more the only remedy is a good faith discussion, with any revision effective the following January 1. The model's meet, credit or release remedy is absent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.85,"page_ref":"Page 48","evidence_quote":"Customer is entitled to one annual Rebate audit, subject to the audit terms and conditions outlined in the Prescription Drug Services Schedule. Customer is entitled to an annual electronic claim audit subject to standard pharmacy benefit audit practices and audit terms and conditions outlined in the Prescription Drug Services Schedule. Pharmacy audits shall be conducted at the Customer's own expense unless otherwise agreed to between the Customer and Aetna.","rationale":"Audit rights exist but are thin: one rebate audit and one electronic claim audit per year, run at the County's own expense, and governed by the Prescription Drug Services Schedule that is not in the file, so the actual limits on scope, auditor independence and records access cannot be verified. Data access is also paywalled: page 54 charges the County per file fees for audit claim files over 24 months old and for its own historical claims data. Pre-adjudication claims access and a guarantee that no data is withheld as proprietary are absent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"DATA","verdict":"bad","confidence":0.82,"page_ref":"Page 54","evidence_quote":"Refill Transfers upon termination $4,500 Per file Precertification history $3,500 Per file Accumulator files $1,000 Per file Historical claims data $1,000 Per file","rationale":"The text never says the County owns its claims, eligibility, accumulator or rebate data, and the fee schedule prices the County's own data back to it: accumulator files at $1,000 per file, historical claims data at $1,000 per file, and termination files for open refills at $5,200. A vendor that can charge a public body for its own accumulated claims data at termination can effectively hold that data at transition, which is the opposite of the model contract's ownership rule.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.82,"page_ref":"Page 43","evidence_quote":"If CVS Health fails to achieve the applicable savings target in any contract year, within ninety (90) days after the end of such contract year, CVS Health will provide Client with a credit against future billing to Client on a dollar for dollar basis up to a maximum payout of 30%of the cost of the program.","rationale":"There are real guarantees: discount, dispensing fee and rebate guarantees reconciled annually, a PrudentRx first year savings target of $106.85 per member per year, and a Drug Savings Review return on investment guarantee. But measurement is annual rather than quarterly, rebate components are reconciled in the aggregate so surpluses offset shortfalls, and remedies are capped credits against future billing, such as the 30 percent cap above, rather than dollar for dollar cash payments. The Drug Savings Review remedy is capped at fees paid.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"ENF","verdict":"missing","confidence":0.82,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the text gives the County liquidated damages or automatic credits when reports are late or when the discount and rebate guarantees are reconciled short, and there is no two strikes or repeat breach termination right. The only self executing remedies run against the County: a 12 percent annual late payment charge on page 48 and the early termination fee on page 47. No automatic enforcement mechanism appears, and if one existed it would sit in the base agreement, which is not in the file.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"AMD","verdict":"bad","confidence":0.9,"page_ref":"Page 14","evidence_quote":"By Aetna upon 30 days’ written notice to the Contract Holder. The Parties agree that an amendment does not require the consent of any Member or other person. Except for automatic amendments to comply with Mandates, all amendments to this Group Agreement must be approved and executed by Aetna.","rationale":"The Group Agreement incorporated by this amendment can be amended by Aetna alone on 30 days written notice, and is deemed automatically amended to conform with regulatory mandates. The First Amendment itself was signed by both parties, but the documents it attaches hand the vendor a unilateral amendment right, which is exactly what the model contract's written amendment rule exists to prevent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"TERM","verdict":"bad","confidence":0.9,"page_ref":"Page 47","evidence_quote":"In the event Customer terminates Aetna's arrangement of prescription drug benefit services as described in the Prescription Drug Services Schedule and Pharmacy Service and Fee Schedule to the Agreement prior to December 31, 2028 (an \"Early Termination\") Aetna shall retain any earned but unpaid rebates as of the Early Termination date subject to any exception thereto provided herein.","rationale":"The Group Agreement does let either party terminate without cause on 90 days notice, which is decent, but the pharmacy fee schedule takes the value back: if the County exits before December 31, 2028 it forfeits earned but unpaid rebates, all pharmacy guarantees become null and void for the plan year, and the County must refund allowances for the unfulfilled term on a prorated basis. The document itself labels this an Early Termination Fee, which is precisely the trap the model contract's termination clause exists to remove.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"SPEC","verdict":"bad","confidence":0.85,"page_ref":"Page 40","evidence_quote":"Aetna Specialty Performance Network – Reconciled OEDThe Overall Effective Discount (OED) offer is conditioned on Plan Participants using the Aetna Specialty Performance Network with Aetna being the exclusive provider of Specialty Services with the exception of the HIV class","rationale":"Specialty is defined by the Aetna Specialty Product List, a label set by the vendor rather than by economic function, and the discount guarantee is measured in the aggregate across all specialty drugs, with Aetna free to amend individual specialty discounts to manage the guarantee. The channel is exclusive to CVS Specialty pharmacies except for HIV drugs, and claims there are priced at AWP discounts ranging widely by drug on pages 59 to 71, not at acquisition cost, with new to market products at only AWP minus 16 percent.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0007","contract_slug":"harris-county-aetna-cvs-2026-amendment","entity":"Harris County","vendor":"Aetna Life Insurance Company (CVS Health)","model":"Kimi K3","rubric_key":"GAG","verdict":"bad","confidence":0.9,"page_ref":"Page 27","evidence_quote":"This proposal contains trade secrets and commercial and financial information that Aetna deems proprietary and confidential and cannot be further released to any third party by Harris County without Aetna's prior written consent.","rationale":"Pricing is wrapped in confidentiality. Section 9.20 of the Group Agreement defines confidential information to include costs and pricing data and the agreement itself, permits compelled disclosure only under a non-appealable court order, and obliges the County to help Aetna seek protective orders. The Public Records Acts clause on page 22 acknowledges the County is subject to state disclosure law, but requires notice to Aetna, time to claim exemptions, and a promise not to oppose Aetna's court action to block release, and every pricing exhibit is footer marked as trade secrets not for distribution. That combination treats what taxpayers pay as the vendor's secret.","model_own_total":17.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FID","verdict":"bad","confidence":0.95,"page_ref":"Page 115","evidence_quote":"neither it nor the Plan intends for ESI to be a fiduciary (as defined under ERISA or state law) of the Plan","rationale":"Exhibit G section 4.2 says the parties negotiated in an arm's length fashion and that A&M does not intend ESI to be a fiduciary under ERISA or state law, except for a narrow appeals role. ESI also reserves the right to stop serving any plan in a state that would require a PBM to be a fiduciary. The model contract from Mark Cuban and collaborators requires a duty of loyalty and care solely to the plan and its members. This clause is written to prevent that duty.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DISC","verdict":"bad","confidence":0.9,"page_ref":"Page 115","evidence_quote":"Unlike the Administrative Fees, the revenues described in the Financial Disclosure are not direct or indirect compensation to ESI from A&M System for services rendered to A&M System or the Plan under this Contract.","rationale":"Section 4.3 points to a Financial Disclosure in the Proposal that ESI may update from time to time. Those extra revenues are labeled as not compensation, ESI and its affiliates keep them, and the plan is told it has no beneficial interest except amounts expressly set in the contract. There is no named officer who certifies quarterly or annually that every dollar has been disclosed and remitted. The Proposal itself is not in this file, so even the listed streams cannot be checked here.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The exhibit list on page 17 runs from Exhibit A through K and has no ownership or affiliate disclosure exhibit. Exhibit G names Accredo Health Group, Inc. and Express Scripts Specialty Distribution Services, Inc. as ESI specialty pharmacies, and section XI.b allows affiliates to perform services, but that is not a signed list of owners, parents, subsidiaries, GPOs, rebate aggregators, and related pharmacies with a 30 day refresh duty.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DEF","verdict":"partial","confidence":0.75,"page_ref":"Page 110","evidence_quote":"“Brand/Generic Algorithm” or “BGA” means ESI’s standard and proprietary brand/generic algorithm, a copy of which may be made available for review by Sponsor or its Auditor upon request.","rationale":"Exhibit G defines AWP, a proprietary brand and generic algorithm, MAC as a list ESI develops or selects, and a Specialty Product List that ESI updates on its own. Several numbered definitions on pages 110 to 112 are blacked out, which is where rebate, manufacturer fee, brand, generic, and specialty product definitions would usually sit. The definitions that can be read leave coding and list placement with ESI rather than closing relabeling loopholes by economic function.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PASS","verdict":"bad","confidence":0.9,"page_ref":"Page 115","evidence_quote":"ESI and ESI’s wholly-owned subsidiaries and affiliates retain all proprietary rights and beneficial interest in such fees and revenues described in the Financial Disclosure","rationale":"ESI will pay only the rebate amounts set forth in Exhibit C, and Exhibit C-3 is blacked out so the share cannot be read. Section 4.3 separately lets ESI and its affiliates keep Financial Disclosure revenues and says the plan has no right to them. That is not 100 percent of manufacturer revenue of every kind. Page 38 notes that rebate and manufacturer administrative fee amounts paid to A&M are treated as discounts, which shows some money moves, but the keep-the-rest language is the opposite of a closed pass through.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NAC","verdict":"bad","confidence":0.8,"page_ref":"Page 24","evidence_quote":"PARTICIPATING PHARMACY _AND_ESI_Mait_ PHARMACY _AVERAGE_AGGREGATE_ANNUAL_INGREDIENT_ COST _AND_DISPENSING FEE Guarantees (Does NoT APPLY TO SPECIALTY PRODUCTS).","rationale":"ESI Mail is an ESI owned pharmacy, yet Exhibit C-2 prices it on average aggregate annual ingredient cost guarantees rather than net acquisition cost plus a stated dispensing fee. Aggregate guarantees leave room for retained margin on individual claims. Specialty is carved out of those guarantees and Exhibit D is blacked out, but the mail channel already contradicts acquisition cost invoicing.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Exhibit C-2 on pages 24 to 27 shows average aggregate ingredient cost guarantees, not a claim by claim ceiling against a published cash benchmark. Exhibit G defines usual and customary price on page 112 but never says plan cost cannot exceed that price or any other public benchmark. No other readable article imposes a cheapest lawful option test.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Copayment is defined on page 110 as the member's share, and a Member Submitted Claim on page 111 is only a paper claim for a drug the member already paid cash for, processed for a fee if A&M elects it. Usual and customary price is defined on page 112 as a pharmacy reported cash amount, not as a cap on what the member pays through the plan. Nothing in Exhibit G, the billing article on page 2, or the readable pricing pages credits a cash purchase toward the deductible or bars accumulator adjustment.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MAC","verdict":"bad","confidence":0.92,"page_ref":"Page 111","evidence_quote":"“MAC List” means a list of prescription drugs or supplies subject to maximum reimbursement payment schedules developed or selected by ESI.","rationale":"The only MAC clause gives ESI the power to develop or select the list. There is no requirement that the same list govern what the plan pays and what pharmacies are paid, no disclosure or update schedule, and no pharmacy appeal path with timelines. Vendor controlled MAC lists are how spread is built. Several nearby definitions on the same pages are blacked out, but this definition is readable and is enough.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPRD","verdict":"unclear","confidence":0.7,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Whether the plan pays exactly what the pharmacy is paid is a claims reimbursement term, and Exhibit C-2 on those pages is blacked out. A bona fide dispute definition on page 4 assumes the plan should receive the pharmacy contracted rate, but Exhibit I on page 127 treats a pass through arrangement as something the sponsor might or might not have. The 15 percent ESI keeps on pharmacy audit recoveries is a retained difference, yet it does not prove spread on every claim. The rate exhibit is the place this would be decided.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"The word GPO, group purchasing, and purchasing entity never appear in the 140 pages. Exhibit C-3 headings on pages 35 to 38 cover rebate amounts and manufacturer administrative fees, not a purchasing organization pass through. Section 4.3 on page 115 talks about other ESI revenues in general terms and does not allocate supplier or GPO payments to the plan.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"FORM","verdict":"partial","confidence":0.9,"page_ref":"Page 110","evidence_quote":"The drugs and supplies included on the Formulary will be modified by ESI from time to time as a result of factors, including, but not limited to, medical appropriateness, manufacturer Rebate arrangements, and patent expirations.","rationale":"The formulary is developed by ESI's pharmacy and therapeutics committee and is selected or adopted by A&M. ESI may change it for rebate arrangements, and those changes are automatically adopted unless A&M elects not to implement them through a Set-Up Form. That is an opt out, not prior approval of every change, and there is no lowest net cost analysis delivered with each change. The EGWP formulary on page 120 is even tighter because Medicare rules limit sponsor edits.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Formulary section 1.14 on pages 110 to 111 and formulary support section 2.6 on page 114 never state a lowest net cost standard for this plan. There is no annual comparison against ESI's book of business and no duty to disclose a drug placed above a cheaper equivalent. Rebate arrangements are an express reason ESI may change the list, which is the opposite of a net cost test.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"NET","verdict":"bad","confidence":0.92,"page_ref":"Page 112","evidence_quote":"ESI will make Members aware of the ability to fill their prescriptions through the ES! Mail Pharmacy, communicate any applicable cost savings, and provide supporting services","rationale":"ESI Mail is owned by ESI, and this clause requires ESI to steer members there and to advertise savings. ESI also maintains multiple networks and may consolidate or migrate clients among them. There is no any willing pharmacy term, no ban on retroactive clawbacks, and no bar on conditioning reimbursement on volume. Exclusive and limited distribution products are defined so specialty can be restricted to selected pharmacies.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The main agreement, Exhibit C headings, Exhibit G, and the EGWP addendum contain no most favored pricing clause and no annual market check with a meet, credit, or release remedy. Pricing is locked to Exhibit C for the term unless the parties sign a change or a change in law applies, which is not a market check.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AUD","verdict":"partial","confidence":0.9,"page_ref":"Page 3","evidence_quote":"Audit by the A&M System may be conducted once annually during the Term of this Contract and the four year period following termination of this Contract.","rationale":"A&M may audit claims, rebates, and performance, and the State Auditor has a statutory right. The A&M auditor must be approved by ESI, may not be a competitor, may not provide litigation services against ESI, and must sit out that work for six months after the audit. One claims audit of 24 months is free each year, rebate contract review is limited to the pieces needed for Exhibit C, Exhibit I caps follow up at 300 claims, and manufacturer contracts may be viewed on site but not copied. Data can be withheld as ESI confidential under those rules.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"DATA","verdict":"partial","confidence":0.88,"page_ref":"Page 8","evidence_quote":"anonymized claims data (de-identified in accordance with HIPAA); ESI Specialty Pharmacy and ESI Mail Pharmacy data; information and contracts relating to Rebates and Manufacturer Administrative Fees, prescription drug evaluation criteria, drug pricing information, and Participating Pharmacy agreements","rationale":"Page 4 says research, reports, studies, and data that ESI specifically generates for A&M and that are specific to this program are A&M property and must be delivered on request at the end of the contract. Page 8 then assigns anonymized claims, mail and specialty data, rebate contracts, and drug pricing to ESI. The business associate agreement on page 130 also allows ESI to create de-identified information. A&M does not solely own every derived data set, and ESI may reuse de-identified claims.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"PERF","verdict":"unclear","confidence":0.72,"page_ref":"Pages 21 to 53","evidence_quote":null,"rationale":"Exhibit I on page 126 lists performance guarantees as something A&M may audit after a true up, so some guarantees exist. The actual measures, whether they are plan specific, whether shortfalls are paid in cash dollar for dollar, and any caps would sit in Exhibit C, which is blacked out on these pages. Without that schedule it is not possible to say whether the remedies are real.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Section VII.b on page 5 allows termination for material breach after a 45 day cure, and section XI.f on page 8 says remedies are cumulative. Exhibit I on page 127 credits claims errors only after both parties accept the audit, through a future invoice. None of those clauses create liquidated damages or automatic credits when a guarantee is missed, and there is no two strikes exit for a second material breach or a regulatory integrity failure.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"AMD","verdict":"good","confidence":0.88,"page_ref":"Page 5","evidence_quote":"Any amendments to this Contract must be in writing and signed by both parties.","rationale":"The amendment article requires a writing signed by both parties. Page 2 separately says ESI will not revise Exhibit C program pricing during the term unless required by law or by written agreement. A change in law on page 115 can reopen fees and rebates, but if the parties cannot agree either may terminate rather than ESI rewriting terms by notice. That is as protective as the model on economic amendments.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"TERM","verdict":"good","confidence":0.9,"page_ref":"Page 5","evidence_quote":"the A&M System may terminate this Contract without cause by giving ESI ninety (90) days’ written notice.","rationale":"A&M may end the contract without cause on ninety days written notice, with no termination fee stated. Either party may also terminate for uncured material breach after 45 days. Loss of legislative funding on page 12 is a further exit. ESI may delay final rebate and CMS amounts for reconciliation at termination, which is not a forfeiture of earned amounts.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"SPEC","verdict":"unclear","confidence":0.8,"page_ref":"Pages 54 to 106","evidence_quote":null,"rationale":"Exhibit D is titled Specialty Drugs Under the Mail Order Pharmacy Program and is fully blacked out on these pages. Page 25's specialty product pricing section is also redacted. Readable text names Accredo as an ESI specialty pharmacy and lets ESI update the Specialty Product List, but the drug level rates, channel ceiling, and whether affiliate specialty claims are billed at acquisition cost would live in Exhibit D.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0001","contract_slug":"tamus-express-scripts-2022","entity":"The Texas A&M University System","vendor":"Express Scripts, Inc.","model":"Grok 4.6","rubric_key":"GAG","verdict":"bad","confidence":0.95,"page_ref":"Page 109","evidence_quote":"The following is a list of information ESI has designated as confidential and/or proprietary, believing it to be exempt from any requests the A&M System may receive under The Texas Public Information Act.","rationale":"Exhibit F tells A&M to treat the Proposal and Exhibits C, D, and E as confidential and proprietary so they can be withheld from public information requests. Section XI.h on page 8 also treats rebate contracts, manufacturer fees, drug pricing, and pharmacy agreements as ESI property. Page 9 lets ESI advocate for an exemption and seek a protective order. A Public Information Act carve out of that kind does not make the gag a good clause, and it is why the posted contract is blacked out.","model_own_total":15.7,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"FID","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"I looked through the two pharmacy memoranda on pages 8 to 11, the agenda request on pages 1 to 3 and the consultant recommendation on pages 16 to 18 and found no statement that Envision owes any duty of loyalty or care to the county or its members. The packet describes a transparent business model and a fee only compensation promise, but a business model is not a fiduciary obligation and there is no disgorgement remedy. The executed pharmacy benefit management agreement is not part of this backup, so any fiduciary language it might contain cannot be seen here.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"DISC","verdict":"partial","confidence":0.72,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"The consultant records a promise that Envision will take only its per employee per month fee and no other money connected to the county's drug spend, which is a real statement about compensation. It is well short of what the model contract published by Mark Cuban and collaborators asks for, because there is no schedule of direct and indirect compensation, no disclosure of payments to consultants or brokers, and no officer certification on any cycle. The promise is also described as something Envision will put in writing rather than language the packet actually contains.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no ownership or affiliate exhibit anywhere in the 18 pages. The only corporate relationships named are Envision's mail and specialty partnership with Costco on page 10 and the fact that the outgoing pharmacy benefit manager, OptumRx, is a United Healthcare subsidiary, noted on pages 4 and 8. Neither is a signed disclosure of owners, parents, subsidiaries, group purchasing organizations or rebate aggregators, and nothing requires Envision to refresh such a list when ownership changes.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"DEF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The packet contains no definitions article. Terms that carry the most money in a pharmacy benefit contract, including rebate, manufacturer revenue, affiliate, generic and specialty, are used in the pricing summary on pages 10 and 11 and in the narrative on page 2 without being defined anywhere. Because the executed agreement is not in the backup, there is no way to tell whether the pass through promise reaches administrative fees, data fees or other manufacturer payments.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"PASS","verdict":"partial","confidence":0.75,"page_ref":"Page 2","evidence_quote":"has agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The agenda request states that Envision has agreed to pass through 100 percent of all monies received or earned from county utilization, and the table on page 11 shows retail and mail order rebates as 100 percent pass through with stated minimums of $17.35 per Brand Rx and $66.60 per Brand Rx. That is a broad promise on its face, but the backup gives no definition of the money covered, no payment schedule, no closed list of excluded claims and no audit right to verify the amount. Because the operative contract is not in this packet, the promise cannot be read as the enforceable clause the model contract published by Mark Cuban and collaborators requires.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the packet prices claims dispensed by a pharmacy related to the pharmacy benefit manager at net acquisition cost plus a stated dispensing fee. Mail order and specialty are described on page 10 as a partnership with Costco, and the mail order rates on page 11 are discounts off average wholesale price rather than cost based pricing. There is no documentation default and no rule against retained margin in any owned or related channel.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"CEIL","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The pricing summary on pages 10 and 11 sets discount rates off average wholesale price but never caps what the plan pays against any external published benchmark such as a transparent cash price. There is no claim by claim test and no statement that the county will never pay more than a publicly available price. The subject does not appear in the memoranda, the consultant notes on page 17 or anywhere else in the packet.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"CASH","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the packet protects a member from paying more through the plan than the pharmacy cash price, and nothing addresses whether a cash purchase counts toward the deductible or out of pocket maximum. The closest item is the point of sale rebate design described on pages 10 and 17, which lowers member cost at the counter but is not a cash price ceiling and says nothing about accumulators. Member cost sharing rules would live in the plan document and the executed agreement, neither of which is in this backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"MAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Maximum allowable cost appears in the tables on pages 10 and 11 only as the label for the current pricing arrangement with OptumRx, while the proposed Envision generic rates are stated as discounts off average wholesale price. There is no statement that a single list governs both what the county pays and what pharmacies are paid, no disclosure requirement, no update schedule and no pharmacy appeals path with timelines. Whether any list governance exists would have to be read in the executed agreement, which is not part of the packet.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"SPRD","verdict":"partial","confidence":0.75,"page_ref":"Page 10","evidence_quote":"which includes no spread pricing on retail, mail or specialty pharmacy","rationale":"The pharmacy award memorandum states that Envision agreed to a complete pass through of pharmacy discounts with no spread pricing in the retail, mail or specialty channels, and page 11 shows a separate administrative fee of $3.50 per employee per month, which is the shape the model contract published by Mark Cuban and collaborators asks for. What is absent is the operative language that would make it enforceable, including a definition of the amount paid to the pharmacy, a reconciliation duty and an audit right. Guaranteed discount rates off average wholesale price, without a stated tie to the pharmacy's actual payment, can still leave room for a difference, so this reads as a strong promise rather than a proven no spread contract.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"GPO","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No group purchasing organization, rebate aggregator or other purchasing entity is named or addressed anywhere in the packet. Page 10 states that Envision contracts directly with pharmacies rather than using rental networks, which speaks to network fees rather than to purchase discounts or supplier payments collected by a related purchasing entity. The broad pass through sentence on page 2 might be argued to reach such money, but the packet contains no clause allocating purchasing entity revenue to the county.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"FORM","verdict":"missing","confidence":0.8,"page_ref":null,"evidence_quote":null,"rationale":"The packet never says who approves the formulary or its changes. Page 10 describes Envision's flexibility through formulary management to meet the county's needs, which is a statement about vendor capability, not a grant of approval rights to the plan sponsor. There is no lowest net cost analysis requirement and no quarterly reporting of utilization management outcomes by drug, and the agreement that would carry those terms is not in the backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"LNC","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"There is no lowest net cost standard for formulary decisions and no annual comparison against Envision's whole book of business anywhere in the 18 pages. The consultant notes on page 17 discuss claim repricing done during the bid evaluation, which is a one time procurement exercise rather than an ongoing contractual standard. Nothing requires disclosure when a drug is placed above a cheaper equivalent.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"NET","verdict":"partial","confidence":0.6,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"The memorandum notes that members may fill 90 day prescriptions at retail rather than being pushed into mail order, and the packet prices a 90 day retail network on pages 10 and 11, which is a mild protection against steering into a single channel. Page 10 also describes a network of more than 67,000 retail pharmacies contracted directly rather than rented. None of the other network protections in the model contract are present, including finality of adjudicated claims, a bar on retroactive clawbacks, a rule against conditioning reimbursement on volume and an any willing pharmacy right.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"MFN","verdict":"missing","confidence":0.93,"page_ref":null,"evidence_quote":null,"rationale":"The packet contains no most favored pricing promise and no market check. Pricing is fixed in the summary tables on pages 10 and 11 with no mechanism to test it against what comparable clients receive during the term. There is no meet, credit or release remedy, and the executed agreement that could contain one is not in this backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"AUD","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"No audit right appears anywhere in the packet, and there is no schedule for delivering claims level or financial data to the county. Reporting appears only as an evaluation criterion for the bid on page 9, listing standard, custom and ad hoc reports, and page 10 describes integrating pharmacy data with medical data for case management. Those are descriptions of capability during scoring, not contractual rights to audit with the county's own auditor or to receive data without asking.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"DATA","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Ownership of claims, eligibility, accumulator and rebate data is never addressed. The only data language is on page 10, where Envision and United Healthcare commit to integrating pharmacy data with medical data for case and disease management, which describes a use of data rather than who owns it. Nothing requires machine readable delivery on request and nothing bars the vendor from reusing or licensing county data.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"PERF","verdict":"partial","confidence":0.7,"page_ref":"Page 2","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan. In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"The agenda request and the pharmacy memorandum both record service performance guarantee money and a 9.5 percent spend reduction guarantee, and page 11 adds rebate minimums per brand prescription, so guarantees clearly exist. The packet does not say how often they are measured, whether they are measured on Travis County data, whether shortfalls are paid in cash or as credits, or whether payouts are capped. Those mechanics would sit in a performance guarantee exhibit that is not part of this agenda backup.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"ENF","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the packet makes a missed guarantee or a late report trigger an automatic credit or liquidated damages. There is no two strikes exit, no regulatory integrity trigger and no statement that the county can recover without proving damages. Enforcement terms would live in the executed agreement, which was not filed with this agenda item.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"AMD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"The packet has no clause requiring amendments to be signed by both parties and no bar on changing economic terms by notice or updated exhibit. Page 3 labels the contract type as annual and unilateral and page 16 says the three year term runs unless changed by Travis County, but neither line is an amendment procedure. Without the executed agreement there is no way to see how pricing could be changed mid term.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"TERM","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"There is no termination provision in the backup, for convenience or for cause. Page 3 gives a contract period of October 1, 2014 through September 30, 2015 and page 16 gives a three year term ending in 2017, but neither states notice requirements, penalties or what happens to earned rebates and guarantee amounts on exit. A reader cannot tell from this packet whether the county can leave without cost.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"SPEC","verdict":"partial","confidence":0.6,"page_ref":"Page 10","evidence_quote":"no spread pricing on retail, mail or specialty pharmacy","rationale":"Specialty pricing is touched only by the statement that there is no spread pricing in the specialty channel and by the note that mail and specialty run through a partnership with Costco. The rate tables on pages 10 and 11 cover retail, 90 day retail and mail order and contain no specialty discounts, dispensing fees or drug level ceilings, and specialty is never defined. There is also no acquisition cost standard for specialty claims, so the single no spread sentence is the only control a reader can see.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Claude Opus 5","rubric_key":"GAG","verdict":"good","confidence":0.7,"page_ref":"Page 11","evidence_quote":"Retail Rebate Minimum                                      $17.35 per Brand Rx","rationale":"Nothing in the packet treats pricing, rebates or fees as confidential or proprietary, and the discount rates, dispensing fees, rebate minimums and administrative fee are printed in a public Commissioners Court agenda record that any resident can read. No language restricts pharmacies from telling members about cheaper options. The caution is that the executed agreement is not in the backup, so a confidentiality article in that document would not be visible here.","model_own_total":19,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"FID","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The PBM recommendation on pages 8 to 11 and the consultant notes on page 17 contain no fiduciary duty, duty of loyalty, duty of care, conflict standard, or disgorgement remedy. The executed Envision agreement is not included in this agenda backup, so any fiduciary language that may exist there cannot be scored from this file.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"DISC","verdict":"partial","confidence":0.93,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"The packet identifies a single compensation stream and rejects other money associated with County drug spending. It does not require disclosure of related-entity compensation, affiliate ownership, consultant payments, conflicts, or quarterly and annual officer certification. The executed agreement is absent, so those additional disclosure duties cannot be confirmed.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"OWN","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The Envision recommendation on pages 8 to 11 identifies a Costco partnership but does not provide a signed ownership and affiliate exhibit. No page lists owners, parents, subsidiaries, rebate aggregators, mail pharmacies, specialty pharmacies, or a 30-day update duty. The executed agreement and its exhibits are not in the packet.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"DEF","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"Pages 8 to 11 discuss rebates, pharmacy discounts, mail order, specialty, and administrative fees but contain no definitions article. The packet therefore does not close relabeling loopholes for manufacturer revenue, rebates, affiliates, specialty drugs, generics, or pharmacies. Any definitions in the executed agreement are not provided.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"PASS","verdict":"partial","confidence":0.95,"page_ref":"Page 2","evidence_quote":"Envision’s business model is focused on delivering full transparency of pharmacy costs and has agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The backup states a broad 100 percent pass-through and the page 11 pricing table also labels retail and mail rebates as 100 percent pass-through. Page 17 adds that rebates can be received at the point of sale. The packet does not define all manufacturer revenue, provide a closed exclusion list, or state a quarterly remittance deadline, and the executed agreement is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"NAC","verdict":"partial","confidence":0.85,"page_ref":"Page 10","evidence_quote":"which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The no-spread commitment protects the County in mail and specialty channels, including the stated Costco partnership. However, pages 10 and 11 price channels through AWP discounts and dispensing fees, not documented net acquisition cost plus a stated fee. The absent executed agreement provides no documentation default for an owned or economically related pharmacy.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"CEIL","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The pricing tables on pages 10 and 11 use AWP discounts and dispensing fees. They do not cap each claim at a published cash benchmark or the cheapest lawful option, and no claim-level ceiling appears elsewhere in the packet. The executed agreement that might contain such a ceiling is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"CASH","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The member access discussion on page 10 addresses 90-day retail fills but not cash-price protection. The packet does not say members pay no more than a pharmacy cash price, that cash purchases count toward deductibles and out-of-pocket limits, or that accumulator adjustments require written election. Those terms cannot be assessed without the executed agreement.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"MAC","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"Page 11 mentions MAC pricing only in the current mail-order comparison, while Envision's proposed generic prices are stated as AWP discounts. No Envision clause requires one disclosed MAC list, scheduled updates, or a pharmacy appeal process with deadlines. The executed agreement is absent.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"SPRD","verdict":"good","confidence":0.96,"page_ref":"Page 10","evidence_quote":"Envision’s proposal includes a partnership with Costco for mail and specialty pharmacy and has agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The packet expressly bars spread pricing in every named dispensing channel and requires complete pass-through of pharmacy discounts. Page 17 reinforces this by limiting Envision to its per employee per month fee and rejecting other money associated with County prescription drug spending. These stated terms meet the model's core no-spread protection, although the executed agreement is not supplied.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"GPO","verdict":"partial","confidence":0.83,"page_ref":"Page 2","evidence_quote":"has agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The phrase all monies received or earned is broad enough to point toward pass-through beyond labeled rebates. The packet does not expressly bind group purchasing organizations, affiliates, rebate aggregators, or offshore purchasing entities, and it gives no allocation method. The missing executed agreement may contain those details, but they are not stated here.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"FORM","verdict":"partial","confidence":0.81,"page_ref":"Page 10","evidence_quote":"Envision also has the flexibility through formulary management and pharmacy network management to meet the County’s current and future needs.","rationale":"Formulary management is part of the proposed service and is described as responsive to County needs. The language gives Envision flexibility rather than reserving approval of the formulary and every change to Travis County. No lowest-net-cost analysis or quarterly drug-level utilization management reporting duty is shown in the absent agreement.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"LNC","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The formulary discussion on page 10 does not require decisions based on lowest net cost for Travis County. Pages 8 to 11 also contain no annual comparison with Envision's full book of business and no disclosure duty when a drug is placed above a cheaper equivalent. The executed agreement is not available to supply these standards.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"NET","verdict":"partial","confidence":0.88,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"Allowing 90-day retail fills avoids one form of mandatory mail steering and preserves member choice. The packet does not prohibit retroactive pharmacy clawbacks, volume-conditioned reimbursement, steering to any related pharmacy, or exclusion of willing pharmacies. Those broader network protections are not visible because the executed agreement is absent.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"MFN","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The pricing discussion and tables on pages 10 and 11 contain no most-favored pricing promise and no annual market-check procedure. There is no meet, credit, or release remedy tied to market results. The executed agreement is not included, so any such right cannot be assessed.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"AUD","verdict":"missing","confidence":0.97,"page_ref":null,"evidence_quote":null,"rationale":"Page 9 lists reporting, transparency tools, and claim-level repricing as proposal evaluation criteria, while page 17 describes pricing as transparent. None of those passages grants Travis County an audit by its chosen auditor, scheduled claims-level financial data, pre-adjudication access, or a ban on proprietary withholding. The executed agreement and any audit article are not in the packet.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"DATA","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"Pages 9 and 10 mention reporting and integration of prescription and medical data, but they do not state that Travis County solely owns claims, eligibility, accumulator, rebate, or derived data. The packet also lacks machine-readable delivery rights and restrictions on reuse, licensing, or sale. Any data ownership article in the executed agreement is not provided.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"PERF","verdict":"partial","confidence":0.92,"page_ref":"Page 10","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan. In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"The proposal includes monetary performance guarantees and a specific spend reduction guarantee. The packet does not state quarterly plan-specific measurement, cash reconciliation, or dollar-for-dollar uncapped payment of shortfalls. The executed guarantee schedule is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"ENF","verdict":"missing","confidence":0.96,"page_ref":null,"evidence_quote":null,"rationale":"Pages 2 and 10 state that guarantee money was proposed, but no passage makes damages or credits automatic after a missed guarantee or late report. The packet also has no two-strikes termination right for repeated breach or regulatory integrity failure. Those enforcement mechanics depend on contract language not included in the backup.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"AMD","verdict":"missing","confidence":0.99,"page_ref":null,"evidence_quote":null,"rationale":"The contract-period references on pages 3 and 16 do not govern amendments. No page says economic or other terms may change only through a writing signed by both parties, and no language bars unilateral changes by notice, portal, or updated exhibit. The executed agreement is not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"TERM","verdict":"partial","confidence":0.74,"page_ref":"Page 16","evidence_quote":"Term of Contract: Three (3) year effective October 1, 2014 ending 12:00 a.m. on September 31, 2017, unless changed by Travis County.","rationale":"The phrase unless changed by Travis County suggests the County retained unilateral control over the stated three-year term. It does not clearly grant termination for convenience, set reasonable notice, waive penalties, preserve earned rebates, or identify regulatory integrity events. Because the executed termination article is missing, the protection is only partial and confidence is lower.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"SPEC","verdict":"partial","confidence":0.86,"page_ref":"Page 10","evidence_quote":"Envision’s proposal includes a partnership with Costco for mail and specialty pharmacy and has agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The packet expressly extends no-spread pricing to specialty pharmacy and identifies Costco as the proposed specialty partner. It does not define specialty by function, impose drug-level ceiling rates in every channel, or require acquisition-cost pricing for a related specialty pharmacy. The executed specialty terms are not included.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"GPT 5.6 Sol","rubric_key":"GAG","verdict":"missing","confidence":0.94,"page_ref":null,"evidence_quote":null,"rationale":"No passage in the agenda backup restricts Travis County or pharmacies from sharing information or discussing cheaper options. However, the packet contains no confidentiality article, pharmacy communication clause, or executed agreement, so it cannot establish that such restrictions are absent from the contract itself. This is missing rather than unclear because nothing is redacted or unreadable.","model_own_total":31,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T20:18:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"FID","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing in the 18 pages imposes a duty of loyalty or care on Envision or addresses conflicts of interest. Pages 8 through 11 are the PBM backup memo and they cover pricing, rebates and network design only. A fiduciary clause would live in the executed services agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"DISC","verdict":"partial","confidence":0.85,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"The consultant records Envision's commitment to take only its per employee per month fee and no other monies from the drug spend, which is a strong compensation transparency statement. But the backup contains no officer certification, no schedule of affiliate or consultant payments, and no periodic disclosure obligation. How this commitment is defined and enforced sits in the executed agreement, which is not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"OWN","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No exhibit or passage lists Envision's owners, parents, subsidiaries or affiliates. The only affiliation mentioned is the Costco partnership for mail and specialty pharmacy on page 10, and it is not described as an ownership relationship. There is no obligation to refresh ownership information during the term.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"DEF","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The document is agenda backup and contains no definitions at all. Rebate, manufacturer revenue, affiliate, specialty and generic are never defined, so the pass-through commitment on page 10 cannot be tested against relabeling. The definitions article of the executed agreement is not in the file, and this item's score depends on that missing language.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"PASS","verdict":"good","confidence":0.85,"page_ref":"Page 11","evidence_quote":"Retail Rebate Minimum $17.35 per Brand Rx","rationale":"The backup states on page 10 that Envision agreed to pass through 100% of all monies received or earned through the utilization of the County and its members, and page 11 shows 100% pass-through on both retail and mail rebates with per-brand-claim minimums of $17.35 retail and $66.60 mail, which is stronger than a bare promise. The confidence is capped because the exclusions, definitions and payment timing would live in the executed agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"NAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 notes a partnership with Costco for mail and specialty and page 11 gives AWP discount rates for mail and retail, but nothing prices any related pharmacy at net acquisition cost with a stated dispensing fee. Whether related-entity pricing rules exist depends on the executed agreement, which is not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page sets a claim-level ceiling tied to a published benchmark or cash price. The rate tables on pages 10 and 11 are AWP discount guarantees only. A benchmark ceiling is not mentioned anywhere in the 18 pages.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Nothing addresses member cost sharing relative to pharmacy cash prices, deductible credit for cash purchases, or accumulator adjustments. Member cost sharing is outside the scope of the pricing tables on pages 10 and 11 and is not discussed elsewhere. This would be contract language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"MAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"The letters MAC appear on pages 10 and 11 only in the current UHC column, where generic pricing is listed as MAC or MAC Pricing, while the proposed Envision pricing is stated as AWP discounts (AWP-74.5% retail, AWP-79.00% mail). There is no mention of a MAC list for the new contract, no disclosure or update schedule, and no pharmacy appeals process.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"SPRD","verdict":"good","confidence":0.85,"page_ref":"Page 10","evidence_quote":"which includes no spread pricing on retail, mail or specialty pharmacy","rationale":"The memo states Envision agreed to a complete pass-through of all pharmacy discounts with no spread pricing in any channel, and page 11 discloses the PBM's fixed compensation as a $3.50 per employee per month administrative fee. That matches the model contract's structure of pass-through pricing plus a disclosed admin fee. Confidence is held below 0.9 because the executed agreement's definitions and any network-level exceptions are not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No page mentions a group purchasing organization, rebate aggregator, or purchase discounts or volume credits received through a related purchasing entity. The 100% pass-through language on page 10 is broad but the file never addresses GPO revenue by name. Any such term would be in the executed agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"FORM","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 says Envision has flexibility through formulary management to meet the County's needs, and page 9 lists a covered PDL as an evaluation criterion, but nothing states that the County approves the formulary or its changes or receives utilization management outcomes. Formulary control terms would be in the executed agreement and the formulary exhibit, neither of which is in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"LNC","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page states a lowest net cost standard for formulary decisions, an annual comparison against the PBM's book of business, or disclosure when a drug is placed above a cheaper equivalent. The entire subject is absent from the backup and would live in the executed agreement.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"NET","verdict":"partial","confidence":0.8,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"The 90-day retail fill option is an affirmative protection against steering members into mail order, and page 10 notes Envision contracts directly with pharmacies rather than using rental networks. But the backup says nothing about final adjudication, retroactive clawbacks, volume-conditioned reimbursement, or any willing pharmacy participation. Those network terms would be in the executed agreement or the network manual, which are not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"MFN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page grants most favored client pricing or an annual market check with a meet, credit or release remedy. The three year term on page 16 has no companion market check provision in this file. Such a clause would be contract language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"AUD","verdict":"partial","confidence":0.75,"page_ref":"Page 9","evidence_quote":"Ability to provide Rx repricing down to the actual claim and pharmacy level","rationale":"The County built claim-level repricing into its evaluation criteria on page 9, and the PBM criteria also list standard, custom and ad hoc reporting, which shows data visibility mattered in scoring. But the backup contains no audit clause: no right to use the plan's own auditor, no audit frequency, no financial data delivery schedule and no pre-adjudication access. Audit and data rights are provisions of the executed agreement, which the backup does not contain, so this can only score partial on what the backup states.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"DATA","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing addresses ownership of claims, eligibility or rebate data, machine readable delivery, or limits on the PBM reusing or selling plan data. Page 7 mentions integration of prescription data from the outside PBM into TPA reports, but that is a service description, not an ownership clause. Data ownership would be defined in the executed agreement, which is not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"PERF","verdict":"partial","confidence":0.82,"page_ref":"Page 10","evidence_quote":"In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"The backup states Envision proposed substantial performance guarantee monies, a 9.5% spend reduction guarantee, and page 11 adds rebate minimums of $17.35 per retail brand claim and $66.60 per mail brand claim. What is missing is the machinery the model requires: measurement on plan-specific data, quarterly reconciliation and dollar-for-dollar cash payment of shortfalls. Whether the guarantees pay out in cash depends on guarantee language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"ENF","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No page provides liquidated damages, automatic credits for late reports or missed guarantees, or a two strikes termination right. Enforcement mechanics would be in the executed agreement's guarantee and default articles, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"AMD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"There is no amendment clause anywhere in the 18 pages, so the file cannot show whether changes require mutual signature. Page 3 describes the contract type as annual and unilateral but says nothing about how the agreement may be amended. Amendment terms would be in the executed agreement, which the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"TERM","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"No termination for convenience provision, notice period, penalty clause or treatment of earned rebates appears in the file. The term itself is described inconsistently, with page 3 stating an annual period ending September 30, 2015 and page 16 stating a three year term ending in 2017 unless changed by Travis County. Termination rights would be contract language the backup does not contain.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"SPEC","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"Specialty is mentioned on pages 8, 9 and 10, including the Costco partnership for mail and specialty and the no-spread commitment covering specialty, but the backup gives no specialty definition and no specialty rate table, ceiling or acquisition cost pricing. Specialty pricing terms would sit in the executed agreement and its rate exhibits, which are not in the file.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Kimi K3","rubric_key":"GAG","verdict":"good","confidence":0.85,"page_ref":"Page 17","evidence_quote":"we agree with the committee that Envision is an excellent choice for the pharmacy spend that will be totally transparent in pricing","rationale":"Reading all 18 pages, there is no confidentiality clause at all: nothing treats pricing, rebates or audit material as proprietary and nothing restricts pharmacies from telling patients about cheaper options. For an agenda backup that is the expected and protective state, and consultant Gallagher describes the pricing as totally transparent. Whether the executed agreement adds a confidentiality article cannot be seen from this file, which is why confidence is not higher.","model_own_total":30.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"FID","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and does not mention whether the PBM owes a fiduciary duty or duty of loyalty to the plan.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"DISC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The summary memo states Envision will deliver full transparency of pharmacy costs. However, the base agreement is absent, so there are no terms requiring a named officer certification or the disclosure of compensation and conflicts.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"OWN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement or an ownership exhibit listing the PBM's affiliates and subsidiaries.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"DEF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and provides no definitions for critical terms like rebate, affiliate, or specialty.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"PASS","verdict":"partial","confidence":0.9,"page_ref":"Page 10","evidence_quote":"agreed in contracts to pass through 100% of all monies received or earned through the utilization of Travis County and its health plan members.","rationale":"The agenda backup states the PBM passes through 100% of all monies received, which is a strong standard. It earns a partial score because the executed agreement is missing, making it impossible to verify quarterly payment timing and the absence of excludable claims.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"NAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup mentions a partnership with Costco for mail and specialty pharmacies but does not include the contract language necessary to verify if affiliate pharmacies are priced at acquisition cost.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"CEIL","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and does not address benchmark ceilings or cheapest lawful option pricing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"CASH","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The document does not mention cash price protections or whether cash purchases count toward the deductible.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"MAC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Although MAC pricing is mentioned in the summary tables, the lack of the base agreement means MAC list governance rules and appeals paths are completely missing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"SPRD","verdict":"good","confidence":0.9,"page_ref":"Page 10","evidence_quote":"agreed to a complete pass-\nthrough of all pharmacy discounts, which includes no spread pricing on retail, mail or specialty pharmacy.","rationale":"The backup memo explicitly states there is no spread pricing on retail, mail, or specialty pharmacy. While the base agreement is missing, the plan also pays a fully disclosed administrative fee, meeting the standard for transparent pricing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"GPO","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"There is no mention of group purchasing organizations or the pass-through of purchasing entity revenues in this backup memorandum.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"FORM","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The memo mentions the PBM's flexibility through formulary management but lacks the executed agreement to confirm if the plan sponsor has final approval control over the formulary.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"LNC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not address lowest net cost standards or book of business comparisons.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"NET","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The text notes the PBM contracts directly with pharmacies but the executed contract is needed to verify protections like any willing pharmacy and anti-steering rules.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"MFN","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Most favored nation pricing and market check rights are not addressed in the provided summary documents.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"AUD","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Because the executed agreement is missing, audit rights, claims-level data access, and reporting schedules are not detailed.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"DATA","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The subject of data ownership is not addressed in the agenda backup memorandum.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"PERF","verdict":"partial","confidence":0.85,"page_ref":"Page 10","evidence_quote":"Envision included substantial performance guarantee monies for the performance and service of the plan.","rationale":"The agenda backup mentions substantial performance guarantee monies and a spend reduction guarantee. It earns a partial score because the full contract is not provided, making it impossible to check if guarantees are reconciled in cash without caps.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"ENF","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"Self-executing enforcement and two strikes exit rights are not addressed in the summary memorandum.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"AMD","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The executed agreement is absent, so rules regarding how amendments are processed are missing.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"TERM","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The backup memo states the contract term but lacks the underlying agreement to show termination rights and penalties.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"SPEC","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"While the memo mentions a partnership with Costco for specialty pharmacy and no spread pricing, the executed agreement is missing and specific specialty drug pricing controls and functional definitions are not provided.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Gemini 3.1 Pro","rubric_key":"GAG","verdict":"missing","confidence":0.95,"page_ref":null,"evidence_quote":null,"rationale":"The agenda backup does not contain the executed agreement and does not address confidentiality. It is impossible to determine if the final contract contains gag clauses.","model_own_total":15.5,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"FID","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The eighteen page agenda backup never states that Envision owes duties of loyalty or care solely to Travis County or its members, must disclose conflicts, or must disgorge amounts retained in breach. Pages 8 through 11 and 16 through 17 describe the award, AWP rates, rebates, and a PEPM fee, not a fiduciary standard. Because the executed agreement is not in this file, a loyalty duty cannot be scored from contract text.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"DISC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Pages 10 and 11 list proposed AWP discounts, dispensing fees, rebate minimums, and a $3.50 PEPM administrative fee, and page 17 says Envision will accept only that PEPM fee. There is no covenant requiring disclosure of all related-entity compensation, affiliate ownership, or broker payments, and no named officer certification quarterly or annually. The backup also says additional fees are in the Contract that is not attached. Full compensation and conflict disclosure as required by the model contract of Mark Cuban and collaborators is not in this packet.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"OWN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No signed ownership exhibit appears in the eighteen pages. Page 10 mentions a Costco partnership for mail and specialty but does not list owners, parents, subsidiaries, affiliates, group purchasing organizations, or rebate aggregators, and does not require a refresh within 30 days after a change in control. The award memos and Gallagher notes on pages 8 through 11 and 16 through 18 do not fill that gap.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"DEF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"The backup has no definitions article. Pages 10 and 11 use rebates, 100% Pass-Through, MAC, and Brand as table labels without defining manufacturer revenue, affiliate, specialty, or generic by economic function. Staff language on page 10 about all monies received or earned is a narrative claim, not a closed definition. Verdict depends on the missing agreement.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"PASS","verdict":"partial","confidence":0.84,"page_ref":"Page 17","evidence_quote":"Envision will put in writing that they will only accept their per employee/per month fee and not accept any other monies associated with the prescription drug spend of Travis County.","rationale":"HRMD on page 10 says Envision has agreed in contracts to pass through 100% of all monies received or earned through Travis County utilization, and Gallagher on page 17 says Envision will put in writing that it will accept only its PEPM fee. Page 11 labels retail and mail rebate management as 100% Pass-Through and states brand rebate minimums of $17.35 and $66.60. That is weaker than the model because this is agenda backup rather than the executed agreement, payment timing and a closed exclusion list are not stated, and additional fees are said to live in the unattached Contract.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"NAC","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Nothing on pages 8 through 11 prices Envision-related or Costco mail or specialty claims at net acquisition cost plus a stated dispensing fee. The Costco partnership and no-spread sentence on page 10 address discounts, not acquisition-cost invoicing or a documentation default if records are not produced. Affiliate acquisition-cost terms are not in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"CEIL","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"The rate tables on pages 10 and 11 are AWP discounts and dispensing fees. There is no claim-by-claim ceiling against a published cash price or other public benchmark. Pages 1 through 18 do not mention a cheapest lawful option test.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"CASH","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Member cash price, deductible credit for cash purchases, and accumulator treatment of manufacturer assistance are not discussed on any page. The PBM recommendation on pages 8 through 11 and the Gallagher notes on pages 16 through 17 address plan cost and rebates, not what a member pays at the counter versus cash. Those protections would have to appear in the missing agreement.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"MAC","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 shows current generic pricing as MAC and proposed generic pricing as AWP-74.5%, and page 11 shows mail generic moving from MAC Pricing to AWP-79.00%. That is a change in the pricing index, not MAC list governance. There is no single list for plan and pharmacy, no disclosure schedule, and no pharmacy appeals path in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"SPRD","verdict":"partial","confidence":0.83,"page_ref":"Page 10","evidence_quote":"no spread pricing on retail, mail or specialty pharmacy.","rationale":"Page 10 states Envision agreed to a complete pass through of all pharmacy discounts, including no spread pricing on retail, mail or specialty, and page 17 says Envision will accept only the PEPM fee. Those terms move toward the model, but the same pages present AWP guarantee tables as the cost structure and warn that additional fees are included in the Contract that is not attached. Without executed adjudication language that the County pays exactly what pharmacies are paid, spread cannot be ruled out.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"GPO","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Group purchasing organizations, offshore aggregators, volume credits, and supplier payments to related purchasing entities are not named on any page. Pages 10, 11, and 17 discuss rebates and all monies in general terms, which is not a GPO pass-through clause. The missing agreement would have to supply that.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"FORM","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Pages 2 and 10 praise Envision flexibility through formulary management to meet County needs. That is PBM-side flexibility, not a rule that Travis County approves the formulary and every change or receives lowest-net-cost analysis and quarterly utilization management outcomes. No formulary control clause appears in the backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"LNC","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"No lowest-net-cost standard, book of business comparison, or disclosure of drugs placed above a cheaper equivalent appears on pages 8 through 11 or 16 through 18. Formulary is mentioned only as Envision flexibility on pages 2 and 10. The executed agreement is not in the file.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"NET","verdict":"partial","confidence":0.8,"page_ref":"Page 10","evidence_quote":"They also have the option for health plan members to fill 90-day prescriptions at retail locations instead of requiring the use of the mail-order service.","rationale":"Page 10 says Envision has over 67,000 retail pharmacies, contracts directly rather than using rental networks, and lets members fill 90-day prescriptions at retail instead of requiring mail order. Those are network access points, but the backup has no claims-final rule, no ban on retroactive clawbacks, and no any-willing-pharmacy term. It also does not forbid steering to a preferred mail or specialty pharmacy such as the Costco partnership described on that page.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"MFN","verdict":"missing","confidence":0.92,"page_ref":null,"evidence_quote":null,"rationale":"Pages 8 through 11 and 16 through 18 contain no most favored customer, comparable client, or annual market check with a meet, credit, or release remedy. The 9.5% spend reduction guarantee on pages 2 and 10 is a savings promise, not an MFN. Market-check rights are not in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"AUD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 9 lists reporting and claim-level repricing as RFP evaluation criteria, and page 10 says Envision completed a one-time re-pricing of prior year claims. That is the procurement process, not a continuing right for the County to audit with its own auditor, receive claims-level financial data on a schedule, or obtain pre-adjudication access. No audit article is in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"DATA","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"Page 10 says Envision and UHC will integrate Rx data with medical data for case management. That is data sharing, not County ownership of claims, eligibility, accumulator, rebate, or derived data, and it does not bar Envision from reusing or selling the data. Ownership language is not in the packet.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"PERF","verdict":"partial","confidence":0.82,"page_ref":"Page 10","evidence_quote":"In addition to service guarantees, Envision is proposing a 9.5% spend reduction guarantee over the current pharmacy costs.","rationale":"Pages 2 and 10 state that Envision included substantial performance guarantee monies and is proposing a 9.5% spend reduction guarantee over current pharmacy costs. Page 11 adds retail and mail brand rebate minimums of $17.35 and $66.60 per Brand Rx. The backup does not say guarantees are measured quarterly on plan-specific data, paid in cash, or uncapped dollar for dollar, and the guarantee exhibit is not attached.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"ENF","verdict":"missing","confidence":0.9,"page_ref":null,"evidence_quote":null,"rationale":"No liquidated damages, automatic credits, two-strikes exit, or termination for a second material breach or integrity failure appears in the eighteen pages. Pages 3 and 16 state term length only. Self-executing enforcement is not in this backup.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"AMD","verdict":"missing","confidence":0.88,"page_ref":null,"evidence_quote":null,"rationale":"Page 3 labels the award Annual, Unilateral, but that is a purchasing classification, not a clause that amendments are effective only if signed by both parties. Nothing on pages 8 through 18 stops midterm economic changes by notice or exhibit. The executed amendment article is not here.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"TERM","verdict":"missing","confidence":0.86,"page_ref":null,"evidence_quote":null,"rationale":"Page 16 states a three year term from October 1, 2014 ending 12:00 a.m. on September 31, 2017, unless changed by Travis County. Page 3 separately lists a one year period through September 30, 2015. Neither passage grants termination for convenience without penalty, preservation of earned amounts, or a regulatory integrity exit.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"SPEC","verdict":"partial","confidence":0.8,"page_ref":"Page 10","evidence_quote":"partnership with Costco for mail and specialty pharmacy","rationale":"Page 10 includes specialty in the no-spread promise and names a Costco partnership for mail and specialty pharmacy. The rate tables on pages 10 and 11 have retail, 90-day retail, and mail rows but no specialty drug-level rates, no functional definition of specialty, and no acquisition-cost rule for affiliated specialty pharmacies. Specialty is addressed only at that high level in this backup, not in an executed specialty exhibit.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"},{"contract_public_id":"TX-PBM-0010","contract_slug":"travis-county-envision-2014","entity":"Travis County","vendor":"Envision Pharmaceutical Services, LLC","model":"Grok 4.6","rubric_key":"GAG","verdict":"missing","confidence":0.85,"page_ref":null,"evidence_quote":null,"rationale":"The eighteen pages are open agenda backup with no confidentiality, trade secret, or pharmacy gag clause. Because this is not the executed agreement, whether the contract restricts the County from sharing pricing or rebate data, or restricts pharmacies from telling members about cheaper options, cannot be determined from this file. Nothing here is redacted. The verdict depends on contract language the backup does not contain.","model_own_total":16,"model_own_grade":"Red flag","rubric_version":2,"reviewed_at":"2026-09-05T00:00:00+00:00"}],"license":"Public record. Attribution appreciated: BetterBuy Rx PBM Commons, betterbuyrx.com/commons"}